Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            to            

Commission file number 000-30684

 

 

 

LOGO

OCLARO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   20-1303994

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

2560 Junction Avenue, San Jose, California 95134

(Address of principal executive offices, zip code)

(408) 383-1400

(Registrant’s telephone number, including area code)

 

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days:     Yes   x     No   ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   x     No   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨   (Do not check if a smaller reporting company)    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act):    Yes   ¨     No   x

51,481,012 shares of common stock outstanding as of May 4, 2012

 

 

 


Table of Contents

OCLARO, INC.

TABLE OF CONTENTS

 

          Page  
   PART I. FINANCIAL INFORMATION   

Item 1.

  

Financial Statements (Unaudited):

  
  

Condensed Consolidated Balance Sheets as of March 31, 2012 and July 2, 2011

     3   
  

Condensed Consolidated Statements of Operations for the three and nine months ended March 31, 2012 and April 2, 2011

     4   
  

Condensed Consolidated Statements of Cash Flows for the nine months ended March 31, 2012 and April 2, 2011

     5   
  

Notes to Condensed Consolidated Financial Statements

     6   

Item 2.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     21   

Item 3.

  

Quantitative and Qualitative Disclosures About Market Risk

     31   

Item 4.

  

Controls and Procedures

     32   
   PART II. OTHER INFORMATION   

Item 1.

   Legal Proceedings      33   

Item 1A.

   Risk Factors      34   

Item 6.

   Exhibits      52   

Signature

     52   


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited)

OCLARO, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

     March 31,
2012
    July 2,
2011
 
     (Thousands, except par value)  
ASSETS   

Current assets:

    

Cash and cash equivalents

   $ 50,543      $ 62,783   

Restricted cash

     595        574   

Accounts receivable, net

     61,723        82,868   

Inventories

     72,671        102,201   

Prepaid expenses and other current assets

     11,717        16,495   

Assets held for sale

     20,296        —     
  

 

 

   

 

 

 

Total current assets

     217,545        264,921   
  

 

 

   

 

 

 

Property and equipment, net

     59,492        69,374   

Other intangible assets, net

     17,453        19,698   

Goodwill

     10,904        10,904   

Other non-current assets

     12,549        10,277   
  

 

 

   

 

 

 

Total assets

   $ 317,943      $ 375,174   
  

 

 

   

 

 

 
LIABILITIES AND STOCKHOLDERS’ EQUITY     

Current liabilities:

    

Accounts payable

   $ 48,710      $ 66,179   

Accrued expenses and other liabilities

     48,646        60,703   

Line of credit payable

     25,500        —     
  

 

 

   

 

 

 

Total current liabilities

     122,856        126,882   
  

 

 

   

 

 

 

Deferred gain on sale-leaseback

     12,098        12,920   

Other non-current liabilities

     6,351        6,277   
  

 

 

   

 

 

 

Total liabilities

     141,305        146,079   
  

 

 

   

 

 

 

Commitments and contingencies (Note 9)

    

Stockholders’ equity:

    

Preferred stock: 1,000 shares authorized; none issued and outstanding

     —          —     

Common stock: $0.01 par value per share; 90,000 shares authorized; 51,480 and 50,476 shares issued and outstanding at March 31, 2012 and July 2, 2011, respectively

     515        505   

Additional paid-in capital

     1,328,703        1,313,931   

Accumulated other comprehensive income

     36,063        40,730   

Accumulated deficit

     (1,188,643     (1,126,071
  

 

 

   

 

 

 

Total stockholders’ equity

     176,638        229,095   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 317,943      $ 375,174   
  

 

 

   

 

 

 

The accompanying notes form an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

OCLARO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
    April 2,
2011
    March 31,
2012
    April 2,
2011
 
     (Thousands, except per share amounts)  

Revenues

   $ 88,709      $ 115,681      $ 281,018      $ 357,327   

Cost of revenues

     75,021        87,269        232,422        258,346   
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     13,688        28,412        48,596        98,981   

Operating expenses:

        

Research and development

     15,045        17,220        49,736        46,627   

Selling, general and administrative

     14,889        16,087        46,848        46,049   

Amortization of intangible assets

     775        722        2,224        2,080   

Restructuring, acquisition and related costs

     2,189        1,019        3,643        2,592   

Flood-related (income) expense, net

     (3,267     —          5,821        —     

Legal settlements

     —          —          —          1,678   

(Gain) loss on sale of property and equipment

     (13     4        84        (65
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     29,618        35,052        108,356        98,961   
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss)

     (15,930     (6,640     (59,760     20   

Other income (expense):

        

Interest income (expense), net

     (303     (487     (705     (1,523

Gain (loss) on foreign currency translation, net

     (261     (2,032     2,429        (6,738

Other income

     —          —          2,238        —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other income (expense)

     (564     (2,519     3,962        (8,261
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss before income taxes

     (16,494     (9,159     (55,798     (8,241

Income tax provision

     668        668        6,774        1,443   
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss

   $ (17,162   $ (9,827   $ (62,572   $ (9,684
  

 

 

   

 

 

   

 

 

   

 

 

 

Net loss per share:

        

Basic

   $ (0.34   $ (0.20   $ (1.25   $ (0.20

Diluted

   $ (0.34   $ (0.20   $ (1.25   $ (0.20

Shares used in computing net loss per share:

        

Basic

     50,814        48,587        50,251        48,321   

Diluted

     50,814        48,587        50,251        48,321   

The accompanying notes form an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

OCLARO, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

     Nine Months Ended  
     March 31,
2012
    April 2,
2011
 
     (Thousands)  

Cash flows from operating activities:

  

Net loss

   $ (62,572   $ (9,684

Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

    

Amortization of deferred gain on sale-leaseback

     (694     (693

Depreciation and amortization

     16,597        12,788   

Adjustment in fair value of earnout obligation

     (2,158     —     

Flood-related non-cash losses

     7,905        —     

Stock-based compensation expense

     4,930        4,629   

Other non-cash and operating activities adjustments

     (4,101     (65

Changes in operating assets and liabilities:

  

Accounts receivable, net

     21,381        6,817   

Inventories

     9,665        (17,908

Prepaid expenses and other current assets

     822        (1,018

Other non-current assets

     (73     141   

Accounts payable

     (16,957     10,204   

Accrued expenses and other liabilities

     1,335        (3,792
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     (23,920     1,419   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property and equipment

     (15,883     (32,881

Proceeds from sales of property and equipment

     —          75   

Proceeds from sale of assets

     2,900        —     

Proceeds from sales of investments

     3,438        —     

Transfers (to) from restricted cash

     (39     3,703   

Cash paid for acquisition

     —          (10,482
  

 

 

   

 

 

 

Net cash used in investing activities

     (9,584     (39,585
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from issuance of common stock, net

     71        2,645   

Proceeds from borrowings under line of credit

     25,500        —     
  

 

 

   

 

 

 

Net cash provided by financing activities

     25,571        2,645   
  

 

 

   

 

 

 

Effect of exchange rate on cash and cash equivalents

     (4,307     3,196   

Net decrease in cash and cash equivalents

     (12,240     (32,325

Cash and cash equivalents at beginning of period

     62,783        107,176   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 50,543      $ 74,851   
  

 

 

   

 

 

 

Supplemental disclosures of non-cash transactions:

    

Issuance of common stock to settle Xtellus escrow liability

   $ 7,000      $ —     

Issuance of common stock to settle Mintera earnout liability

   $ 2,758      $ —     

The accompanying notes form an integral part of these condensed consolidated financial statements.

 

5


Table of Contents

OCLARO, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1. BASIS OF PRESENTATION

Oclaro, Inc., a Delaware corporation, is sometimes referred to in this Quarterly Report on Form 10-Q as “Oclaro,” “we,” “us” or “our.” The accompanying unaudited condensed consolidated financial statements of Oclaro as of March 31, 2012 and for the three and nine months ended March 31, 2012 and April 2, 2011 have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) for interim financial information and with the instructions to Article 10 of Securities and Exchange Commission (SEC) Regulation S-X, and include the accounts of Oclaro and all of our subsidiaries. Accordingly, they do not include all of the information and footnotes required by such accounting principles for annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of our consolidated financial position and results of operations have been included. The condensed consolidated results of operations for the three and nine months ended March 31, 2012 are not necessarily indicative of results that may be expected for any other interim period or for the full fiscal year ending June 30, 2012.

The condensed consolidated balance sheet as of July 2, 2011 has been derived from our audited financial statements as of such date, but does not include all disclosures required by U.S. GAAP. These unaudited condensed consolidated financial statements should be read in conjunction with our audited financial statements included in our Annual Report on Form 10-K for the year ended July 2, 2011 (2011 Form 10-K).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenue and expenses during the reported periods. These judgments can be subjective and complex, and consequently, actual results could differ materially from those estimates and assumptions. Descriptions of some of the key estimates and assumptions are included in our 2011 Form 10-K.

For presentation purposes, we have reclassified certain prior period amounts to conform to the current period financial statement presentation. These reclassifications did not affect our consolidated net loss, cash flows, cash and cash equivalents or stockholders’ equity as previously reported. On March 19, 2012, we entered into a definitive agreement to sell certain assets to Venture Corporation Limited (Venture). The assets to be transferred to Venture within the next 12 months are classified as assets held for sale within current assets on the condensed consolidated balance sheet at March 31, 2012. We have also committed to a plan to market and sell our building in Shenzhen, China. The building’s carrying value is classified in assets held for sale within our condensed consolidated balance sheet as of March 31, 2012.

 

NOTE 2. RECENT ACCOUNTING PRONOUNCEMENTS

In December 2011, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2011-11, Disclosures about Offsetting Assets and Liabilities, which requires us to disclose gross information and net information about instruments and transactions eligible for offset in the statement of financial position. ASU No. 2011-11 will be effective for our fiscal year beginning on June 30, 2013. The adoption of this update will require a change in the format of our current presentation.

In September 2011, the FASB issued ASU No. 2011-09, which updates Accounting Standards Codification (ASC) Subtopic 715-80, Compensation – Retirement Benefits – Multiemployer Plans, enhancing disclosures by requiring transparency about the nature of the commitments and risks involved in participating in multiemployer pension plans. ASU No. 2011-09 will be effective for our fiscal year ending June 30, 2012. The adoption of this update will require certain additional disclosures.

 

6


Table of Contents

In June 2011, the FASB issued ASU No. 2011-05, an amendment to ASC Topic 220, Comprehensive Income , which amends current comprehensive income guidance. ASU No. 2011-05 eliminates the option to present the components of other comprehensive income as part of our statement of stockholders’ equity. Instead, we must report comprehensive income in either a single continuous statement of comprehensive income that contains two sections, net income and other comprehensive income, or in two separate but consecutive statements. ASU No. 2011-05 will be effective for our fiscal year beginning July 1, 2012. The adoption of this update will require a change in the format of our current presentation.

 

NOTE 3. FAIR VALUE MEASUREMENTS

We define fair value as the estimated price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk. We apply the following fair value hierarchy, which ranks the quality and reliability of the information used to determine fair values:

 

Level 1   –

   Quoted prices in active markets for identical assets or liabilities.

Level 2   –

   Inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices of identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets), or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3   –

   Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.

Our cash equivalents and non-current marketable securities are generally classified within Level 1 or Level 2 of the fair value hierarchy because they are valued using quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency. The types of instruments valued based on quoted market prices in active markets include most marketable securities and money market securities. Such instruments are generally classified within Level 1 of the fair value hierarchy. The types of instruments valued based on other observable inputs are foreign currency forward exchange contracts. Such instruments are generally classified within Level 2 of the fair value hierarchy.

During the eighteen month period ending January 20, 2012, we classified the earnout obligations arising from our acquisition of Mintera Corporation (Mintera) within Level 3 of the fair value hierarchy because their values were primarily derived from management estimates of future operating results. At March 31, 2012, the remaining earnout obligations were classified within Level 2 of the fair value hierarchy as the amounts to be paid were fixed based on sales of Mintera products through the eighteen month period ended January 20, 2012. See Note 4, Business Combinations , for additional details regarding these earnout obligations.

We have a defined benefit pension plan in Switzerland whose assets are classified within Level 1 of the fair value hierarchy for plan assets of cash, equity investments and fixed income investments, and Level 3 of the fair value hierarchy for plan assets of real estate and alternative investments. These pension plan assets are not reflected in the accompanying condensed consolidated balance sheets, and are thus not included in the following tables.

 

7


Table of Contents

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at fair value are shown in the table below by their corresponding balance sheet caption and consisted of the following types of instruments at March 31, 2012:

 

     Fair Value Measurement at Reporting Date Using  
     Quoted Prices
in Active
Markets for
Identical Assets
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (Thousands)  

Assets:

  

Cash and cash equivalents:

           

Money market funds

   $ 16,001       $ —         $ —         $ 16,001   

Other non-current assets:

           

Marketable securities

     109         —           —           109   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total assets measured at fair value

   $ 16,110       $ —         $ —         $ 16,110   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities:

  

Accrued expenses and other liabilities:

           

Earnout obligation for Mintera acquisition

   $ —         $ 10,760       $ —         $ 10,760   

Unrealized gain on currency instruments designated as cash flow hedges

     —           65         —           65   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total liabilities measured at fair value

   $ —         $ 10,825       $ —         $ 10,825   
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table provides details regarding the changes in accrued expenses and other liabilities classified within Level 3 from July 2, 2011 to March 31, 2012:

 

     Accrued Expenses
and Other
Liabilities
 
     (Thousands)  

Balance at July 2, 2011

   $ 16,140   

Fair value adjustment to Mintera earnout obligations

     (2,158

Payouts related to Mintera 12 month earnout obligation

     (3,306

Interest expense on Mintera 18 month earnout obligation

     84   

Transfer of Mintera 18 month earnout obligation to Level 2 in January 2012

     (10,760
  

 

 

 

Balance at March 31, 2012

   $ —     
  

 

 

 

Derivative Financial Instruments

At the end of each accounting period, we mark-to-market all foreign currency forward exchange contracts that have been designated as cash flow hedges and changes in fair value are recorded in accumulated other comprehensive income until the underlying cash flows are settled and the contracts are recognized in other income (expense) in our condensed consolidated statements of operations. As of March 31, 2012, we held six outstanding foreign currency forward exchange contracts to sell U.S. dollars and buy U.K. pounds sterling. All of these contracts have been designated as cash flow hedges. These contracts had an aggregate notional value of approximately $4.0 million of put and call options which expire, or expired, at various dates ranging from April 2012 through September 2012. To date, we have not entered into any such contracts for longer than 12 months and, accordingly, all amounts included in accumulated other comprehensive income as of March 31, 2012 will generally be reclassified into other income (expense) within the next 12 months. As of March 31, 2012, each of the six designated cash flow hedges were determined to be fully effective; therefore, we recorded an unrealized gain of $0.1 million to accumulated other comprehensive income related to recording the fair value of these foreign currency forward exchange contracts for accounting purposes.

 

8


Table of Contents
NOTE 4. BUSINESS COMBINATIONS

Merger with Opnext

On March 26, 2012, we entered into an Agreement and Plan of Merger and Reorganization (Merger Agreement), by and among Opnext, Inc. (Opnext), Tahoe Acquisition Sub, Inc., a newly formed wholly-owned subsidiary of Oclaro (Merger Sub) and Oclaro, pursuant to which Oclaro and Opnext will combine our businesses through a merger of Merger Sub with and into Opnext (Merger).

Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, by virtue of the Merger and without any action on the part of any stockholder, each outstanding share of common stock of Opnext, par value $0.01 per share, will be converted into the right to receive 0.42 of a share of common stock of Oclaro, par value $0.01 per share. Options to purchase Opnext common stock will be assumed by Oclaro pursuant to the terms of the Merger Agreement. Stock appreciation rights with respect to Opnext common stock and restricted stock units of Opnext will be converted into stock appreciation rights with respect to Oclaro common stock and restricted stock units of Oclaro pursuant to the terms described in the Merger Agreement.

Each of Opnext and Oclaro has made customary representations, warranties and covenants in the Merger Agreement. Consummation of the Merger is subject to customary conditions, including the adoption of the Merger Agreement by the stockholders of Opnext and the approval by the stockholders of Oclaro of the issuance of shares of Oclaro common stock and of a Certificate of Amendment to Oclaro’s Certificate of Incorporation in connection with the Merger. The Merger Agreement contains certain termination rights for both Opnext and Oclaro in certain circumstances, some of which would require Opnext or Oclaro to pay the other a termination fee of $6.0 million.

Asset Sale

In December 2011, we entered into an asset sale agreement to sell certain assets related to a legacy product, including inventory, equipment and intangibles, in exchange for $3.9 million of initial consideration plus potential earnout consideration, based on the purchaser’s revenues from the legacy product over a 15 month period following the closing date. As of March 31, 2012, we have received $2.9 million of the initial consideration

In the second fiscal quarter of 2012, we recorded a deferred gain of $1.3 million related to the sale of these assets and classified this amount in accrued expenses and other liabilities in our condensed consolidated balance sheet. In the third fiscal quarter of 2012, we completed the asset transfer and recognized a gain of $1.9 million within restructuring, acquisition and related costs in the condensed consolidated statements of operations. Earnout consideration, if any, will be recognized in the period it is reported to us as due, provided we believe cash collections are reasonably assured.

Acquisition of Mintera

In July 2010, we acquired Mintera. For accounting purposes, the initial fair value of consideration given in connection with the acquisition of Mintera was $25.6 million. This acquisition is more fully discussed in Note 3, Business Combinations , to our consolidated financial statements included in our 2011 Form 10-K.

Under the terms of this acquisition, we agreed to pay certain revenue-based consideration, whereby former security holders of Mintera are entitled to receive up to $20.0 million, determined based on a set of sliding scale formulas, to the extent revenue from Mintera products was more than $29.0 million in the 12 months following the acquisition and/or is more than $40.0 million in the 18 months following the acquisition. The earnout consideration is payable in cash or, at our option, newly issued shares of our common stock, or a combination of cash and stock.

During the three and nine months ended March 31, 2012, we reassessed the fair value of the earnout obligations, determining that the fair value of the obligations increased by $0.7 million during the three month period and decreased by $2.2 million during the nine month period. The $0.7 million increase in fair value during the three months ended March 31, 2012 and the $2.2 million decrease in fair value during the nine months ended March 31, 2012 were recorded within restructuring, acquisition and related expenses in the condensed consolidated statements of operations.

 

9


Table of Contents

In October 2011, we settled the 12 month earnout obligation with the former security holders by paying them $0.5 million in cash and issuing 0.8 million shares of our common stock valued at $2.8 million.

At March 31, 2012, we determined the fair value of the 18 month earnout obligation to be fixed at $10.8 million based on sales of Mintera products during the eighteen month period ended January 20, 2012. We recorded the $10.8 million in accrued expenses and other liabilities in our condensed consolidated balance sheet. We intend to settle the remaining earnout obligation of $10.8 million in cash during the fourth quarter of fiscal 2012.

During the three and nine months ended March 31, 2012, we recorded minimal amounts in interest expense related to the earnout obligations. During the three and nine months ended April 2, 2011, we recorded $0.3 million and $0.7 million, respectively, in interest expense related to the earnout obligations.

 

NOTE 5. BALANCE SHEET DETAILS

The following table provides details regarding our cash and cash equivalents at the dates indicated:

 

     March 31,
2012
     July 2,
2011
 
     (Thousands)  

Cash and cash equivalents:

     

Cash-in-bank

   $ 34,542       $ 42,585   

Money market funds

     16,001         20,198   
  

 

 

    

 

 

 
   $ 50,543       $ 62,783   
  

 

 

    

 

 

 

The following table provides details regarding our inventories at the dates indicated:

 

     March 31,
2012
     July 2,
2011
 
     (Thousands)  

Inventories:

     

Raw materials

   $ 18,064       $ 38,863   

Work-in-process

     39,447         37,084   

Finished goods

     15,160         26,254   
  

 

 

    

 

 

 
   $ 72,671       $ 102,201   
  

 

 

    

 

 

 

The following table provides details regarding our assets held for sale at the dates indicated:

 

     March 31,
2012
     July 2,
2011
 
     (Thousands)  

Assets held for sale:

     

Building

   $ 5,296       $ —     

Property and equipment

     2,500         —     

Inventory

     12,500         —     
  

 

 

    

 

 

 
   $ 20,296       $ —     
  

 

 

    

 

 

 

On March 19, 2012, we entered into a definitive agreement with Venture to transfer our Shenzhen, China final assembly and test operations in a phased and gradual transfer of products over the next three years. As part of this transfer, we also entered into a definitive Equipment and Inventory Purchase Agreement with Venture and their affiliates to sell certain equipment and inventory. We anticipate that we will transfer at least $15.0 million in equipment and inventory to Venture within the next 12 months, and have classified this amount as assets held for sale within our condensed consolidated balance sheet as of March 31, 2012.

We have also committed to a plan to market and sell our building in Shenzhen, China. The building’s carrying value of $5.3 million is classified in assets held for sale within our condensed consolidated balance sheet as of March 31, 2012.

 

10


Table of Contents

The following table provides details regarding our property and equipment, net at the dates indicated:

 

     March 31, 2012     July 2, 2011  
     (Thousands)  

Property and equipment, net:

  

Buildings

   $ 9,705      $ 17,640   

Plant and machinery

     136,985        149,120   

Fixtures, fittings and equipment

     1,807        1,802   

Computer equipment

     13,873        14,235   
  

 

 

   

 

 

 
     162,370        182,797   

Less: Accumulated depreciation

     (102,878     (113,423
  

 

 

   

 

 

 
   $ 59,492      $ 69,374   
  

 

 

   

 

 

 

As noted above, certain equipment to be sold to Venture, along with our building in Shenzhen, China, have been reclassified from property and equipment, net to assets held for sale within our condensed consolidated balance sheet as of March 31, 2012.

The following table presents details regarding our accrued expenses and other liabilities at the dates indicated:

 

     March 31, 2012      July 2, 2011  
     (Thousands)  

Accrued expenses and other liabilities:

  

Trade payables

   $ 7,139       $ 6,241   

Compensation and benefits related accruals

     8,719         11,097   

Warranty accrual

     2,679         2,175   

Escrow liability for Xtellus acquisition

     —           7,000   

Earnout liability for Mintera acquisition

     10,760         16,140   

Other accruals

     19,349         18,050   
  

 

 

    

 

 

 
   $ 48,646       $ 60,703   
  

 

 

    

 

 

 

The following table presents the components of accumulated other comprehensive income at the dates indicated:

 

     March 31, 2012     July 2, 2011  
     (Thousands)  

Accumulated other comprehensive income:

  

Currency translation adjustments

   $ 38,916      $ 43,536   

Unrealized gain on currency instruments designated as cash flow hedges

     65        54   

Unrealized loss on marketable securities

     (197     (139

Adjustment for Swiss defined benefit plan

     (2,721     (2,721
  

 

 

   

 

 

 
   $ 36,063      $ 40,730   
  

 

 

   

 

 

 

 

NOTE 6. FLOOD-RELATED (INCOME) EXPENSE, NET

In October 2011, certain areas in Thailand suffered major flooding as a result of monsoons. This flooding had a material impact on our business and results of operations. Our primary contract manufacturer, Fabrinet, suspended operations at two factories located in Chokchai, Thailand and Pinehurst, Thailand. The Chokchai factory suffered extensive flood damage and became inaccessible due to high water levels inside and surrounding the manufacturing facility. As a result of this flooding, we experienced a significant decline in product sales due to our inability or limited ability to manufacture certain Oclaro products and we incurred significant damage to our inventory and property and equipment located at the Chokchai facility.

 

11


Table of Contents

During the three and nine months ended March 31, 2012, we recorded impairment charges related to the write-off of the net book value of damaged inventory and property and equipment based on our current estimates of the damage caused by the flooding. These impairment charges are recorded within the operating expense caption flood-related (income) expense, net in our condensed consolidated statement of operations. Flood-related (income) expense, net for the three and nine months ended March 31, 2012 also includes personnel-related costs, professional fees and related expenses incurred in connection with our recovery efforts. We continue to evaluate our estimates of flood-related losses, and in future quarters we may record additional losses for damaged equipment and inventory.

On February 2, 2012, we received a $6.4 million advance payment from one of our insurers relating to losses we incurred due to the flooding in Thailand. This payment is a general advance from our insurer against all Thailand flood-related claims and was not specifically identified as reimbursement for any particular loss or claim. As there were no contingencies associated with this payment, we recorded this advance payment within flood related income (expense), net in our condensed consolidated statements of operations for the three and nine months ended March 31, 2012.

Flood-related (income) expense, net for the three and nine months ended March 31, 2012 included the following:

 

     Three Months Ended
March 31, 2012
    Nine Months Ended
March 31, 2012
 
     (Thousands)  

Write-off of net book value of damaged inventory

   $ —        $ 4,246   

Write-off of net book value of damaged property and equipment

     624        3,659   

Personnel-related costs, professional fees and related expenses

     2,474        4,281   

Advance payment from insurer

     (6,365     (6,365
  

 

 

   

 

 

 
   $ (3,267   $ 5,821   
  

 

 

   

 

 

 

While we maintain both property and business interruption insurance coverage, there can be no assurance as to the amount or timing of future insurance recoveries, or that we will be able to fully and timely resume production of each of our affected product lines. Insurance recoveries related to impairment losses previously recorded and other recoverable expenses will be recognized to the extent of the related loss or expense in the period that recoveries become probable and realizable. Insurance recoveries under business interruption coverage and insurance recovery gains in excess of amounts previously written-off related to impaired inventory and equipment or in excess of other recoverable expenses previously recognized will be recognized when they become realizable and all contingencies have been resolved. The evaluation of insurance recoveries requires estimates and judgments about future results which affect reported amounts and certain disclosures. Actual results could differ from those estimates. Insurance recoveries we receive in future periods will be recorded net of flood-related expense in the condensed consolidated statement of operations. As of March 31, 2012, we have not recorded any estimated amounts relating to potential future insurance recoveries in the condensed consolidated statement of operations.

 

NOTE 7. CREDIT AGREEMENT

On July 26, 2011, Oclaro Technology Ltd., as “Borrower,” and Oclaro, Inc., as “Parent,” entered into an amendment and restatement to our existing senior secured credit facility (the Credit Agreement) with Wells Fargo Capital Finance, Inc. and other lenders, increasing the facility size from $25 million to $45 million and extending the term thereof to August 1, 2014. This Credit Agreement is more fully discussed in Note 6, Credit Agreement , and Note 16, Subsequent Event , to our consolidated financial statements included in our 2011 Form 10-K.

 

12


Table of Contents

At March 31, 2012, there was $25.5 outstanding under the Credit Agreement with an average interest rate of 3.4 percent. As of March 31, 2012, we were in compliance with all covenants under the Credit Agreement. As of July 2, 2011, there were no amounts outstanding under the Credit Agreement. At March 31, 2012 and July 2, 2011, there were $0.1 million and $1.1 million, respectively, in outstanding standby letters of credit secured under the Credit Agreement. These letters of credit expire at various intervals through April 2014.

 

NOTE 8. POST-RETIREMENT BENEFITS

We have a pension plan covering employees of our Swiss subsidiary (the Swiss Plan). Net periodic pension costs associated with our Swiss Plan for the three and nine months ended March 31, 2012 and April 2, 2011 included the following:

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
    April 2,
2011
    March 31,
2012
    April 2,
2011
 
     (Thousands)  

Service cost

   $ 629      $ 447        1,870        1,302   

Interest cost

     216        188        641        547   

Expected return on plan assets

     (282     (248     (838     (721
  

 

 

   

 

 

   

 

 

   

 

 

 

Net periodic pension costs

   $ 563      $ 387      $ 1,673      $ 1,128   
  

 

 

   

 

 

   

 

 

   

 

 

 

During the three and nine months ended March 31, 2012, we contributed $0.3 million and $0.9 million, respectively, to our Swiss Plan. We currently anticipate contributing an additional $0.3 million to this pension plan during the remainder of fiscal year 2012.

 

NOTE 9. COMMITMENTS AND CONTINGENCIES

Guarantees

We indemnify our directors and certain employees as permitted by law, and have entered into indemnification agreements with our directors and executive officers. We have not recorded a liability associated with these indemnification arrangements, as we historically have not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that we maintain, however, such insurance may not cover any, or may cover only a portion of, the amounts we may be required to pay. In addition, we may not be able to maintain such insurance coverage in the future.

We also have indemnification clauses in various contracts that we enter into in the normal course of business, such as those issued by our bankers in favor of certain suppliers or indemnification in favor of customers in respect of liabilities they may incur as a result of purchasing our products should such products infringe the intellectual property rights of a third party. We have not historically paid out any material amounts related to these indemnifications, therefore, no accrual has been made for these indemnifications.

Warranty accrual

We generally provide a warranty for our products for twelve months from the date of sale. We accrue for the estimated costs to provide warranty services at the time revenue is recognized. Our estimate of costs to service our warranty obligations is based on historical experience and expectation of future conditions. To the extent we experience increased warranty claim activity or increased costs associated with servicing those claims, our warranty costs would increase, resulting in a decrease in gross profit.

 

13


Table of Contents

The following table summarizes movements in the warranty accrual for the periods indicated:

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
    April 2,
2011
    March 31,
2012
    April 2,
2011
 
     (Thousands)  

Warranty provision - beginning of period

   $ 2,430      $ 2,241      $ 2,175      $ 2,437   

Warranties assumed in acquisitions

     —          —          —          357   

Warranties issued

     627        450        1,925        1,326   

Warranties utilized or expired

     (444     (741     (1,410     (2,221

Currency translation adjustment

     66        60        (11     111   
  

 

 

   

 

 

   

 

 

   

 

 

 

Warranty provision - end of period

   $ 2,679      $ 2,010      $ 2,679      $ 2,010   
  

 

 

   

 

 

   

 

 

   

 

 

 

Litigation

Five putative class actions challenging the Merger have been filed in the Superior Court of the State of California in and for the County of Alameda: (1) Martin Zilberberg v. Charles J. Abbe, No RG12623460, on March 28, 2012; (2) Eleanor Welty v. Harry L. Bosco, Case No. RG12624240, on April 4, 2012; (3) Todd Wright v. Harry L. Bosco, Case No. RG12624343, on April 5, 2012; (4) Stephen Greenberg v. Charles J. Abbe, No. RG12624444, on April 5, 2012; and (5) Mark Graf v. Opnext, Inc., No. RG12624798, on April 9, 2012 (the Graf Action). Two putative class actions challenging the Merger have been filed in the Delaware Court of Chancery: Glenn Freedman v. Opnext, Inc., CA No. 7400-VCL, on April 5, 2012; and (2) Berger v. Bosco, No. 7406-VCL, on April 9, 2012. The two Delaware actions have been consolidated under the caption In re Opnext, Inc. Shareholders Litigation, C.A. No. 7400-VCL. The defendants in each case are Opnext, Inc. and the members of Opnext’s Board (collectively, the Opnext Defendants), Oclaro, Inc. and Tahoe Acquisition Sub, Inc. (collectively, the Oclaro Defendants). Each action alleges that the Opnext Defendants breached their fiduciary duties to Opnext stockholders by entering into the Merger Agreement. Each action further alleges that the Oclaro Defendants aided and abetted those breaches of fiduciary duties.

Among other relief, the plaintiff in each case seeks an order enjoining the Merger, and seeking attorneys’ fees. All of the actions except for the Graf Action seek damages and an accounting. Plaintiffs have served discovery in certain of these actions, but no trial date has been set in any of these actions. We believe that the claims asserted in each of these actions are without merit and intend to defend them vigorously. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

On May 19, 2011, Curtis and Charlotte Westley filed a purported class action complaint in the United States District Court for the Northern District of California, against us and certain of our officers and directors. The Court subsequently appointed the Connecticut Laborers’ Pension Fund (Pension Fund) as lead plaintiff for the putative class. On October 27, 2011, the Pension Fund filed an Amended Complaint, captioned as Westley v. Oclaro, Inc., No. 11 Civ. 2448 EMC, allegedly on behalf of persons who purchased our common stock between May 6 and October 28, 2010, alleging that defendants issued materially false and misleading statements during this time period regarding our current business and financial condition, including projections for demand for our products, as well as our revenues, earnings, and gross margins, for the first quarter of fiscal year 2011 as well as the full fiscal year. The complaint alleges violations of section 10(b) of the Securities Exchange Act and Securities and Exchange Commission Rule 10b-5, as well as section 20(a) of the Securities Exchange Act. The complaint seeks damages and costs of an unspecified amount. On December 12, 2011, defendants filed a motion to dismiss the complaint. That motion was granted with leave to file the amended complaint. Discovery has not commenced, and no trial has been scheduled in this action. We intend to defend this litigation vigorously. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

On June 10, 2011, a purported shareholder, Stanley Moskal, filed a purported derivative action in the Superior Court for the State of California, County of Santa Clara, against us, as nominal defendant, and certain of our current and former officers and directors, as defendants. The case is styled Moskal v. Couder, No. 1:11 CV 202880 (Santa Clara County Super. Ct. filed June 10, 2011). Four other purported shareholders, Matteo Guindani, Jermaine Coney,

 

14


Table of Contents

Jefferson Braman and Toby Aguilar, separately filed substantially similar lawsuits in the United States District Court for the Northern District of California on June 27, June 28, July 7 and July 26, 2011, respectively. By Order dated September 14, 2011, the Guindani, Coney, and Braman actions were consolidated under In re Oclaro, Inc. Derivative Litigation , Lead Case No. 11 Civ. 3176 EMC. On October 5, 2011, the Aguilar action was voluntarily dismissed. Each remaining purported derivative complaint alleges that Oclaro has been, or will be, damaged by the actions alleged in the Westley complaint, and the litigation of the Westley action, and any damages or settlement paid in the Westley action. Each purported derivative complaint alleges counts for breaches of fiduciary duty, waste, and unjust enrichment. Each purported derivative complaint seeks damages and costs of an unspecified amount, as well as injunctive relief. By Order dated November 23, 2011, the parties in the Moskal action agreed that defendants shall not be required to respond to the original complaint, that plaintiff would serve an amended complaint no later than March 9, 2012, and the stay of discovery would remain in effect until further order of the Court or agreement by the parties. By Order dated November 29, 2011, the parties to In re Oclaro, Inc. Derivative Litigation agreed to stay all proceedings, including motion practice and discovery, until such time as (a) the defendants file an answer to any complaint in the Westley Action; or (b) the Westley Action is dismissed in its entirety with prejudice. Discovery has not commenced, and no trial has been scheduled in any of these actions. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

 

NOTE 10. STOCKHOLDERS’ EQUITY

Comprehensive Income (Loss)

For the three and nine months ended March 31, 2012 and April 2, 2011, comprehensive income (loss) is primarily comprised of our net loss, changes in the unrealized gain on currency instruments designated as cash flow hedges, unrealized gain (loss) on marketable securities and currency translation adjustments. The components of comprehensive income (loss) were as follows for the periods indicated:

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
    April 2,
2011
    March 31,
2012
    April 2,
2011
 
     (Thousands)  

Net loss

   $ (17,162   $ (9,827   $ (62,572   $ (9,684

Other comprehensive income (loss):

        

Unrealized gain on currency instruments designated as cash flow hedges

     77        149        11        184   

Currency translation adjustments

     2,256        4,062        (4,620     11,454   

Unrealized gain (loss) on marketable securities

     3        (38     (58     (38
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

   $ (14,826   $ (5,654   $ (67,239   $ 1,916   
  

 

 

   

 

 

   

 

 

   

 

 

 

Warrants

The following table summarizes activity relating to warrants to purchase our common stock for the nine months ended March 31, 2012:

 

           Weighted-  
     Warrants     Average  
     Outstanding     Exercise Price  
     (Thousands)        

Balance at July 2, 2011

     1,398      $ 16.18   

Expired on September 1, 2011

     (580     20.00   

Expired on March 22, 2012

     (818     13.48   
  

 

 

   

Balance at March 31, 2012

     —       
  

 

 

   

 

15


Table of Contents

Common Stock

In December 2009, we acquired Xtellus, Inc. (Xtellus). As part of the consideration, we were obligated to pay $7.0 million in consideration to the former Xtellus stockholders after an 18 month escrow period. During the three months ended October 1, 2011, we settled the $7.0 million liability with the former Xtellus stockholders by transferring approximately 0.9 million shares of common stock held in escrow, valued at $7.0 million. The transfer of the shares resulted in a $7.0 million increase to our additional paid-in capital and a corresponding decrease to our accrued expenses and other liabilities. The balance of 0.1 million shares of common stock held in escrow were returned to us, retired and returned to the status of authorized but unissued common stock in September 2011.

In connection with our July 2010 acquisition of Mintera, we paid $0.5 million in cash and issued 0.8 million shares of our common stock valued at $2.8 million to settle our 12 month earnout obligation in October 2011. The transfer of the shares resulted in a $2.8 million increase to our additional paid-in capital and a corresponding decrease to our accrued expenses and other liabilities. See Note 4, Business Combinations .

 

NOTE 11. EMPLOYEE STOCK PLANS

Amended and Restated 2004 Stock Incentive Plan

We currently maintain the Amended and Restated 2004 Stock Incentive Plan (Plan). Under the Plan, there are a total of 7.8 million shares of common stock authorized for issuance, with full value awards being counted as 1.25 shares of common stock for purposes of the share limit. The Plan expires in October 2020.

As of March 31, 2012, there were approximately 2.6 million shares of our common stock available for grant under the Plan. We generally grant stock options that vest over a four year service period, and restricted stock awards and units that vest over a one to four year service period, and in certain cases each may vest earlier based upon the achievement of specific performance-based objectives as set by our board of directors.

In July 2011, our board of directors approved the grant of 0.2 million performance stock units (PSUs) to certain executive officers with an aggregate estimated grant date fair value of $0.9 million. These PSUs will be earned through June 30, 2013 based upon the achievement of certain revenue growth targets relative to certain comparable companies. Vesting is also contingent upon service conditions being met through August 2015. If the performance conditions are not achieved, then the corresponding PSUs will be forfeited in the first quarter of fiscal year 2014.

The following table summarizes the combined stock option and restricted stock activity under all of our equity incentive plans for the nine months ended March 31, 2012:

 

     Shares
Available
For Grant
    Stock
Options
Outstanding
    Weighted- Average
Exercise Price
     Restricted Stock
Awards / Units
Outstanding
    Weighted-
Average Grant
Date Fair Value
 
     (Thousands)     (Thousands)            (Thousands)        

Balances at July 2, 2011

     3,727        3,350      $ 9.38         799      $ 10.15   

Granted

     (1,178     468        4.18         568        4.21   

Granted - performance stock

     (250     —          —           200        4.33   

Exercised or released

     —          (43     2.13         (324     9.19   

Cancelled or forfeited

     296        (305     21.72         (214     9.88   
  

 

 

   

 

 

      

 

 

   

Balances at March 31, 2012

     2,595        3,470      $ 7.89         1,029      $ 6.04   
  

 

 

   

 

 

      

 

 

   

 

16


Table of Contents

Supplemental disclosure information about our stock options outstanding as of March 31, 2012 is as follows:

 

     Shares      Weighted-
Average
Exercise Price
     Weighted-
Average
Remaining
Contractual Life
     Aggregate
Intrinsic

Value
 
     (Thousands)             (Years)      (Thousands)  

Options exercisable at March 31, 2012

     2,055       $ 8.72         6.1       $ 915   

Options outstanding at March 31, 2012

     3,470       $ 7.89         7.0       $ 1,278   

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value, based on the closing price of our common stock of $3.94 on March 30, 2012, which would have been received by the option holders had all option holders exercised their options as of that date. There were approximately 0.7 million shares of common stock subject to in-the-money options which were exercisable as of March 31, 2012. We settle employee stock option exercises with newly issued shares of common stock.

2011 Employee Stock Purchase Plan

On October 26, 2011, our 2011 Employee Stock Purchase Plan (ESPP) was approved by our stockholders. Under the ESPP, we have reserved 1.7 million shares of our common stock for issuance. As of March 31, 2012, no shares have been issued under the ESPP and the full 1.7 million shares remain available for issuance. Our ESPP provides that eligible employees may contribute up to 15% of their eligible earnings toward the semi-annual purchase of our common stock. Participants may not purchase more than $25,000 worth of common stock in any calendar year or 15,000 shares in any offering period. The ESPP is qualified under Section 423 of the Internal Revenue Code. The ESPP became effective January 24, 2012, and our first six-month offering period (or the look-back period) began February 16, 2012 and will end on August 15, 2012.

The purchase price with respect to each offering period is equal to 85% of the lesser of (i) the fair market value of our common stock at the commencement of the applicable six-month offering period or (ii) the fair market value of our common stock on the purchase date (or, if not a trading day, on the immediately preceding trading day).

During the three and nine months ended March 31, 2012, we received $0.1 million from employees for the issuance of shares under the ESPP and the weighted-average fair value per share of each purchase right was $1.92.

 

NOTE 12. STOCK-BASED COMPENSATION

We recognize compensation expense in our statement of operations related to all share-based awards, including grants of stock options and purchase rights under our ESPP, based on the grant date fair value of such share-based awards. Estimating the grant date fair value of such share-based awards requires us to make judgments in the determination of inputs into the Black-Scholes stock option pricing model which we use to arrive at an estimate of the grant date fair value for such awards.

 

17


Table of Contents

The weighted-average assumptions used in this model to value stock option grants and purchase rights under the ESPP for the three and nine months ended March 31, 2012 and April 2, 2011 were as follows:

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
    April 2,
2011
    March 31,
2012
    April 2,
2011
 

Stock options:

        

Expected life

     4.8 years        4.5 years        4.8 years        4.5 years   

Risk-free interest rate

     0.9     1.9     1.0     1.3

Volatility

     89.6     97.8     92.1     96.8

Dividend yield

     —          —          —          —     

Purchase rights under ESPP:

        

Expected life

     0.5 years        —          0.5 years        —     

Risk-free interest rate

     0.1     —          0.1     —     

Volatility

     87.0     —          87.0     —     

Dividend yield

     —          —          —          —     

The amounts included in cost of revenues and operating expenses for stock-based compensation for the three and nine months ended March 31, 2012 and April 2, 2011 were as follows:

 

     Three Months Ended     Nine Months Ended  
     March 31,
2012
     April 2,
2011
    March 31,
2012
    April 2,
2011
 
     (Thousands)  

Stock-based compensation by category of expense:

         

Cost of revenues

   $ 460       $ 352      $ 1,157        1,012   

Research and development

     349         344        1,090        1,053   

Selling, general and administrative

     863         901        2,683        2,564   
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 1,672       $ 1,597      $ 4,930      $ 4,629   
  

 

 

    

 

 

   

 

 

   

 

 

 

Stock-based compensation by type of award:

         

Stock options

   $ 833       $ 988      $ 2,586        2,658   

Restricted stock awards

     652         639        2,264        2,109   

Purchase rights under ESPP

     104         —          104        —     

Inventory adjustment to cost of revenues

     83         (30     (24     (138
  

 

 

    

 

 

   

 

 

   

 

 

 
   $ 1,672       $ 1,597      $ 4,930      $ 4,629   
  

 

 

    

 

 

   

 

 

   

 

 

 

As of March 31, 2012 and July 2, 2011, we had capitalized approximately $0.4 million and $0.4 million, respectively, of stock-based compensation as inventory.

Included in stock-based compensation for the three and nine months ended March 31, 2012 is approximately $0.1 million and $0.1 million, respectively, in compensation cost related to the issuance of PSUs. As of March 31, 2012, we have determined that the achievement of the performance conditions associated with the PSUs is probable at 100 percent of the target level. The amount of stock-based compensation expense recognized in any one period can vary based on the achievement or anticipated achievement of the performance conditions. If the performance conditions are not met or not expected to be met, no compensation cost would be recognized on the underlying PSUs, and any previously recognized compensation expense related to those PSUs would be reversed.

 

18


Table of Contents
NOTE 13. INCOME TAXES

For the three and nine months ended March 31, 2012, our income tax provisions of $0.7 million and $6.8 million, respectively, primarily related to our foreign operations. During the nine months ended March 31, 2012, we recorded $4.1 million in income tax provision due to the impact of an impairment of certain net operating loss carryforwards in a foreign jurisdiction.

For the three and nine months ended April 2, 2011, our income tax provisions of $0.7 million and $1.4 million, respectively, primarily related to our foreign operations.

The total amount of our unrecognized tax benefits as of March 31, 2012 and July 2, 2011 were approximately $7.1 million and $6.9 million, respectively. For the three and nine months ended March 31, 2012, we had $2.0 million in unrecognized tax benefits that, if recognized, would affect our effective tax rate. We are currently under tax audit in France and Israel. We believe that an adequate provision has been made for any adjustments that may result from tax audits. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in our tax audits are resolved in a manner not consistent with our expectations, we could be required to adjust our income tax provision in the period such resolution occurs. Although timing of the resolution and/or closure of audits is not certain, we do not believe it is reasonably possible that our unrecognized tax benefits will materially change in the next 12 months.

 

NOTE 14. NET LOSS PER SHARE

Basic net income (loss) per share is computed using only the weighted-average number of shares of common stock outstanding for the applicable period, while diluted net income (loss) per share is computed assuming conversion of all potentially dilutive securities, such as stock options, unvested restricted stock awards, warrants and obligations under escrow agreements during such period.

For the three and nine months ended March 31, 2012, we excluded 4.2 million and 4.7 million, respectively, of outstanding stock options, warrants and restricted stock units from the calculation of diluted net loss per share because their effect would have been anti-dilutive. For the three and nine months ended April 2, 2011, we excluded 5.0 million and 4.7 million, respectively, of outstanding stock options, warrants and restricted stock units from the calculation of diluted net loss per share because their effect would have been anti-dilutive.

 

NOTE 15. GEOGRAPHIC AND CUSTOMER CONCENTRATION INFORMATION

Geographic Information

The following table shows revenues by geographic area based on the delivery locations of our products:

 

     Three Months Ended      Nine Months Ended  
     March 31,
2012
     April 2,
2011
     March 31,
2012
     April 2,
2011
 
     (Thousands)  

United States

   $ 14,861       $ 18,222       $ 47,716         55,778   

Canada

     2,283         3,838         9,927         10,022   

Europe

     19,329         30,744         67,517         101,027   

Asia

     46,590         58,558         139,444         169,220   

Rest of world

     5,646         4,319         16,414         21,280   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 88,709       $ 115,681       $ 281,018       $ 357,327   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

19


Table of Contents

S ignificant Customers and Concentration of Credit Risk

For the three months ended March 31, 2012, Fujitsu Limited (Fujitsu) accounted for 16 percent of our revenues. For the nine months ended March 31, 2012, Fujitsu accounted for 14 percent and Huawei Technologies Co., Ltd. (Huawei) accounted for 10 percent of our revenues.

For the three months ended April 2, 2011, Huawei accounted for 19 percent and Alcatel-Lucent accounted for 10 percent of our revenues. For the nine months ended April 2, 2011, Huawei accounted for 17 percent, Alcatel-Lucent accounted for 12 percent and Ciena accounted for 10 percent of our revenues.

As of March 31, 2012, Huawei accounted for 10 percent of our accounts receivable. As of July 2, 2011, no customer accounted for 10 percent or more of our accounts receivable.

 

20


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Quarterly Report on Form 10-Q and the documents incorporated herein by reference contain forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, about our future expectations, plans or prospects and our business. You can identify these statements by the fact that they do not relate strictly to historical or current events, and contain words such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “will,” “plan,” “believe,” “should,” “outlook,” “could,” “target” and other words of similar meaning in connection with discussion of future operating or financial performance. We have based our forward looking statements on our management’s beliefs and assumptions based on information available to our management at the time the statements are made. There are a number of important factors that could cause our actual results or events to differ materially from those indicated by such forward-looking statements, including (i) expectations related to our pending merger with Opnext, Inc., (ii) the impact to our operations and financial condition attributable to the flooding in Thailand and our ability to obtain insurance recoveries for claims related to such flooding, (iii) our ability to effectively and efficiently transition to an outsourced back-end assembly and test model over the next three years, and receive the expected benefits of our transaction with Venture Corporation Limited, (iv) the impact of continued uncertainty in world financial markets and any resulting or other reduction in demand for our products, (v) our ability to maintain our gross margin, (vi) our ability to respond to evolving technologies and customer requirements, (vii) our ability to develop and commercialize new products in a timely manner, (viii) our ability to protect our intellectual property rights and the resolution of allegations that we infringe the intellectual property rights of others, (ix) our dependence on a limited number of customers for a significant percentage of our revenues, (x) our ability to effectively compete with companies that have greater name recognition, broader customer relationships and substantially greater financial, technical and marketing resources than we do, (xi) the effect of fluctuating product mix, currency prices and consumer demand on our financial results, (xii) our performance following the closing of acquisitions and mergers, (xiii) our potential inability to realize the expected benefits and synergies from our acquisitions and mergers, including our merger with Opnext, Inc., (xiv) increased costs related to downsizing and compliance with regulatory requirements in connection with such downsizing, (xv) the impact of events beyond our control such as natural disasters, including additional information that will become available in the future regarding the impact of the flooding in Thailand on our results of operations, and political unrest, (xvi) the outcome of our currently pending litigation and future litigation that may be brought by or against us, (xvii) our ability to increase our cash reserves and the potential lack of availability of credit or opportunity for equity-based financing on terms acceptable to us and (xviii) the risks associated with our international operations. You should not place undue reliance on forward-looking statements. We cannot guarantee any future results, levels of activity, performance or achievements. Moreover, we assume no obligation to update forward-looking statements or update the reasons actual results could differ materially from those anticipated in forward-looking statements. Several of the important factors that may cause our actual results to differ materially from the expectations we describe in forward-looking statements are identified in the sections captioned “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in this Quarterly Report on Form 10-Q and the documents incorporated herein by reference.

OVERVIEW

We are a tier-one provider and innovator of high-performance core optical network components, modules and subsystems to global telecommunications (telecom) equipment manufacturers. We leverage our proprietary core technologies and vertically integrated product development to provide our customers with cost-effective and innovative optical solutions in metro and long-haul network applications. Increasingly, we have new opportunities with customers who are managing and building out wide area networks with certain characteristics common to telecom networks. In addition, we utilize our optical expertise to address new and emerging optical product opportunities in selective non-telecom markets, such as materials processing, consumer, medical, industrial, printing and biotechnology. In all markets, our approach is to offer a differentiated solution that is designed to make it easier for our customers to do business by combining optical technology innovation, photonic integration, and a vertically integrated approach to manufacturing and product development.

 

21


Table of Contents

RECENT DEVELOPMENTS

On March 26, 2012, we entered into an Agreement and Plan of Merger and Reorganization (Merger Agreement), by and among Opnext, Inc. (Opnext), Tahoe Acquisition Sub, Inc., a newly formed wholly owned subsidiary of Oclaro (Merger Sub) and Oclaro, pursuant to which Oclaro and Opnext will combine their businesses through a merger of Merger Sub with and into Opnext (Merger).

Pursuant to the terms of the Merger Agreement, at the effective time of the Merger, each share of common stock of Opnext will be converted into the right to receive 0.42 of a share of common stock of Oclaro. Options to purchase Opnext common stock will be assumed by Oclaro pursuant to the terms of the Merger Agreement. Stock appreciation rights with respect to Opnext common stock and restricted stock units of Opnext will be converted into stock appreciation rights with respect to Oclaro common stock and restricted stock units of Oclaro pursuant to the terms described in the Merger Agreement.

Each of Opnext and Oclaro has made customary representations, warranties and covenants in the Merger Agreement. Consummation of the Merger is subject to customary conditions, including the adoption of the Merger Agreement by the stockholders of Opnext and the approval by the stockholders of Oclaro of the issuance of shares of Oclaro common stock and of a Certificate of Amendment to Oclaro’s Certificate of Incorporation in connection with the Merger. The Merger Agreement contains certain termination rights for both Opnext and Oclaro in certain circumstances, some of which would require Opnext or Oclaro to pay the other a termination fee of $6.0 million.

On March 19, 2012, we entered into a definitive agreement with Venture Corporation Limited (Venture) to transfer our Shenzhen, China final assembly and test operations in a phased and gradual transfer of products over the next three years. As part of the transfer, we have entered into a five-year supply agreement, in which Venture will manufacture and supply us with certain products that were previously manufactured by us in our Shenzhen facility. We have also entered into an Equipment and Inventory Purchase Agreement with Venture and their affiliates, in which we will sell Venture certain of our equipment and inventory. We anticipate that we will transfer $15 million in equipment and inventory to Venture within the next 12 months. Over the transition period, the outsourcing activities associated with these agreements are expected to free up in excess of $35 million from lower working capital requirements, net of transition and employee retention costs. No guarantee can be provided that the corresponding transactions will result in the anticipated benefits, or that the transactions will result in us receiving the expected cash proceeds and the timing of receipt of such proceeds.

On March 28, 2012, shortly after announcing this agreement with Venture, certain of our employees in Shenzhen initiated a work stoppage. The work stoppage impacted our Shenzhen manufacturing capabilities temporarily up to and including April 4, 2012. Revenues for the quarter ended March 31, 2012 were adversely impacted by approximately $4 million by the work stoppage, which has since been resolved.

We have also committed to a plan to market and sell our building in Shenzhen, China. We expect the sale of the building to be completed within the next 12 months.

We are continuing to evaluate the broader supply chain implications of the flooding in Thailand across our entire manufacturing operations. Although our management cannot fully quantify the possible impact of the flooding in Thailand on our business, the supply disruption materially and adversely impacted our results of operations, including our revenue, for the second and third fiscal quarters of 2012, and is expected to materially and adversely affect our results of operations, including revenue, for at least the next fiscal quarter. While we believe our insurance coverage, both property and business interruption, will mitigate a portion of the adverse impacts, there can be no assurance as to the amount or timing of future insurance recoveries, or that we will be able to fully and timely resume production of each of our affected product lines.

 

22


Table of Contents

RESULTS OF OPERATIONS

The following tables set forth our condensed consolidated results of operations for the three and nine month periods indicated, along with amounts expressed as a percentage of revenues, and comparative information regarding the absolute and percentage changes in these amounts:

 

     Three Months Ended           Increase
(Decrease)
 
     March 31, 2012     April 2, 2011     Change    
     (Thousands)     %     (Thousands)     %     (Thousands)     %  

Revenues

   $ 88,709        100.0      $ 115,681        100.0      $ (26,972     (23.3

Cost of revenues

     75,021        84.6        87,269        75.4        (12,248     (14.0
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Gross profit

     13,688        15.4        28,412        24.6        (14,724     (51.8
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Operating expenses:

            

Research and development

     15,045        17.0        17,220        14.9        (2,175     (12.6

Selling, general and administrative

     14,889        16.8        16,087        13.9        (1,198     (7.4

Amortization of intangible assets

     775        0.9        722        0.6        53        7.3   

Restructuring, acquisition and related costs

     2,189        2.4        1,019        0.9        1,170        114.8   

Flood-related (income) expense, net

     (3,267     (3.7     —          —          (3,267     n/m (1)  

(Gain) loss on sale of property and equipment

     (13     —          4        —          (17     n/m (1)  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Total operating expenses

     29,618        33.4        35,052        30.3        (5,434     (15.5
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Operating income (loss)

     (15,930     (18.0     (6,640     (5.7     (9,290     139.9   

Other income (expense):

            

Interest income (expense), net

     (303     (0.3     (487     (0.4     184        (37.8

Gain (loss) on foreign currency translation

     (261     (0.3     (2,032     (1.8     1,771        (87.2
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Total other income (expense)

     (564     (0.6     (2,519     (2.2     1,955        (77.6
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Loss from continuing operations before income taxes

     (16,494     (18.6     (9,159     (7.9     (7,335     80.1   

Income tax provision

     668        0.7        668        0.6        —          —     
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Net loss

   $ (17,162     (19.3   $ (9,827     (8.5   $ (7,335     74.6   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

(1) Not meaningful.

 

23


Table of Contents
     Nine Months Ended           Increase
(Decrease)
 
     March 31, 2012     April 2, 2011     Change    
     (Thousands)     %     (Thousands)     %     (Thousands)     %  

Revenues

   $ 281,018        100.0      $ 357,327        100.0      $ (76,309     (21.4

Cost of revenues

     232,422        82.7        258,346        72.3        (25,924     (10.0
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Gross profit

     48,596        17.3        98,981        27.7        (50,385     (50.9
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Operating expenses:

            

Research and development

     49,736        17.7        46,627        13.0        3,109        6.7   

Selling, general and administrative

     46,848        16.7        46,049        12.9        799        1.7   

Amortization of intangible assets

     2,224        0.8        2,080        0.6        144        6.9   

Restructuring, acquisition and related costs

     3,643        1.3        2,592        0.7        1,051        40.5   

Flood-related (income) expense, net

     5,821        2.1        —          —          5,821        n/m (1)  

Legal settlements

     —          —          1,678        0.5        (1,678     (100.0

(Gain) loss on sale of property and equipment

     84        —          (65     —          149        n/m (1)  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Total operating expenses

     108,356        38.5        98,961        27.7        9,395        9.5   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Operating income (loss)

     (59,760     (21.3     20        —          (59,780     n/m (1)  

Other income (expense):

            

Interest income (expense), net

     (705     (0.3     (1,523     (0.4     818        (53.7

Gain (loss) on foreign currency translation

     2,429        0.9        (6,738     (1.9     9,167        n/m (1)  

Other income

     2,238        0.8        —          —          2,238        n/m (1)  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Total other income (expense)

     3,962        1.4        (8,261     (2.3     12,223        n/m (1)  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Loss from continuing operations before income taxes

     (55,798     (19.9     (8,241     (2.3     (47,557     577.1   

Income tax provision

     6,774        2.4        1,443        0.4        5,331        369.4   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

Net loss

   $ (62,572     (22.3   $ (9,684     (2.7   $ (52,888     546.1   
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

(1) Not meaningful.

Revenues

Revenues for the three months ended March 31, 2012 decreased by $27.0 million, or 23 percent, compared with the three months ended April 2, 2011. The decrease was primarily due to the disruption in our business caused by the flooding of our contract manufacturer in Thailand which resulted in the suspension of the manufacturing of five of our product lines. We have resumed operations at pre-flood manufacturing capacity for three of the affected product lines and we currently expect to achieve pre-flood capacity for the remaining two product lines by June 2012. Revenues were also adversely impacted by approximately $4.0 million from a short-term work stoppage in our China factory, which has since been resolved.

For the three months ended March 31, 2012, Fujitsu Limited (Fujitsu) accounted for $14.3 million, or 16 percent, of our revenues. For the three months ended April 2, 2011, Huawei Technologies Co., Ltd. (Huawei) accounted for $21.5 million, or 19 percent, and Alcatel-Lucent accounted for $12.0 million, or 10 percent, of our revenues.

Revenues for the nine months ended March 31, 2012 decreased by $76.3 million, or 21 percent, compared with the nine months ended April 2, 2011. The decrease was largely due to the disruption in our business caused by the flooding of our contract manufacturer in Thailand which resulted in the suspension of the manufacturing of a significant number of our products; a decrease in demand in our telecommunications related markets, largely associated with uncertain global macroeconomic conditions; and by approximately $4.0 million from a short-term work stoppage in our China factory, which has since been resolved.

 

24


Table of Contents

For the nine months ended March 31, 2012, Fujitsu accounted for $38.2 million, or 14 percent, and Huawei accounted for $28.5 million, or 10 percent, of our revenues. For the nine months ended April 2, 2011, Huawei accounted for $60.6 million, or 17 percent, Alcatel-Lucent accounted for $41.5 million, or 12 percent, and Ciena accounted for $35.7 million, or 10 percent, of our revenues.

Cost of Revenues

Our cost of revenues for the three months ended March 31, 2012 decreased by $12.2 million, or 14 percent, compared with the three months ended April 2, 2011. The decrease was primarily related to reduced costs associated with lower volumes of revenue attributable to lower product sales.

Our cost of revenues for the nine months ended March 31, 2012 decreased by $25.9 million, or 10 percent, compared with the nine months ended April 2, 2011. The decrease was primarily related to reduced costs associated with lower volumes of revenue attributable to a decrease in product sales. As part of our Thailand flood recovery efforts, certain of our manufacturing employees were redirected to efforts to restore our production capacity. For the three and nine months ended March 31, 2012, costs of revenues were $1.2 million and $1.7 million lower, respectively, than they would have been otherwise as these flood recovery costs have been included in flood-related expense and not cost of revenues.

Gross Profit

Gross profit is calculated as revenues less cost of revenues. Gross margin rate is gross profit reflected as a percentage of revenues.

Our gross margin rate decreased to 15 percent for the three months ended March 31, 2012, compared with 25 percent for the three months ended April 2, 2011. The decrease in gross margin rate was primarily related to the impact of our fixed costs on lower revenues, and correspondingly lower production volumes, caused by the disruption in our business from the flooding in Thailand. While we experienced a significant decline in sales of our products, many of our costs are fixed and did not decline with our revenue. Our gross profit was favorably impacted by approximately $0.3 million as a result of the U.K. pound sterling weakening relative to the U.S. dollar and the Swiss franc strengthening relative to the U.S. dollar. As part of our Thailand flood recovery efforts, certain of our manufacturing employees were redirected to efforts to restore our production capacity. For the three months ended March 31, 2012, gross profit was $1.2 million higher than it would have been otherwise as these flood recovery costs have been included in flood-related expense.

Our gross margin rate decreased to 17 percent for the nine months ended March 31, 2012, compared with 28 percent for the nine months ended April 2, 2011. The decrease in gross margin rate was primarily due to the impact of our fixed costs on lower revenues, and correspondingly lower production volumes, which is a result of the disruption in our business from the flooding in Thailand, coupled with a lower mix of relatively higher margin 10 Gbps transmission products and a higher mix of less mature, currently lower margin 40 Gbps transmission products that are not yet margin optimized. While we experienced a significant decline in sales of our products, many of our costs are fixed and did not decline with our revenue. Our gross profit was also unfavorably impacted by approximately $1.3 million as a result of the Swiss franc strengthening relative to the U.S. dollar and the U.K. pound sterling weakening relative to the U.S. dollar. For the nine months ended March 31, 2012, gross profit was $1.7 million higher than it would have been otherwise as these flood recovery costs have been included in flood-related expense.

Research and Development Expenses

Research and development expenses decreased by $2.2 million, or 13 percent, for the three months ended March 31, 2012, compared with the three months ended April 2, 2011. Personnel-related costs increased to $10.6 million for the three months ended March 31, 2012, compared with $9.6 million for the three months ended April 2, 2011. Other costs, including the costs of design tools and facilities-related costs decreased to $4.5 million for the three months ended March 31, 2012, compared with $7.6 million for the three months ended April 2, 2011. As part of our Thailand flood recovery efforts, certain of our research and development employees were redirected to efforts to restore our production capacity. For the three months ended March 31, 2012, research and development expenses were $0.6 million lower than they would have been otherwise as these flood recovery costs have been included in flood-related expense.

 

25


Table of Contents

Research and development expenses increased by $3.1 million, or 7 percent, for the nine months ended March 31, 2012, compared with the nine months ended April 2, 2011. The increase was primarily due to increased investment in research and development resources, primarily personnel-related. Personnel-related costs increased to $30.8 million for the nine months ended March 31, 2012, compared with $26.6 million for the nine months ended April 2, 2011. Other costs, including engineering materials, the costs of design tools and facilities-related costs decreased to $18.9 million for the nine months ended March 31, 2012, compared with $20.0 million for the nine months ended April 2, 2011. Research and development expenses were unfavorably impacted by approximately $0.7 million as a result of the U.K. pound sterling weakening and Swiss franc strengthening relative to the U.S. dollar. For the nine months ended March 31, 2012, research and development expenses were $1.1 million lower than they would have been otherwise as these flood recovery costs have been included in flood-related expense.

Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased by $1.2 million, or 7 percent, for the three months ended March 31, 2012, compared with the three months ended April 2, 2011. Personnel-related costs decreased to $9.1 million for the three months ended March 31, 2012, compared with $9.2 million for the three months ended April 2, 2011. Other costs, including legal and professional fees, facilities expenses and other miscellaneous expenses, decreased to $5.8 million for the three months ended March 31, 2012, compared with $6.9 million for the three months ended April 2, 2011.

Selling, general and administrative expenses increased by $0.8 million, or 2 percent, for the nine months ended March 31, 2012, compared with the nine months ended April 2, 2011. Personnel-related costs increased to $28.5 million for the nine months ended March 31, 2012, compared with $25.5 million for the nine months ended April 2, 2011. Other costs, including legal and professional fees, facilities expenses and other miscellaneous expenses, decreased to $18.4 million for the nine months ended March 31, 2012, compared with $20.6 million for the nine months ended April 2, 2011.

Restructuring, Acquisition and Related Costs

During the three months ended March 31, 2012, we accrued $1.2 million in employee separation costs related to ongoing restructuring plans. During the three months ended April 2, 2011, we reduced our restructuring reserve by $0.5 million due to revised estimates for employee separation cost estimates, lease cancellation and commitments and other charges. During the three months ended March 31, 2012 and April 2, 2011, we also incurred $0.8 million and $1.5 million, respectively, in external consulting charges associated with the optimization of past acquisitions as we focus on the associated infrastructure and processes required to support sustainable growth, including, for the three months ended March 31, 2012, external costs associated with potential transactions to outsource our Shenzhen manufacturing operations, which culminated in our transaction with Venture.

During the nine months ended March 31, 2012, we accrued $2.3 million in employee separation costs related to ongoing restructuring plans. We also incurred $3.9 million of expenses during the nine months ended March 31, 2012, in external consulting charges associated with the next phase of our optimization of past acquisitions as we focus on the associated infrastructure and processes required to support sustainable growth, including external costs associated with potential transactions to outsource our Shenzhen manufacturing operations, which culminated in our transaction with Venture.

During the nine months ended April 2, 2011, we accrued $1.1 million in employee separation costs in connection with previously announced restructuring plans, offset by reductions to our restructuring reserve of $0.8 million from revised estimates for employee separation costs, lease cancellation and commitments and other charges. We also incurred $2.1 million during the nine months ended April 2, 2011 in external consulting charges associated with the optimization of past acquisitions. In addition, we recorded $0.2 million in acquisition-related professional fees during this same period.

 

26


Table of Contents

During the three and nine months ended March 31, 2012, we reassessed the fair value of the 12 and 18 month earnout obligations related to our acquisition of Mintera, determining that the fair value of the obligations increased by $0.7 million during the three month period and decreased by $2.2 million during the nine month period. The $0.7 million increase in fair value during the three months ended March 31, 2012 and the $2.2 million decrease in fair value during the nine months ended March 31, 2012 were recorded within restructuring, acquisition and related expenses.

Flood-Related (Income) Expense, Net

In October 2011, certain areas in Thailand suffered major flooding as a result of monsoons. This flooding had a material and adverse impact on our business and results of operations. Our primary contract manufacturer, Fabrinet, suspended operations at two factories located in Chokchai, Thailand and Pinehurst, Thailand. The Chokchai factory suffered extensive flood damage and became inaccessible due to high water levels inside and surrounding the manufacturing facility. As a result of this flooding, we experienced a significant decline in products sales due to our inability or limited ability to manufacture certain Oclaro products and we incurred significant damage to our inventory and property and equipment located at the Chokchai facility.

During the three and nine months ended March 31, 2012, we recorded impairment charges related to the write-off of the net book value of damaged inventory and property and equipment based on our current estimates of the damage caused by the flooding. Flood-related (income) expense, net for the three and nine months ended March 31, 2012 also includes personnel-related costs, professional fees and related expenses incurred in connection with our recovery efforts. We continue to evaluate our estimates of flood-related losses, and in future quarters we may record additional losses for damaged equipment and inventory.

On February 2, 2012, we received a $6.4 million advance payment from one of our insurers relating to losses we incurred due to the flooding in Thailand. This payment is a general advance from our insurer against all Thailand flood-related claims and was not specifically identified as reimbursement for any particular loss or claim.

Flood-related (income) expense, net for the three and nine months ended March 31, 2012 and April 2, 2011 included the following:

 

     Three Months Ended
March 31, 2012
    Nine Months Ended
March 31, 2012
 
     (Thousands)  

Write-off of net book value of damaged inventory

   $ —        $ 4,246   

Write-off of net book value of damaged property and equipment

     624        3,659   

Personnel-related costs, professional fees and related expenses

     2,474        4,281   

Advance payment from insurer

     (6,365     (6,365
  

 

 

   

 

 

 
   $ (3,267   $ 5,821   
  

 

 

   

 

 

 

Legal Settlements

Legal settlements expense of $1.7 million during the three and nine months ended April 2, 2011 includes amounts reserved in connection with a legal settlement with QinetiQ Limited and in connection with other legal settlements and related legal costs.

Other Income (Expense)

Other income (expense) for the three months ended March 31, 2012 increased by $2.0 million compared with the three months ended April 2, 2011. This increase was primarily due to a $1.8 million decrease in foreign exchange losses from the re-measurement of short term receivables and payables among certain of our wholly-owned international subsidiaries for fluctuations in the U.S. dollar relative to our other local functional currencies during the corresponding periods.

 

27


Table of Contents

Other income (expense) for the nine months ended March 31, 2012 increased by $12.2 million compared with the nine months ended April 2, 2011. This increase was primarily due to a $2.2 million gain on the sale of a minority equity investment in a private company in the second quarter of 2012 and a $9.2 million increase in foreign exchange gains from the re-measurement of short term receivables and payables among certain of our wholly-owned international subsidiaries for fluctuations in the U.S. dollar relative to our other local functional currencies during the corresponding periods.

Income Tax Provision

For the three months ended March 31, 2012, our income tax provision of $0.7 million primarily related to our foreign operations. For the three months ended April 2, 2011, our income tax provision of $0.7 million primarily related to income taxes on our operations in Italy and China.

For the nine months ended March 31, 2012, our income tax provision of $6.8 million primarily related to our foreign operations, including a $4.1 million charge due to the impairment of certain net operating loss carryforwards in a foreign jurisdiction. For the nine months ended April 2, 2011, our income tax provision of $1.4 million primarily related to income taxes on our operations in Italy and China.

Recent Accounting Pronouncements

See Note 1, Basis of Preparation , to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for information regarding the effect of new accounting pronouncements on our financial statements.

Application of Critical Accounting Policies

The discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements contained elsewhere in this Quarterly Report on Form 10-Q, which have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP). The preparation of our financial statements requires us to make estimates and judgments that affect our reported assets and liabilities, revenues and expenses and other financial information. Actual results may differ significantly from those based on our estimates and judgments or could be materially different if we used different assumptions, estimates or conditions. In addition, our financial condition and results of operations could vary due to a change in the application of a particular accounting standard.

We identified our critical accounting policies in our Annual Report on Form 10-K for the year ended July 2, 2011 (2011 Form 10-K) related to revenue recognition and sales returns, inventory valuation, business combinations, impairment of goodwill and other intangible assets, accounting for stock-based compensation and income taxes. It is important that the discussion of our operating results be read in conjunction with the critical accounting policies discussed in our 2011 Form 10-K.

Based on the adverse effects the flooding in Thailand has had on our business and the significant insurance recoveries we have received to date, we have designated our accounting policy for insurance recoveries as a critical accounting policy beginning in the three months ended December 31, 2011.

Insurance Recoveries

Insurance recoveries related to impairment losses previously recorded and other recoverable expenses will be recognized up to the amount of the related loss or expense in the period that recoveries become realizable. Insurance recoveries under business interruption coverage and insurance recovery gains in excess of amounts previously written off related to impaired inventory and equipment or in excess of other recoverable expenses previously recognized will be recognized when they become realizable and all contingencies have been resolved.

On February 2, 2012, we received a $6.4 million advance payment from one of our insurers relating to losses we incurred due to the flooding in Thailand. This payment is a general advance from our insurer against all Thailand flood-related claims and was not specifically identified as reimbursement for any particular loss or claim. As there

 

28


Table of Contents

were no contingencies associated with this payment, we recorded this advance payment within flood related income (expense), net in our condensed consolidated statements of operations for the three and nine months ended March 31, 2012.

The evaluation of insurance recoveries requires estimates and judgments about future results which affect reported amounts and certain disclosures. Actual results could differ from those estimates. Insurance recoveries we receive in future periods will be recorded net of flood-related expense in the condensed consolidated statement of operations. As of March 31, 2012, we have not recorded any estimated amounts relating to potential future insurance recoveries in the condensed consolidated statement of operations.

Liquidity and Capital Resources

Cash Flows from Operating Activities

Net cash used by operating activities for the nine months ended March 31, 2012 was $23.9 million, primarily resulting from a net loss of $62.6 million, partially offset by $22.5 million of non-cash adjustments and a $16.2 million increase in cash due to changes in operating assets and liabilities. The $22.5 million of non-cash adjustments was primarily comprised of $16.6 million of expense related to depreciation and amortization, $7.9 million of expense related to our non-cash flood-related impairments and $4.9 million of expense related to stock-based compensation, partially offset by $2.2 million due to the revaluation of the Mintera earnout liability, $2.2 million gain on the sale of an investment, $1.9 million gain from the sale of certain assets related to a legacy product and $0.7 million from the amortization of deferred gain from a sales-leaseback transaction. The $16.2 million increase in cash due to changes in operating assets and liabilities was primarily comprised of a $21.4 million decrease in accounts receivable, a $9.7 million decrease in inventory, a $1.3 million increase in accrued expenses and other liabilities, a $0.8 million decrease in prepaid expenses and other current assets, partially offset by a $17.0 million decrease in accounts payable and a $0.1 million increase in other non-current assets.

Although our management cannot yet definitively quantify the total impacts of the flooding in Thailand on our business, it is likely that the supply disruption will materially and adversely affect our results of operations, including our revenue, for at least the next fiscal quarter. There is no assurance that the adverse impact will be limited to the next fiscal quarter. While we believe our insurance coverage, both property and business interruption, will mitigate a portion of the adverse impact, there can be no assurance as to the amount or timing of future insurance recoveries, or that we will be able to fully and timely resume production of each of our affected product lines.

Net cash provided by operating activities for the nine months ended April 2, 2011 was $1.4 million, primarily resulting from $16.7 million of non-cash adjustments, partially offset by a net loss of $9.7 million and a $5.6 million decrease in cash due to changes in operating assets and liabilities. The $16.7 million of non-cash adjustments was comprised of $12.8 million of expense related to depreciation and amortization and $4.6 million of expense related to stock-based compensation, offset in part by $0.7 million from the amortization of deferred gain from a sales-leaseback transaction. The $5.6 million decrease in cash due to changes in operating assets and liabilities was comprised of a $17.9 million increase in inventory as we are investing to match the rate of our anticipated revenue growth and to provide us with strategic flexibility, a $3.8 million decrease in accrued expenses and other liabilities and a $1.0 million increase in prepaid expenses and other current assets, offset in part by cash generated from a $10.2 million increase in accounts payable, a $6.8 million decrease in accounts receivable and a $0.1 million decrease in other non-current assets.

 

29


Table of Contents

Cash Flows from Investing Activities

Net cash used in investing activities for the nine months ended March 31, 2012 was $9.6 million, primarily consisting of $15.9 million used in capital expenditures, partially offset by $3.4 million in proceeds from the sale of an investment and $2.9 million in proceeds from the sale of certain assets related to a legacy product.

Net cash used in investing activities for the nine months ended April 2, 2011 was $39.6 million, primarily consisting of $32.9 million used in capital expenditures to support new product introductions and our anticipated revenue growth and $10.5 million used in the acquisition of Mintera, partially offset by a reduction of $3.7 million in restricted cash related to a facility lease from which we exited during the first quarter of the current fiscal year.

Cash Flows from Financing Activities

Net cash provided by financing activities of $25.6 million for the nine months ended March 31, 2012 primarily consisted of $25.5 million in borrowings under our revolving credit facility and $0.1 million in proceeds from the issuance of common stock through stock option exercises.

Net cash provided by financing activities of $2.6 million for the nine months ended April 2, 2011 primarily resulted from $2.3 million received from issuance of common stock, primarily through stock option exercises, and $0.3 million in additional proceeds related to our May 2010 follow-on stock offering due to finalization of our previous estimates of offering related expenses.

Effect of Exchange Rates on Cash and Cash Equivalents for the Nine months Ended March 31, 2012 and April 2, 2011

The effect of exchange rates on cash and cash equivalents for the nine months ended March 31, 2012 was a decrease of $4.3 million, primarily consisting of $0.6 million loss due to the revaluation of foreign currency cash balances to the functional currency of the respective subsidiaries and from a loss of approximately $3.7 million related to the revaluation of U.S. dollar denominated operating intercompany payables and receivables of our foreign subsidiaries.

The effect of exchange rates on cash and cash equivalents for the nine months ended April 2, 2011 was an increase of $3.2 million, primarily consisting of $1.3 million in net gain due to the revaluation of foreign currency cash balances to the functional currency of the respective subsidiaries and from gains of approximately $2.4 million related to the revaluation of U.S. dollar denominated operating intercompany payables and receivables of our foreign subsidiaries.

Credit Facility

As of March 31, 2012, we had a $45.0 million senior secured revolving credit facility with Wells Fargo Capital Finance, Inc. and other lenders (the Credit Agreement) with an expiration date of August 1, 2014. See Note 7, Credit Agreement , to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding this credit facility. As of March 31, 2012, there was $25.5 million outstanding under the Credit Agreement and we were in compliance with all covenants. As of July 2, 2011, there were no amounts outstanding under the Credit Agreement. At March 31, 2012 and July 2, 2011, there were $0.1 million and $1.1 million, respectively, in outstanding standby letters of credit secured under the Credit Agreement. These letters of credit expire at various intervals through April 2014.

Future Cash Requirements

As of March 31, 2012, we held $50.5 million in cash and cash equivalents and $0.6 million in restricted cash. In the future, in order to strengthen our financial position, in the event of unforeseen circumstances, in the event we need to fund our growth in future financial periods, or in the event insurance proceeds are not sufficient or timely enough to offset our expenses or lost revenue associated with the flooding in Thailand, we may need to raise additional funds by any one or a combination of the following: (i) issuing equity securities, (ii) incurring indebtedness secured by our assets, (iii) issuing debt and/or convertible debt securities, or (iv) selling product lines,

 

30


Table of Contents

other assets and/or other portions of our business. There can be no guarantee that we will be able to raise additional funds on terms acceptable to us, or at all. We are committed to a plan to market and sell our building in Shenzhen, China. We expect the sale of the building to be completed within the next 12 months. In addition to the $6.4 million insurance coverage advance payment we received in February 2012 associated with the flooding in Thailand, we also expect to receive substantial additional insurance proceeds, although neither the amounts nor the timing of such payments can be reasonably estimated at this time.

At March 31, 2012, we determined the fair value of the 18 month earnout obligation to be fixed at $10.8 million based on sales of Mintera products during the eighteen month period ended January 20, 2012. We recorded the $10.8 million in accrued expenses and other liabilities in our condensed consolidated balance sheet. We intend to settle the remaining earnout obligation of $10.8 million in cash during the fourth quarter of fiscal 2012.

From time to time, we have engaged in discussions with third parties concerning potential acquisitions of product lines, technologies and businesses, such as our pending merger with Opnext, our merger with Avanex, our acquisitions of Xtellus and Mintera, our exchange of assets agreement with Newport and our sale of a legacy product line in the second quarter of fiscal year 2012. We continue to consider potential acquisition candidates. Any such transactions could result in us issuing a significant number of new equity or debt securities (including promissory notes), the incurrence or assumption of debt, and the utilization of our cash and cash equivalents. We may also be required to raise additional funds to complete any such acquisition, through either the issuance of equity securities and/or borrowings. If we raise additional funds or acquire businesses or technologies through the issuance of equity securities, our existing stockholders may experience significant dilution.

Off-Balance Sheet Arrangements

We indemnify our directors and certain employees as permitted by law, and have entered into indemnification agreements with our directors and executive officers. We have not recorded a liability associated with these indemnification arrangements, as we historically have not incurred any material costs associated with such indemnification obligations. Costs associated with such indemnification obligations may be mitigated by insurance coverage that we maintain, however, such insurance may not cover any, or may cover only a portion of, the amounts we may be required to pay. In addition, we may not be able to maintain such insurance coverage in the future.

We also have indemnification clauses in various contracts that we enter into in the normal course of business, such as indemnification in favor of customers in respect of liabilities they may incur as a result of purchasing our products should such products infringe the intellectual property rights of a third party. We have not historically paid out any material amounts related to these indemnifications; therefore, no accrual has been made for these indemnifications.

Other than as set forth above, we are not currently party to any material off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Interest Rates

We finance our operations through a mixture of the issuance of equity securities, finance leases, working capital and by drawing on our Credit Agreement. Our primary exposure to interest rate fluctuations is on our cash deposits and for amounts borrowed under our Credit Agreement. As of March 31, 2012, we had $25.5 million in outstanding borrowings at an average interest rate of 3.4 percent and $0.1 million in outstanding standby letters of credit secured under our Credit Agreement. An increase in our average interest rate on our Credit Agreement of 1.0 percent would increase our annual interest expense by $0.3 million.

We monitor our interest rate risk on cash balances primarily through cash flow forecasting. Cash that is surplus to immediate requirements is generally invested in short-term deposits with banks accessible within one day’s notice and invested in overnight money market accounts. We believe our interest rate risk is immaterial.

 

31


Table of Contents

Foreign currency

As our business is multinational in scope, we are subject to fluctuations based upon changes in the exchange rates between the currencies in which we collect revenues and pay expenses. A significant majority of our revenues are be denominated in U.S. dollars, while a significant portion of our expenses are be denominated in U.K. pounds sterling and the Swiss franc. Fluctuations in the exchange rate between the U.S. dollar, the U.K. pound sterling and the Swiss franc and, to a lesser extent, other currencies in which we collect revenues and pay expenses, could affect our operating results. This includes the Chinese yuan, the Korean won, the Israeli shekel and the Euro in which we pay expenses in connection with operating our facilities in Shenzhen and Shanghai, China; Daejeon, South Korea; Jerusalem, Israel and San Donato, Italy. To the extent the exchange rate between the U.S. dollar and these currencies were to fluctuate more significantly than experienced to date, our exposure would increase.

As of March 31, 2012, our U.K. subsidiary had $68.0 million, net, in U.S. dollar denominated operating intercompany payables, $14.8 million in U.S. dollar denominated cash balances and $49.4 million in U.S. dollar denominated net accounts receivable related to sales to external customers. It is estimated that a 10 percent fluctuation in the U.S. dollar relative to the U.K. pound sterling would lead to a profit of $0.4 million (U.S. dollar strengthening), or a loss of $0.4 million (U.S. dollar weakening) on the translation of these balances, which would be recorded as gain (loss) on foreign exchange in our condensed consolidated statement of operations.

Hedging Program

We enter into foreign currency forward exchange contracts in an effort to mitigate a portion of our exposure to fluctuations between the U.S. dollar and the U.K. pound sterling. We do not currently hedge our exposure to the Chinese yuan, the Korean won, the Israeli shekel, the Swiss franc or the Euro, but we may in the future if conditions warrant. We also do not currently hedge our exposure related to our U.S. dollar denominated intercompany payables and receivables. We may be required to convert currencies to meet our obligations. Under certain circumstances, foreign currency forward exchange contracts can have an adverse effect on our financial condition. As of March 31, 2012, we held six outstanding foreign currency forward exchange contracts with a notional value of $4.0 million which include put and call options which expire, or expired, at various dates from April 2012 to September 2012. We have recorded an unrealized gain of $0.1 million to accumulated other comprehensive income in connection with marking these contracts to fair value as of March 31, 2012. It is estimated that a 10 percent fluctuation in the dollar between March 31, 2012 and the maturity dates of the put and call instruments underlying these contracts would lead to a profit of $0.4 million dollars (U.S. dollar weakening) on our outstanding foreign currency forward exchange contracts, should they be held to maturity.

 

Item 4 . Controls and Procedures

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2012. The term “disclosure controls and procedures,” as defined in Rules13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by the company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2012, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level.

As disclosed in our Amendments No. 1 to our Quarterly Reports on Form 10-Q for the quarters ended October 1, 2011 and December 31, 2011, we identified a material weakness in our internal control over financial reporting such that our disclosure controls and procedures related to accounting for income taxes were not effective. During the quarter ended March 31, 2012, we implemented enhancements to our internal controls over financial reporting, including adding additional monitoring controls over the preparation and filing of foreign income tax returns. Our remediation efforts, including the testing of these controls, will continue throughout our fiscal year 2012. We expect that the material weakness will be considered remediated in the fourth quarter of fiscal year 2012 once these controls have been operational for a sufficient period of time to allow management to conclude that these controls are operating effectively.

Except as noted in the preceding paragraph, there was no change in our internal control over financial reporting during the three months ended March 31, 2012 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

32


Table of Contents

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

Five putative class actions challenging the Merger have been filed in the Superior Court of the State of California in and for the County of Alameda: (1) Martin Zilberberg v. Charles J. Abbe, No RG12623460, on March 28, 2012; (2) Eleanor Welty v. Harry L. Bosco, Case No. RG12624240, on April 4, 2012; (3) Todd Wright v. Harry L. Bosco, Case No. RG12624343, on April 5, 2012; (4) Stephen Greenberg v. Charles J. Abbe, No. RG12624444, on April 5, 2012; and (5) Mark Graf v. Opnext, Inc., No. RG12624798, on April 9, 2012. Two putative class actions challenging the Merger have been filed in the Delaware Court of Chancery: Glenn Freedman v. Opnext, Inc., CA No. 7400-VCL, on April 5, 2012; and (2) Berger v. Bosco, No. 7406-VCL, on April 9, 2012. The two Delaware actions have been consolidated under the caption In re Opnext, Inc. Shareholders Litigation, C.A. No. 7400-VCL. The defendants in each case are Opnext, Inc. and the members of Opnext’s Board (collectively, the Opnext Defendants), Oclaro, Inc. and Tahoe Acquisition Sub, Inc. (collectively, the Oclaro Defendants). Each action alleges that the Opnext Defendants breached their fiduciary duties to Opnext stockholders by entering into the Merger Agreement. Each action further alleges that the Oclaro Defendants aided and abetted those breaches of fiduciary duties.

Among other relief, the plaintiff in each case seeks an order enjoining the Merger, and seeking attorneys’ fees. All of the actions except for the Graf Action seek damages and an accounting. Plaintiffs have served discovery in certain of these actions, but no trial date has been set in any of these actions. We believe that the claims asserted in each of these actions are without merit and intend to defend them vigorously. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

On May 19, 2011, Curtis and Charlotte Westley filed a purported class action complaint in the United States District Court for the Northern District of California, against us and certain of our officers and directors. The Court subsequently appointed the Connecticut Laborers’ Pension Fund (Pension Fund) as lead plaintiff for the putative class. On October 27, 2011, the Pension Fund filed an Amended Complaint, captioned as Westley v. Oclaro, Inc., No. 11 Civ. 2448 EMC, allegedly on behalf of persons who purchased our common stock between May 6 and October 28, 2010, alleging that defendants issued materially false and misleading statements during this time period regarding our current business and financial condition, including projections for demand for our products, as well as our revenues, earnings, and gross margins, for the first quarter of fiscal year 2011 as well as the full fiscal year. The complaint alleges violations of section 10(b) of the Securities Exchange Act and Securities and Exchange Commission Rule 10b-5, as well as section 20(a) of the Securities Exchange Act. The complaint seeks damages and costs of an unspecified amount. On December 12, 2011, defendants filed a motion to dismiss the complaint. That motion was granted with leave to file the amended complaint. Discovery has not commenced, and no trial has been scheduled in this action. We intend to defend this litigation vigorously. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

On June 10, 2011, a purported shareholder, Stanley Moskal, filed a purported derivative action in the Superior Court for the State of California, County of Santa Clara, against us, as nominal defendant, and certain of our current and former officers and directors, as defendants. The case is styled Moskal v. Couder, No. 1:11 CV 202880 (Santa Clara County Super. Ct. filed June 10, 2011). Four other purported shareholders, Matteo Guindani, Jermaine Coney, Jefferson Braman and Toby Aguilar, separately filed substantially similar lawsuits in the United States District Court for the Northern District of California on June 27, June 28, July 7 and July 26, 2011, respectively. By Order dated September 14, 2011, the Guindani, Coney, and Braman actions were consolidated under In re Oclaro, Inc. Derivative Litigation , Lead Case No. 11 Civ. 3176 EMC. On October 5, 2011, the Aguilar action was voluntarily dismissed. Each remaining purported derivative complaint alleges that Oclaro has been, or will be, damaged by the actions alleged in the Westley complaint, and the litigation of the Westley action, and any damages or settlement paid in the Westley action. Each purported derivative complaint alleges counts for breaches of fiduciary duty, waste,

 

33


Table of Contents

and unjust enrichment. Each purported derivative complaint seeks damages and costs of an unspecified amount, as well as injunctive relief. By Order dated November 23, 2011, the parties in the Moskal action agreed that defendants shall not be required to respond to the original complaint, that plaintiff would serve an amended complaint no later than March 9, 2012, and the stay of discovery would remain in effect until further order of the Court or agreement by the parties. By Order dated November 29, 2011, the parties to In re Oclaro, Inc. Derivative Litigation agreed to stay all proceedings, including motion practice and discovery, until such time as (a) the defendants file an answer to any complaint in the Westley Action; or (b) the Westley Action is dismissed in its entirety with prejudice. Discovery has not commenced, and no trial has been scheduled in any of these actions. We are unable at this time to estimate the effects of these lawsuits on our financial position, results of operations or cash flows.

 

Item 1A. Risk Factors

Investing in our securities involves a high degree of risk. The risks described below are not the only ones facing us. Additional risks not currently known to us or that we currently believe are immaterial also may impair our business, operations, liquidity and stock price materially and adversely. You should carefully consider the risks and uncertainties described below in addition to the other information included or incorporated by reference in this Quarterly Report on Form 10-Q. If any of the following risks actually occur, our business, financial condition or results of operations would likely suffer. In that case, the trading price of our common stock could fall and you could lose all or part of your investment.

RISKS RELATED TO OUR BUSINESS

Our results of operations have been and will be materially and adversely affected by the flooding in Thailand.

In October 2011, certain areas in Thailand suffered major flooding as a result of monsoons. This flooding had a material impact on our business and results of operations. Our primary contract manufacturer, Fabrinet, suspended operations at two factories located in Chokchai, Thailand and Pinehurst, Thailand. The Chokchai factory suffered extensive flood damage and became inaccessible due to high water levels inside and surrounding the manufacturing facility. As a result of this flooding, we experienced a significant decline in products sales and we incurred significant damage to our inventory and property and equipment located at the Chokchai facility. During the nine months ended March 31, 2012, we recorded impairment charges of $4.2 million related to the write-off of the net book value of damaged inventory and $3.7 million related to the write-off of the net book value of property and equipment based on our preliminary estimates of the damage caused by the flooding and we incurred $4.3 million in personnel-related costs, professional fees and related expenses incurred in connection with our recovery efforts. We continue to evaluate our estimates of flood-related losses, and in future quarters we may record additional losses for damaged equipment and inventory.

It is possible that our customers could experience supply chain disruptions as a result of other suppliers whose manufacturing operations in Thailand have been impacted by the flooding which could impact our customers’ demand, or the timing of their demand, for our products. It is also possible that our customers will seek alternative suppliers of comparable products if we are unable to meet their supply needs as a result of the flooding in Thailand. Although our management cannot yet definitively quantify the total impacts of the flooding in Thailand on our business, it is likely that the supply disruption will continue to materially and adversely affect our results of operations, including our revenue, for at least the next fiscal quarter. There is no assurance that the adverse impact will be limited to the next fiscal quarter. While we believe our insurance coverage, both property and business interruption, will mitigate a portion of the adverse impact, there can be no assurance as to the amount or timing of insurance recoveries beyond those received in February 2012, or that the timing or amounts will be sufficient to fully compensate for negative impacts on our operating cash flow during the recovery period. If we do not efficiently and effectively mitigate the impact of the flooding on our business or if the adverse impact extends for a longer period of time than expected, our results of operations would be materially and adversely affected.

 

34


Table of Contents

We may undertake mergers or acquisitions that do not prove successful, such as our pending merger with Opnext.

From time to time we consider mergers or acquisitions, collectively referred to as “acquisitions,” of other businesses, assets or companies that would complement our current product offerings, enhance our intellectual property rights or offer other competitive opportunities. For example, on March 26, 2012, we entered into an Agreement and Plan of Merger and Reorganization with Opnext. However, in the future, we may not be able to identify suitable acquisition candidates at prices we consider appropriate. In addition, we are in an industry that is actively consolidating and, as a result, there is no guarantee that we will successfully and satisfactorily bid against third parties, including competitors, when we identify a critical target we want to acquire.

We cannot readily predict the timing, size or success of our future acquisitions. Failure to successfully implement our acquisition plans could have a material adverse effect on our business, prospects, financial condition and results of operations. Even successful acquisitions could have the effect of reducing our cash balances, diluting the ownership interests of existing stockholders or increasing our indebtedness. For example, our pending merger with Opnext will require us to issue a significant number of newly issued shares of our common stock. In addition, during the first quarter of fiscal year 2012, we issued 0.9 million shares of our common stock related to the settlement of our Xtellus escrow liability. In October 2011, we paid $0.5 million in cash and issued 0.8 million shares of our common stock to pay the 12 month Mintera earnout obligation; and we intend to settle the $10.8 million due under the 18 month Mintera earnout obligation in the fourth quarter of fiscal year 2012.

We cannot predict with certainty which strategic, financial or operating synergies or other benefits, if any, will actually be achieved from our pending merger with Opnext or any other transaction we undertake, the timing of any such benefits, or whether those benefits which have been achieved will be sustainable on a long-term basis. Our failure to identify, consummate or integrate suitable acquisitions could adversely affect our business and results of operations.

Our pending merger with Opnext and other acquisitions could involve a number of other potential risks to our business, including the following, any of which could harm our business:

 

   

failure to realize the potential financial or strategic benefits of the merger or acquisition;

 

   

increased costs associated with merged or acquired operations;

 

   

economic dilution to gross and operating profit and earnings (loss) per share;

 

   

failure to successfully further develop the combined, acquired or remaining technology, which could, among other things, result in the impairment of amounts recorded as goodwill or other intangible assets;

 

   

unanticipated costs and liabilities and unforeseen accounting charges;

 

   

difficulty in integrating product offerings;

 

   

difficulty in coordinating and rationalizing research and development activities to enhance introduction of new products and technologies with reduced cost;

 

   

difficulty in coordinating and integrating the manufacturing activities of our acquired businesses, including with respect to third-party manufacturers, including executing a production capacity ramp up of our South Korea facility and our contract manufacturers to support the potential revenue demand for the WSS-related products of Xtellus, managing the manufacturing activities of the laser diode business acquired from Newport while these activities are being transferred from Tucson, Arizona to Europe and Asia, and transferring certain production of Mintera products to our internal facilities;

 

35


Table of Contents
   

delays and difficulties in delivery of products and services;

 

   

failure to effectively integrate or separate management information systems, personnel, research and development, marketing, sales and support operations;

 

   

difficulty in maintaining internal control procedures and disclosure controls that comply with the requirements of the Sarbanes-Oxley Act of 2002, or poor integration of a target’s procedures and controls;

 

   

difficulty in preserving important relationships of our acquired businesses and resolving potential conflicts between business cultures;

 

   

uncertainty on the part of our existing customers, or the customers of an acquired company, about our ability to operate effectively after a transaction, and the potential loss of such customers;

 

   

loss of key employees;

 

   

difficulty in coordinating the international activities of our acquired businesses, including Opnext, which has substantial operations in Japan as well as the United States, and which uses contract manufacturing suppliers in Southeast Asia;

 

   

the effect of tax laws due to increasing complexities of our global operating structure;

 

   

the effect of employment law or regulations or other limitations in foreign jurisdictions that could have an impact on timing, amounts or costs of achieving expected synergies; and

 

   

substantial demands on our management as a result of these transactions that may limit their time to attend to other operational, financial, business and strategic issues.

Our integration with acquired businesses has been and will continue to be a complex, time-consuming and expensive process. We cannot assure you that we will be able to successfully integrate these businesses in a timely manner, or at all, or that any of the anticipated benefits from our pending merger with Opnext or previous acquisitions will be realized. We may have difficulty, and may incur unanticipated expenses related to, integrating management and personnel from our pending merger with Opnext and previously acquired entities with our management and personnel. Our failure to achieve the strategic objectives of our pending merger with Opnext or previous acquisitions could have a material adverse effect on our revenues, expenses and our other operating results and cash resources, and could result in us not achieving the anticipated potential benefits of these transactions. In addition, we cannot assure you that the growth rate of the combined company will equal the historical growth rate experienced by any of the companies that we have acquired or Opnext. Comparable risks would accompany any divestiture of business or assets we might undertake.

 

36


Table of Contents

We depend on a limited number of suppliers who could disrupt our business if they stopped, decreased, delayed or were unable to meet our demand for shipments of their products.

We depend on a limited number of suppliers of raw materials and equipment used to manufacture our products. We currently also depend on a limited number of contract manufacturers, principally Fabrinet in Thailand, to manufacture certain of our products. We will also increasingly depend on Venture Corporation Limited (Venture) as we transfer our Shenzhen assembly and test operations in a phased and gradual transfer of products to Venture over the next three years. Some of these suppliers are sole sources. We typically have not entered into long-term agreements with our suppliers other than Fabrinet and Venture, therefore, these suppliers generally may stop supplying us materials and equipment at any time. Our reliance on a sole supplier or limited number of suppliers could result in delivery problems, reduced control over product pricing and quality, and an inability to identify and qualify another supplier in a timely manner. Given the recent macroeconomic downturn, some of our suppliers that may be small or undercapitalized may experience financial difficulties that could prevent them from supplying us materials and equipment. In addition, our suppliers, including our sole source suppliers, may experience manufacturing delays or shut downs due to circumstances beyond their control such as earthquakes, floods, fires or other natural disasters.

Fabrinet’s manufacturing operations are located in Thailand. In October 2011, due to flooding in Thailand, Fabrinet suspended operations at both of their factories that supply us with finished goods. Thailand has also been subject to political unrest in the recent past, including the temporary interruption of service at one of its international airports, and may again experience such political unrest in the future. If Fabrinet is unable to supply us with materials or equipment, or if they are unable to ship our materials or equipment out of Thailand due to future flooding or political unrest, this could materially adversely affect our ability to fulfill customer orders and our results of operations.

Any supply deficiencies relating to the quality or quantities of materials or equipment we use to manufacture our products could materially adversely affect our ability to fulfill customer orders and our results of operations. Lead times for the purchase of certain materials and equipment from suppliers have increased and in some cases have limited our ability to rapidly respond to increased demand, and may continue to do so in the future. These conditions have been exacerbated by suppliers, customers and companies reducing their inventory levels in response to the recent macroeconomic downturn. We are currently evaluating the capabilities of additional potential contract manufacturing partners to ensure we have a scalable and cost effective manufacturing strategy appropriate for executing our business objectives over a long-term horizon. To the extent we introduce additional contract manufacturing partners, introduce new products with new partners and/or move existing internal or external production lines to new partners, we could experience supply disruptions during the transition process. In addition, due to our customers’ requirements relating to the qualification of our suppliers and contract manufacturing facilities and operations, we cannot quickly enter into alternative supplier relationships, which prevents us from being able to respond immediately to adverse events affecting our suppliers.

We may not realize the anticipated benefits from the transition of our Shenzhen assembly and test operations, and the corresponding long term supply agreement, with Venture.

In March 2012, we entered into a definitive agreement with Venture to transfer our Shenzhen final assembly and test operations to Venture’s Malaysia facility in a phased and gradual transfer of products over the next three years. In conjunction with this agreement, we entered into a 5 year supply agreement with Venture to manufacture and supply us with certain products that were previously manufactured at our Shenzhen facility. There can be no assurance that the transition of our Shenzhen assembly and test operations and the corresponding long term supply agreement with Venture will result in the benefits that we expect. There can be no assurance that we will realize the anticipated $35 million in lower working capital requirements due to the outsourcing of these activities.

On March 28, 2012, shortly after announcing this agreement, certain of our employees in Shenzhen initiated a work stoppage up to and including April 4, 2012. Although we negotiated a resolution to this work stoppage, there can be no assurance that work stoppages will not arise in the future having a material adverse impact on our production output and/or the levels and gross margins of the corresponding product revenues supported by the production output. Any such work stoppage may adversely impact our revenues and our ability to deliver products to our customers.

 

37


Table of Contents

We have a history of large operating losses and we may not be able to achieve profitability in the future.

We have historically incurred losses and negative cash flows from operations since our inception. As of March 31, 2012, we had an accumulated deficit of $1,188.6 million. For the nine months ended March 31, 2012, we incurred a net loss of $62.6 million. For the year ended July 2, 2011 we incurred a loss from continuing operations of $46.4 million. Even though we generated income of $11.0 million from continuing operations for the year ended July 3, 2010, our results of operations are currently being materially and adversely impacted by the flooding in Thailand, and we may not be able to achieve profitability in any future periods. If we are unable to do so, we may need additional financing, which may not be available to us on commercially acceptable terms or at all, to execute on our current or future business strategies.

We may not be able to maintain gross margin levels.

We may not be able to maintain or improve our historical gross margin levels, due to the current economic uncertainty, changes in customer demand (including a change in product mix between different areas of our business) and pricing pressure from increased competition or other factors. During fiscal year 2011, our gross margin decreased compared with fiscal year 2010, and has further decreased for the nine months ended March 31, 2012. We attempt to reduce our product costs and improve our product mix to offset price competition and erosion expected in most product categories, but there is no assurance that we will be successful. Our gross margins have been, and will be in the future, adversely impacted for reasons including, but not limited to, fixed manufacturing costs that will not decrease in tandem with lower revenues due to the flooding in Thailand, unfavorable production yields or variances, increases in costs of input parts and materials, the timing of movements in our inventory balances, warranty costs and related returns, changes in foreign currency exchange rates, and possible exposure to inventory valuation reserves. Any failure to maintain, or improve, our gross margins will adversely affect our financial results, including our goal to achieve sustainable cash flow positive operations.

Our business and results of operations may be negatively impacted by general economic and financial market conditions and such conditions may increase the other risks that affect our business.

Over the past few years, the world’s financial markets have experienced significant turmoil, resulting in reductions in available credit, increased costs of credit, extreme volatility in security prices, potential changes to existing credit terms, rating downgrades of investments and reduced valuations of securities generally. In light of these economic conditions, many of our customers reduced their spending plans, leading them to draw down their existing inventory and reduce orders for our products. It is possible that economic conditions could result in further setbacks, and that these customers, or others, could as a result significantly reduce their capital expenditures, draw down their inventories, reduce production levels of existing products, defer introduction of new products or place orders and accept delivery for products for which they do not pay us due to their economic difficulties or other reasons. These actions could have an adverse impact on our revenues. In addition, the financial downturn affected the financial strength of certain of our customers, including their ability to obtain credit to finance purchases of our products, and could adversely affect additional customers in the future. Our suppliers may also be adversely affected by economic conditions that may impact their ability to provide important components used in our manufacturing processes on a timely basis, or at all.

These conditions could also result in reduced capital resources because of the potential lack of credit availability, higher costs of credit and the stretching of payables by creditors seeking to preserve their own cash resources. We are unable to predict the likely duration, severity and potential continuation of any disruption in financial markets and adverse economic conditions in the U.S. and other countries, but the longer the duration the greater the risks we face in operating our business.

Our success will depend on our ability to anticipate and respond to evolving technologies and customer requirements.

The market for telecommunications equipment is characterized by substantial capital investment, rapid and unpredictable changes in customer demand and diverse and evolving technologies. For example, the market for optical components is currently characterized by a trend toward the adoption of pluggable components and tunable transmitters that do not require the customized interconnections of traditional fixed wavelength “gold box” devices

 

38


Table of Contents

and the increased integration of components on subsystems. Our ability to anticipate and respond to these and other changes in technology, industry standards, customer requirements and product offerings and to develop and introduce new and enhanced products will be significant factors in our ability to succeed. We expect that new technologies will continue to emerge as competition in the telecommunications industry increases and the need for higher and more cost efficient bandwidth expands. The introduction of new products embodying new technologies or the emergence of new industry standards could render our existing products or products in development uncompetitive from a pricing standpoint, obsolete or unmarketable, which would negatively affect our financial condition and results of operations.

We depend on a limited number of customers for a significant percentage of our revenues.

Historically, we have generated most of our revenues from a limited number of customers. Our dependence on a limited number of customers is due to the fact that the optical telecommunications systems industry is dominated by a small number of large companies. These companies in turn depend primarily on a limited number of major telecommunications carrier customers to purchase their products that incorporate our optical components. For example, for the nine months ended March 31, 2012 and the years ended July 2, 2011 and July 3, 2010, our three largest customers accounted for 32 percent, 36 percent and 29 percent of our revenues, respectively. Because we rely on a limited number of customers for significant percentages of our revenues, a decrease in demand for our products from any of our major customers for any reason (including due to market conditions, catastrophic events or otherwise) could have a materially adverse impact on our financial conditions and results of operations. For example, our revenues for the fiscal quarter ended July 2, 2011 were adversely impacted by a change in customer demand expectations, including a significant change in demand expectations from a particular major customer. Further, the industry in which our customers operate is subject to a trend of consolidation. To the extent this trend continues, we may become dependent on even fewer customers to maintain and grow our revenues.

The majority of our long-term customer contracts do not commit customers to specified buying levels, and our customers may decrease, cancel or delay their buying levels at any time with little or no advance notice to us.

The majority of our customers typically purchase our products pursuant to individual purchase orders or contracts that do not contain purchase commitments. Some customers provide us with their expected forecasts for our products several months in advance, but many of these customers may decrease, cancel or delay purchase orders already in place, and the impact of any such actions may be intensified given our dependence on a small number of large customers. If any of our major customers decrease, stop or delay purchasing our products for any reason, our business and results of operations would be harmed. Cancellation or delays of such orders may cause us to fail to achieve our short-term and long-term financial and operating goals and result in excess and obsolete inventory. For example, in mid-September 2010, we did experience certain deferrals and cancellation of orders which adversely impacted our financial results. In addition, our revenues for the fiscal quarter ended July 2, 2011 were adversely impacted by a change in customer demand expectations, including a significant change in demand expectations from a particular major customer.

We have significant manufacturing and research and development operations in China, which exposes us to risks inherent in doing business in China.

The majority of our assembly and test operations, chip-on-carrier operations and manufacturing and supply chain management operations are concentrated in our facility in Shenzhen, China. In addition, we have substantial research and development related activities in Shenzhen and Shanghai, China. To be successful in China we will need to:

 

   

qualify our manufacturing lines and the products we produce in Shenzhen, as required by our customers;

 

   

attract and retain qualified personnel to operate our Shenzhen facility; and

 

   

attract and retain research and development employees at our Shenzhen and Shanghai facilities.

We cannot be assured that we will be able to do any of these.

 

39


Table of Contents

Employee turnover in China is high due to the intensely competitive and fluid market for skilled labor. To operate our Shenzhen facility under these conditions, we will need to continue to hire direct manufacturing personnel, administrative personnel and technical personnel; obtain and retain required legal authorization to hire such personnel; and incur the time and expense to hire and train such personnel. On March 28, 2012, shortly after announcing this agreement with Venture, certain of our employees in Shenzhen initiated a work stoppage. The work stoppage impacted our Shenzhen manufacturing capabilities temporarily up to and including April 4, 2012. Revenues for the quarter ended March 31, 2012 were adversely impacted by approximately $4 million by the work stoppage, which has since been resolved.

Inflation rates in China are higher than in most jurisdictions in which we operate. We believe that salary inflation rates for the skilled personnel we hire and seek to retain in Shenzhen and Shanghai are likely to be higher than overall inflation rates.

Operations in China are subject to greater political, legal and economic risks than our operations in other countries. In particular, the political, legal and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our ability to operate in China may be adversely affected by changes in Chinese laws and regulations such as those related to, among other things, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property, currency controls, employee benefits and other matters. In addition, we may not obtain or retain the requisite legal permits to continue to operate in China, and costs or operational limitations may be imposed in connection with obtaining and complying with such permits.

We intend to continue to export the products manufactured at our Shenzhen facility for the estimated three year period of transfer of production to Venture. Under current regulations, upon application and approval by the relevant governmental authorities, we will not be subject to certain Chinese taxes and will be exempt from certain duties on imported materials that are used in the manufacturing process and subsequently exported from China as finished products. However, Chinese trade regulations are in a state of flux, and we may become subject to other forms of taxation and duties in China or may be required to pay export fees in the future. In the event that we become subject to new forms of taxation or export fees in China, our business and results of operations could be materially adversely affected. We may also be required to expend greater amounts than we currently anticipate in connection with increasing production in product lines active at our Shenzhen facility, even while in the process of transitioning product lines to Venture. Any one of the factors cited above, or a combination of them, could result in unanticipated costs or interruptions in production, which could materially and adversely affect our business.

Our results of operations may suffer if we do not effectively manage our inventory, and we may incur inventory-related charges.

We need to manage our inventory of component parts and finished goods effectively to meet changing customer requirements. Accurately forecasting customers’ product needs is difficult. Even though our inventory balances decreased to $72.7 million as of March 31, 2012 from $102.2 million as of July 2, 2011, our quarterly revenues also decreased, to $88.7 million for the fiscal quarter ended March 31, 2012 from $109.2 million for the fiscal quarter ended July 2, 2011. Some of our products and supplies have in the past, and may in the future, become obsolete while in inventory due to rapidly changing customer specifications or a decrease in customer demand. We also have exposure to contractual liabilities to our contract manufacturers for inventories purchased by them on our behalf, based on our forecasted requirements, which may become excess or obsolete. Our inventory balances also represent an investment of cash. To the extent our inventory turns are slower than we anticipate based on historical practice, our cash conversion cycle extends and more of our cash remains invested in working capital. If we are not able to manage our inventory effectively, we may need to write down the value of some of our existing inventory or write off non-saleable or obsolete inventory. We have from time to time incurred significant inventory-related charges. Any such charges we incur in future periods could materially and adversely affect our results of operations. Should we enter into a contract to transition our Shenzhen manufacturing facility to a major contract manufacturer we may need to invest in additional inventories during the corresponding transition period, and in the future may be exposed to contractual liabilities to the new contract manufacturer for inventories purchased by them on our behalf.

 

40


Table of Contents

Sales of our products could decline if customer and/or supplier relationships are disrupted by our recent acquisition activities.

The customers of acquired businesses, and/or of predecessor companies, may not continue their historical buying patterns. Customers may defer purchasing decisions as they evaluate the likelihood of successful integration of our products and our future product strategy, or consider purchasing products of our competitors.

Customers may also seek to modify or terminate existing agreements, or prospective customers may delay entering into new agreements or purchasing our products or may decide not to purchase any products from us. In addition, by increasing the breadth of our business, the transactions may make it more difficult for us to enter into relationships, including customer relationships, with strategic partners, some of whom may view us as a more direct competitor than any of the predecessor and/or acquired businesses as independent companies.

Competitive positions in the market, including relative to suppliers who are also competitors, could change as a result of an acquisition, and this could impact supplier relationships, including the terms under which we do business with such suppliers.

As a result of our recent business combinations, we have become a larger and more geographically diverse organization, with greater available market opportunities. If our management is unable to manage the combined organization efficiently, including the challenges of managing the growth potentially available from expanded market opportunities, our operating results will suffer.

As of March 31, 2012, we had approximately 2,692 employees in a total of 15 facilities around the world. As a result, we face challenges inherent in efficiently managing an increased number of employees over large geographic distances, including the need to implement appropriate systems, policies, benefits and compliance programs. Our inability to manage successfully the geographically more diverse (including from a cultural perspective) and substantially larger combined organization could have a material adverse effect on our operating results and, as a result, on the market price of our common stock. Certain of these acquisitions have increased our serviceable available markets and scaling the company to address the growth potentially available from addressing these markets, and potentially available within our previously existing markets, creates additional challenges of a similar nature.

Our products are complex and may take longer to develop than anticipated and we may not recognize revenues from new products until after long field testing and customer acceptance periods.

Many of our new products must be tailored to customer specifications. As a result, we are developing new products and using new technologies in those products. For example, while we currently manufacture and sell discrete “gold box” technology, we expect that many of our sales of “gold box” technology will soon be replaced by pluggable modules. New products or modifications to existing products often take many quarters or even years to develop because of their complexity and because customer specifications sometimes change during the development cycle. We often incur substantial costs associated with the research and development, design, sales and marketing activities in connection with products that may be purchased long after we have incurred such costs. In addition, due to the rapid technological changes in our market, a customer may cancel or modify a design project before we begin large-scale manufacture of the product and receive revenues from the customer. It is unlikely that we would be able to recover the expenses for cancelled or unutilized design projects. It is difficult to predict with any certainty, particularly in the present economic climate, the frequency with which customers will cancel or modify their projects, or the effect that any cancellation or modification would have on our results of operations.

As a result of our global operations, our business is subject to currency fluctuations that have adversely affected our results of operations in recent quarters and may continue to do so in the future.

Our financial results have been and will continue to be materially impacted by foreign currency fluctuations. At certain times in our history, declines in the value of the U.S. dollar versus the U.K. pound sterling have had a major negative effect on our margins and our cash flow. A significant portion of our expenses are denominated in U.K. pounds sterling and substantially all of our revenues are denominated in U.S. dollars.

 

41


Table of Contents

Fluctuations in the exchange rate between these two currencies and, to a lesser extent, other currencies in which we collect revenues and/or pay expenses could have a material effect on our future operating results. For example during fiscal year 2011, the Swiss franc appreciated approximately 28 percent relative to the U.S. dollar, and the U.K. pound sterling appreciated 7 percent relative to the U.S. dollar, causing increases of approximately $3.1 million related to the Swiss franc and $4.4 million related to the U.K. pound sterling, respectively, in our annual manufacturing overhead and operating expenses. If the U.S. dollar maintains the same value or depreciates relative to the Swiss franc and/or U.K. pound sterling in the future, our future operating results may be materially impacted. Additional exposure could also result should the exchange rate between the U.S. dollar and the Chinese yuan, the South Korean won, the Israeli shekel, or the Euro vary more significantly than they have to date.

We engage in currency hedging transactions in an effort to cover some of our exposure to U.S. dollar to U.K. pound sterling currency fluctuations, and we may be required to convert currencies to meet our obligations. These transactions may not operate to fully hedge our exposure to currency fluctuations, and under certain circumstances, these transactions could have an adverse effect on our financial condition.

We may record additional impairment charges that will adversely impact our results of operations.

We review our goodwill, intangible assets and long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amounts of these assets may not be recoverable, and also review goodwill annually.

During the fourth quarter of fiscal year 2011 we completed our annual first step analysis for potential impairment of our goodwill, which included examining the impact of current general economic conditions on our future prospects and the current level of our market capitalization. Based on this analysis, we concluded that goodwill related to our WSS reporting unit was impaired. Our WSS reporting unit’s goodwill was originally recorded in connection with our acquisition of Xtellus. During the fourth quarter of fiscal year 2011 we also completed our second step analysis of goodwill impairment, determining that the $20.0 million of goodwill related to our WSS reporting unit was fully impaired. Based upon this evaluation, we recorded $20.0 million for the goodwill impairment loss in our consolidated statement of operations for the fiscal year ended July 2, 2011.

As of March 31, 2012, we had $10.9 million in goodwill and $17.5 million in other intangible assets on our condensed consolidated balance sheet. In the event that we determine in a future period that impairment of our goodwill, other intangible assets or long-lived assets exists for any reason, we would record additional impairment charges in the period such determination is made, which would adversely impact our financial position and results of operations.

We may incur additional significant restructuring charges that will adversely affect our results of operations.

We have previously enacted a series of restructuring plans and cost reduction plans designed to reduce our manufacturing overhead and our operating expenses that have resulted in significant restructuring charges. Such charges have adversely affected, and will continue to adversely affect, our results of operations for the periods in which such charges have been, or will be, incurred. Additionally, actual costs have in the past, and may in the future, exceed the amounts estimated and provided for in our financial statements. Significant additional charges could materially and adversely affect our results of operations in the periods that they are incurred and recognized.

For instance, we accrued $2.2 million in restructuring charges during fiscal year 2010 in connection with our merger with Avanex. On July 4, 2009, we completed the exchange of our New Focus business to Newport in exchange for Newport’s high powered laser diode business, which resulted in us incurring $0.5 million in restructuring charges in fiscal year 2010 in connection with the transfer of the Tucson manufacturing operations to our European facilities. During fiscal year 2011, we incurred $0.6 million in restructuring charges related to a restructuring plan specific to our acquisition of Mintera.

 

42


Table of Contents

If our customers do not qualify our manufacturing lines or the manufacturing lines of our subcontractors for volume shipments, our operating results could suffer.

Most of our customers do not purchase products, other than limited numbers of evaluation units, prior to qualification of the manufacturing line for volume production. Our existing manufacturing lines, as well as each new manufacturing line, must pass through varying levels of qualification with our customers. Our manufacturing lines have passed our qualification standards, as well as our technical standards. However, our customers also require that our manufacturing lines pass their specific qualification standards and that we, and any subcontractors that we may use, be registered under international quality standards. In addition, we have in the past, and may in the future, encounter quality control issues as a result of relocating our manufacturing lines or introducing new products to fill production. We may be unable to obtain customer qualification of our manufacturing lines or we may experience delays in obtaining customer qualification of our manufacturing lines. Such delays or failure to obtain qualifications would harm our operating results and customer relationships. We are currently evaluating the capabilities of additional potential contract manufacturing partners to ensure we have a scalable and cost effective manufacturing strategy appropriate for executing to our business objectives over a long-term horizon. To the extent we introduce new contract manufacturing partners and move any production lines from existing internal or external facilities the new production lines will likely need to be requalified with customers. Exposures to these risks could increase during the transition of our Shenzhen product lines to Venture Malaysia over what is anticipated to be a two to three year period.

Delays, disruptions or quality control problems in manufacturing could result in delays in product shipments to customers and could adversely affect our business.

We may experience delays, disruptions or quality control problems in our manufacturing operations or the manufacturing operations of our subcontractors. As a result, we could incur additional costs that would adversely affect our gross margins, and our product shipments to our customers could be delayed beyond the shipment schedules requested by our customers, which would negatively affect our revenues, competitive position and reputation. Furthermore, even if we are able to deliver products to our customers on a timely basis, we may be unable to recognize revenues at the time of delivery based on our revenue recognition policies. Exposures to these risks could increase during the transition of our Shenzhen product lines to Venture Malaysia over what is anticipated to be a two to three year period.

We may experience low manufacturing yields.

Manufacturing yields depend on a number of factors, including the volume of production due to customer demand and the nature and extent of changes in specifications required by customers for which we perform design-in work. Higher volumes due to demand for a fixed, rather than continually changing, design generally results in higher manufacturing yields, whereas lower volume production generally results in lower yields. In addition, lower yields may result, and have in the past resulted, from commercial shipments of products prior to full manufacturing qualification to the applicable specifications. Changes in manufacturing processes required as a result of changes in product specifications, changing customer needs and the introduction of new product lines have historically caused, and may in the future cause, significantly reduced manufacturing yields, resulting in low or negative margins on those products. Moreover, an increase in the rejection rate of products during the quality control process, before, during or after manufacture, results in lower yields and margins. Finally, manufacturing yields and margins can also be lower if we receive or inadvertently use defective or contaminated materials from our suppliers. Any reduction in our manufacturing yields will adversely affect our gross margins and could have a material impact on our operating results.

Our intellectual property rights may not be adequately protected.

Our future success will depend, in large part, upon our intellectual property rights, including patents, copyrights, design rights, trade secrets, trademarks and know-how. We maintain an active program of identifying technology appropriate for patent protection. Our practice is to require employees and consultants to execute non-disclosure and proprietary rights agreements upon commencement of employment or consulting arrangements. These agreements acknowledge our exclusive ownership of all intellectual property developed by the individuals during their work for

 

43


Table of Contents

us and require that all proprietary information disclosed will remain confidential. Although such agreements may be binding, they may not be enforceable in full or in part in all jurisdictions and any breach of a confidentiality obligation could have a negative effect on our business and our remedy for such breach may be limited.

Our intellectual property portfolio is an important corporate asset. The steps we have taken and may take in the future to protect our intellectual property may not adequately prevent misappropriation or ensure that others will not develop competitive technologies or products. We cannot assure you that our competitors will not successfully challenge the validity of our patents or design products that avoid infringement of our proprietary rights with respect to our technology. There can be no assurance that other companies are not investigating or developing other similar technologies, that any patents will be issued from any application pending or filed by us or that, if patents are issued, that the claims allowed will be sufficiently broad to deter or prohibit others from marketing similar products. In addition, we cannot assure you that any patents issued to us will not be challenged, invalidated or circumvented, or that the rights under those patents will provide a competitive advantage to us or that our products and technology will be adequately covered by our patents and other intellectual property. Further, the laws of certain regions in which our products are or may be developed, manufactured or sold, including Asia-Pacific, Southeast Asia and Latin America, may not be enforceable to protect our products and intellectual property rights to the same extent as the laws of the United States, the U.K. and continental European countries. This is especially relevant now that we have transferred all of our assembly and test operations and chip-on-carrier operations, including certain engineering-related functions, from our facilities in the U.K. to Shenzhen, China.

Our products may infringe the intellectual property rights of others, which could result in expensive litigation or require us to obtain a license to use the technology from third parties, or we may be prohibited from selling certain products in the future.

Companies in the industry in which we operate frequently are sued or receive informal claims of patent infringement or infringement of other intellectual property rights. We have, from time to time, received such claims, including from competitors and from companies that have substantially more resources than us.

Third parties may in the future assert claims against us concerning our existing products or with respect to future products under development, or with respect to products that we may acquire through acquisitions. We have entered into and may in the future enter into indemnification obligations in favor of some customers that could be triggered upon an allegation or finding that we are infringing other parties’ proprietary rights. If we do infringe a third party’s rights, we may need to negotiate with holders of those rights in order to obtain a license to those rights or otherwise settle any infringement claim. We have from time to time received notices from third parties alleging infringement of their intellectual property and where appropriate have entered into license agreements with those third parties with respect to that intellectual property. Any license agreements that we wish to enter into the future with respect to intellectual property rights may not be available to us on commercially reasonable terms, or at all. We may not in all cases be able to resolve allegations of infringement through licensing arrangements, settlement, alternative designs or otherwise. We may take legal action to determine the validity and scope of the third-party rights or to defend against any allegations of infringement. The recent economic downturn could result in holders of intellectual property rights becoming more aggressive in alleging infringement of their intellectual property rights and we may be the subject of such claims asserted by a third party. In the course of pursuing any of these means or defending against any lawsuits filed against us, we could incur significant costs and diversion of our resources and our management’s attention. Due to the competitive nature of our industry, it is unlikely that we could increase our prices to cover such costs. In addition, such claims could result in significant penalties or injunctions that could prevent us from selling some of our products in certain markets or result in settlements or judgments that require payment of significant royalties or damages.

If we fail to obtain the right to use the intellectual property rights of others necessary to operate our business, our business and results of operations will be materially and adversely affected.

Certain companies in the telecommunications and optical components markets in which we sell our products have experienced frequent litigation regarding patent and other intellectual property rights. Numerous patents in these industries are held by others, including academic institutions and our competitors. Optical component suppliers may seek to gain a competitive advantage or other third parties, inside or outside our market, may seek an economic return on their intellectual property portfolios by making infringement claims against us. We currently in-

 

44


Table of Contents

license certain intellectual property of third parties, and in the future, we may need to obtain license rights to patents or other intellectual property held by others to the extent necessary for our business. Unless we are able to obtain such licenses on commercially reasonable terms, patents or other intellectual property held by others could be used to inhibit or prohibit our production and sale of existing products and our development of new products for our markets. Licenses granting us the right to use third-party technology may not be available on commercially reasonable terms, or at all. Generally, a license, if granted, would include payments of up-front fees, ongoing royalties or both. These payments or other terms could have a significant adverse impact on our operating results. In addition, in the event we are granted such a license, it is likely such license would be non-exclusive and other parties, including competitors, may be able to utilize such technology. Our larger competitors may be able to obtain licenses or cross-license their technology on better terms than we can, which could put us at a competitive disadvantage. In addition, our larger competitors may be able to buy such technology and preclude us from licensing or using such technology.

The inability to obtain government licenses and approvals for desired international trading activities or technology transfers may prevent the profitable operation of our business.

Many of our present and future business activities are subject to licensing by the United States government under the Export Administration Act, the Export Administration Regulations and other laws, regulations and requirements governing international trade and technology transfer. We presently manufacture products in China and Thailand that require such licenses. The profitable operations of our business may require the continuity of these licenses and may require further licenses and approvals for future products in these and other countries. However, there is no certainty to the continuity of these licenses, nor that further desired licenses and approvals may be obtained.

The markets in which we operate are highly competitive, which could result in lost sales and lower revenues.

The market for optical components and modules is highly competitive and this competition could result in our existing customers moving their orders to our competitors. We are aware of a number of companies that have developed or are developing optical component products, including tunable lasers, pluggables, wavelength selective switches and thin film filter products, among others, that compete directly with our current and proposed product offerings.

Certain of our competitors may be able to more quickly and effectively:

 

   

develop or respond to new technologies or technical standards;

 

   

react to changing customer requirements and expectations;

 

   

devote needed resources to the development, production, promotion and sale of products; and

 

   

deliver competitive products at lower prices.

Some of our current competitors, as well as some of our potential competitors, have longer operating histories, greater name recognition, broader customer relationships and industry alliances and substantially greater financial, technical and marketing resources than we do. In addition, market leaders in industries such as semiconductor and data communications, who may also have significantly more resources than we do, may in the future enter our market with competing products. Our competitors and new Chinese companies are establishing manufacturing operations in China to take advantage of comparatively low manufacturing costs. All of these risks may be increased if the market were to further consolidate through mergers or other business combinations between competitors.

Certain of our competitors may not be impacted by the flooding in Thailand and this may place competitive pressures on our ability to recover our flood-affected revenue losses.

We may not be able to compete successfully with our competitors and aggressive competition in the market may result in lower prices for our products and/or decreased gross margins. Any such development could have a material adverse effect on our business, financial condition and results of operations.

 

45


Table of Contents

We generate a significant portion of our revenues internationally and therefore are subject to additional risks associated with the extent of our international operations.

For the nine months ended March 31, 2012 and the fiscal years ended July 2, 2011 and July 3, 2010, 17 percent, 17 percent and 19 percent of our revenues, respectively, were derived from sales to customers located in the United States and 83 percent, 83 percent and 81 percent of our revenues, respectively, were derived from sales to customers located outside the United States. We are subject to additional risks related to operating in foreign countries, including:

 

   

currency fluctuations, which could result in increased operating expenses and reduced revenues;

 

   

greater difficulty in accounts receivable collection and longer collection periods;

 

   

difficulty in enforcing or adequately protecting our intellectual property;

 

   

ability to hire qualified candidates;

 

   

foreign taxes;

 

   

political, legal and economic instability in foreign markets;

 

   

foreign regulations;

 

   

changes in, or impositions of, legislative or regulatory requirements;

 

   

trade restrictions, including restrictions imposed by the United States government on trading with parties in foreign countries;

 

   

transportation delays;

 

   

epidemics and illnesses;

 

   

terrorism and threats of terrorism;

 

   

work stoppages and infrastructure problems due to adverse weather conditions or natural disasters;

 

   

work stoppages related to employee dissatisfaction;

 

   

changes in import/export regulations, tariffs, and freight rates; and

 

   

the effective protections of, and the ability to enforce, contractual arrangements.

Any of these risks, or any other risks related to our foreign operations, could materially adversely affect our business, financial condition and results of operations.

Changes in effective tax rates or adverse outcomes resulting from examination of our income tax returns could adversely affect our results.

Our future effective tax rates could be adversely affected by earnings being lower than anticipated in countries where we have lower statutory rates and higher than anticipated in countries where we have higher statutory rates, by changes in the valuation of our deferred tax assets and liabilities, or by changes in tax laws, regulations, accounting principles or interpretations thereof. In addition, we are subject to the continuous examination of our income tax returns by the Internal Revenue Service and other tax authorities. We regularly assess the likelihood of adverse outcomes resulting from these examinations to determine the adequacy of our provision for income taxes. There can be no assurance that the outcomes from these continuous examinations will not have an adverse effect on our operating results and financial condition.

 

46


Table of Contents

We may face product liability claims.

Despite quality assurance measures, defects may occur in our products. The occurrence of any defects in our products could give rise to liability for damages caused by such defects, including consequential damages. Such defects could, moreover, impair market acceptance of our products. Both could have a material adverse effect on our business and financial condition. In addition, we may assume product warranty liabilities related to companies we acquire, which could have a material adverse effect on our business and financial condition. In order to mitigate the risk of liability for damages, we carry product liability insurance with a $25.0 million aggregate annual limit and errors and omissions insurance with a $5.0 million annual limit. We cannot assure you that this insurance would adequately cover our costs arising from any defects in our products or otherwise.

If we fail to attract and retain key personnel, our business could suffer.

Our future success depends, in part, on our ability to attract and retain key personnel. Competition for highly skilled technical personnel is extremely intense and we continue to face difficulty identifying and hiring qualified engineers in many areas of our business. We may not be able to hire and retain such personnel at compensation levels consistent with our existing compensation and salary structure. Our future success also depends on the continued contributions of our executive management team and other key management and technical personnel, each of whom would be difficult to replace. The loss of services of these or other executive officers or key personnel or the inability to continue to attract qualified personnel could have a material adverse effect on our business.

In addition, certain employees of companies we have acquired that are now employed by us may decide to no longer work for us with little or no notice for a number of reasons, including dissatisfaction with our corporate culture, compensation, and new roles or responsibilities, among others.

Our business and operating results may be adversely affected by natural disasters or other catastrophic events beyond our control.

Our business and operating results are vulnerable to natural disasters, such as earthquakes, fires and floods, as well as other events beyond our control such as power loss, telecommunications failures and uncertainties arising out of terrorist attacks in the United States and armed conflicts overseas. For example, in the second and third quarters of fiscal year 2012, our results of operations were materially and adversely impacted by the flooding in Thailand, and we expect the results of the flooding in Thailand to continue to materially and adversely impact our results of operations for at least the next fiscal quarter. Additionally, our corporate headquarters and a portion of our research and development and manufacturing operations are located in Silicon Valley, California. This region in particular has been vulnerable to natural disasters, such as earthquakes. The occurrence of any of these events could pose physical risks to our property and personnel, which may adversely affect our ability to produce and deliver products to our customers. Although we presently maintain insurance against certain of these events, we cannot be certain that our insurance will be adequate to cover any damage sustained by us or by our customers.

RISKS RELATED TO REGULATORY COMPLIANCE AND LITIGATION

We are subject to anti-corruption laws in the jurisdictions in which we operate, including the U.S. Foreign Corrupt Practices Act, or the FCPA. Our failure to comply with these laws could result in penalties which could harm our reputation and have a material adverse effect on our business, results of operations and financial condition.

We are subject to the FCPA, which generally prohibits companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or keeping business and/or other benefits, along with various other anticorruption laws. Although we have implemented policies and procedures designed to ensure that we, our employees and other intermediaries comply with the FCPA and other anticorruption laws to which we are subject, there is no assurance that such policies or procedures will work effectively all of the time or protect us against liability under the FCPA or other laws for actions taken by our employees and other intermediaries with respect to our business or any businesses that we may acquire. We have manufacturing operations in China and other jurisdictions, many of which pose elevated risks of anti-corruption violations, and we export our products for sale internationally. This puts us in frequent contact with persons who may be considered “foreign officials” under

 

47


Table of Contents

the FCPA, resulting in an elevated risk of potential FCPA violations. If we are not in compliance with the FCPA and other laws governing the conduct of business with government entities (including local laws), we may be subject to criminal and civil penalties and other remedial measures, which could have an adverse impact on our business, financial condition, results of operations and liquidity. Any investigation of any potential violations of the FCPA or other anticorruption laws by U.S. or foreign authorities could harm our reputation and have an adverse impact on our business, financial condition and results of operations.

A lack of effective internal control over our financial reporting could result in an inability to report our financial results accurately, which could lead to a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

In April 2012, in connection with the restatement of our previously issued consolidated financial statements as of and for the quarters ended December 31, 2011 and October 1, 2011, our management re-evaluated the effectiveness of our disclosure controls and procedures. As a result of that re-evaluation, our management determined that a material weakness existed in our internal controls over financial reporting such that our disclosure controls and procedures related to accounting for income taxes were not effective as of December 31, 2011 and October 1, 2011. Additional information regarding the prior period restatements are contained in Note 1 to the condensed consolidated financial statements included as part of Amendment No. 1 to Quarterly Report on Form 10-Q for each of the respective quarters. During the quarter ended March 31, 2012, we implemented enhancements to our internal controls over financial reporting, including adding additional monitoring controls over the preparation and filing of foreign income tax returns. Our remediation efforts, including the testing of these controls will continue throughout our fiscal year 2012. We expect that the material weakness will be considered remediated in the fourth quarter of fiscal year 2012 once these controls have been operational for a sufficient period of time to allow management to conclude that these controls are operating effectively. However, we cannot assure you that our efforts to fully remediate this internal control weakness will be successful or that similar material weaknesses will not recur. If additional material weaknesses or significant deficiencies in our internal control are discovered or occur in the future, our condensed consolidated financial statements may contain material misstatements and we could be required to restate our financial results.

Effective internal controls over financial reporting are necessary for us to provide reliable financial reports. If we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed. Our failure to implement and maintain effective internal control over financial reporting could result in a material misstatement of our financial statements or otherwise cause us to fail to meet our financial reporting obligations. This, in turn, could result in a loss of investor confidence in the accuracy and completeness of our financial reports, which could have an adverse effect on our business, financial condition, operating results and our stock price, and we could be subject to stockholder litigation as a result. Even if we are able to implement and maintain effective internal control over financial reporting, the costs of doing business may increase and our management may be required to dedicate greater time and resources to that effort. In addition, we have in the past, and may in the future, acquire companies that have either experienced material weaknesses in their internal controls over financial reporting or have had no previous reporting obligations under Sarbanes-Oxley. Failure to integrate acquired businesses into our internal controls over financial reporting could cause those controls to fail.

Litigation may substantially increase our costs and harm our business.

We are a party to numerous lawsuits and will continue to incur legal fees and other costs related thereto, including potentially expenses for the reimbursement of legal fees of officers and directors under indemnification obligations. The expense of continuing to defend such litigation may be significant. In addition, there can be no assurance that we will be successful in any defense. Further, the amount of time that will be required to resolve these lawsuits is unpredictable and these actions may divert management’s attention from the day-to-day operations of our business, which could adversely affect our business, results of operations and cash flows. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters that may arise from time to time could have a material adverse effect on our business, results of operations and financial condition.

For a description of our current material litigation, see Part II, Item 1 – Legal Proceedings of this Quarterly Report on Form 10-Q.

In addition, from time to time, we have been a party to certain intellectual property infringement litigation as more fully described above under “Risks Related to Our Business — Our products may infringe the intellectual property rights of others, which could result in expensive litigation or require us to obtain a license to use the technology from third parties, or we may be prohibited from selling certain products in the future.”

 

48


Table of Contents

Our business involves the use of hazardous materials, and we are subject to environmental and import/export laws and regulations that may expose us to liability and increase our costs.

We historically handled hazardous materials as part of our manufacturing activities. Consequently, our operations are subject to environmental laws and regulations governing, among other things, the use and handling of hazardous substances and waste disposal. We may incur costs to comply with current or future environmental laws. As with other companies engaged in manufacturing activities that involve hazardous materials, a risk of environmental liability is inherent in our manufacturing activities, as is the risk that our facilities will be shut down in the event of a release of hazardous waste, or that we would be subject to extensive monetary liabilities. The costs associated with environmental compliance or remediation efforts or other environmental liabilities could adversely affect our business. Under applicable European Union regulations, we, along with other electronics component manufacturers, are prohibited from using lead and certain other hazardous materials in our products. We could lose business or face product returns if we fail to maintain these requirements properly.

In addition, the sale and manufacture of certain of our products require on-going compliance with governmental security and import/export regulations. We may, in the future, be subject to investigation which may result in fines for violations of security and import/export regulations. Furthermore, any disruptions of our product shipments in the future, including disruptions as a result of efforts to comply with governmental regulations, could adversely affect our revenues, gross margins and results of operations.

RISKS RELATED TO OUR COMMON STOCK

A variety of factors could cause the trading price of our common stock to be volatile or to decline and we may incur significant costs from class action litigation due to our expected stock volatility.

The trading price of our common stock has been, and is likely to continue to be, highly volatile. Many factors could cause the market price of our common stock to rise and fall. In addition to the matters discussed in other risk factors included herein, some of the reasons for the fluctuations in our stock price are:

 

   

fluctuations in our results of operations, including our gross margins;

 

   

changes in our business, operations or prospects;

 

   

hiring or departure of key personnel;

 

   

new contractual relationships with key suppliers or customers by us or our competitors;

 

   

proposed acquisitions by us or our competitors;

 

   

financial results or projections that fail to meet public market analysts’ expectations and changes in stock market analysts’ recommendations regarding us, other optical technology companies or the telecommunication industry in general;

 

   

future sales of common stock, or securities convertible into or exercisable for common stock;

 

   

adverse judgments or settlements obligating us to pay damages;

 

   

future issuances of common stock in connection with acquisitions or other transactions;

 

   

acts of war, terrorism, natural disasters and other events that are either unanticipated or uncontrollable by us;

 

   

industry, domestic and international market and economic conditions, including the global macroeconomic downturn over the last three years and related sovereign debt issues in certain parts of the world;

 

   

low trading volume in our stock;

 

   

developments relating to patents or property rights; and

 

   

government regulatory changes.

 

49


Table of Contents

In connection with our acquisition of Xtellus, during the first quarter of fiscal year 2012 we issued 0.9 million shares of our common stock to settle our escrow liability. In October 2011, we issued 0.8 million shares of our common stock to pay portions of the 12 month earnout obligations associated with our acquisition of Mintera. These issuances and the subsequent sale of these shares will dilute our existing stockholders and could potentially have a negative impact on our stock price.

Our shares of common stock have experienced substantial price and volume fluctuations, in many cases without any direct relationship to our operating performance. An outgrowth of this market volatility is the significant vulnerability of our stock price to any actual or perceived fluctuation in the strength of the markets we serve, regardless of the actual consequence of such fluctuations. As a result, the market price for our stock is highly volatile. These broad market and industry factors have caused the market price of our common stock to fluctuate, and may in the future cause the market price of our common stock to fluctuate, regardless of our actual operating performance.

We are subject to pending securities class action and shareholder derivative legal proceedings.

When the market price of a stock experiences a sharp decline, as our stock price recently has, holders of that stock have occasionally brought securities class action litigation against the company that issued the stock. Several securities class action lawsuits have been filed against us and certain of our current and former officers and directors. Each purported derivative complaint alleges, among other things, counts for breaches of fiduciary duty, waste, and unjust enrichment. For a description of these lawsuits, see Part II, Item 1 – Legal Proceedings of this Quarterly Report on Form 10-Q. These lawsuits will likely divert the time and attention of our management. In addition, if these suits are resolved in a manner adverse to us, the damages we could be required to pay may be substantial and could have an adverse impact on our results of operations and our ability to operate our business.

Fluctuations in our operating results could adversely affect the market price of our common stock.

Our revenues and other operating results are likely to fluctuate significantly in the future. In particular, we anticipate that our results of operations will be adversely affected for at least the next fiscal quarter as a result of the flooding in Thailand. In addition, the timing of order placement, size of orders and satisfaction of contractual customer acceptance criteria, changes in the pricing of our products due to competitive pressures as well as order or shipment delays or deferrals, with respect to our products, may cause material fluctuations in revenues. Our lengthy sales cycle, which may extend to more than one year, may cause our revenues and operating results to vary from period to period and it may be difficult to predict the timing and amount of any variation. Delays or deferrals in purchasing decisions by our customers may increase as we develop new or enhanced products for new markets, including data communications, industrial, research, consumer and biotechnology markets. Our current and anticipated future dependence on a small number of customers increases the revenue impact of each such customer’s decision to delay or defer purchases from us, or decision not to purchase products from us. Our expense levels in the future will be based, in large part, on our expectations regarding future revenue sources and, as a result, operating results for any quarterly period in which material orders fail to occur, or are delayed or deferred, could vary significantly.

Because of these and other factors, quarter-to-quarter comparisons of our results of operations may not be indicative of our future performance. In future periods, our results of operations may differ, in some cases materially, from the estimates of public market analysts and investors. Such a discrepancy, or our failure to meet published financial projections, could cause the market price of our common stock to decline.

We may not be able to raise capital when desired on favorable terms without dilution to our stockholders, or at all.

As of March 31, 2012, we held $50.5 million in cash and cash equivalents and $0.6 million in restricted cash. The rapidly changing industry in which we operate, the length of time between developing and introducing a product to market and frequent changing customer specifications for products, among other things, makes our prospects difficult to evaluate. It is possible that we may not generate sufficient cash flow from operations, or be

 

50


Table of Contents

able to draw down on our $45.0 million senior secured revolving credit facility, or otherwise have sufficient capital resources to meet our future capital needs. If this occurs, we may need additional financing to execute on our current or future business strategies.

If we raise funds through the issuance of equity, equity-linked or convertible debt securities, our stockholders may be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of securities held by existing stockholders. If we raise funds through the issuance of debt instruments, the agreements governing such debt instruments may contain covenant restrictions that limit our ability to, among other things: (i) incur additional debt, assume obligations in connection with letters of credit, or issue guarantees; (ii) create liens; (iii) make certain investments or acquisitions; (iv) enter into transactions with our affiliates; (v) sell certain assets; (vi) redeem capital stock or make other restricted payments; (vii) declare or pay dividends or make other distributions to stockholders; and (viii) merge or consolidate with any entity. We cannot assure you that additional financing will be available on terms favorable to us, or at all. If adequate funds are not available or are not available on acceptable terms, if and when needed, our ability to fund our operations, develop or enhance our products, or otherwise respond to competitive pressures and operate effectively could be significantly limited.

Because we do not intend to pay dividends, stockholders will benefit from an investment in our common stock only if it appreciates in value.

We have never declared or paid any dividends on our common stock. We anticipate that we will retain any future earnings to support operations and to finance the development of our business and do not expect to pay cash dividends in the foreseeable future. As a result, the success of an investment in our common stock will depend entirely upon any future appreciation in its value. There is no guarantee that our common stock will appreciate in value or even maintain the price at which stockholders have purchased their shares.

We can issue shares of preferred stock that may adversely affect your rights as a stockholder of our common stock.

Our certificate of incorporation authorizes us to issue up to 1,000,000 shares of preferred stock with designations, rights and preferences determined from time-to-time by our board of directors. Accordingly, our board of directors is empowered, without stockholder approval, to issue preferred stock with dividend, liquidation, conversion, voting or other rights superior to those of holders of our common stock. For example, an issuance of shares of preferred stock could:

 

   

adversely affect the voting power of the holders of our common stock;

 

   

make it more difficult for a third-party to gain control of us;

 

   

discourage bids for our common stock at a premium;

 

   

limit or eliminate any payments that the holders of our common stock could expect to receive upon our liquidation; or

 

   

otherwise adversely affect the market price of our common stock.

We may in the future issue shares of authorized preferred stock at any time.

Delaware law and our charter documents contain provisions that could discourage or prevent a potential takeover, even if such a transaction would be beneficial to our stockholders.

Some provisions of our certificate of incorporation and bylaws, as well as provisions of Delaware law, may discourage, delay or prevent a merger or acquisition that a stockholder may consider favorable. These include provisions:

 

   

authorizing the board of directors to issue preferred stock;

 

51


Table of Contents
   

prohibiting cumulative voting in the election of directors;

 

   

limiting the persons who may call special meetings of stockholders;

 

   

prohibiting stockholder actions by written consent;

 

   

creating a classified board of directors pursuant to which our directors are elected for staggered three-year terms;

 

   

permitting the board of directors to increase the size of the board and to fill vacancies;

 

   

requiring a super-majority vote of our stockholders to amend our bylaws and certain provisions of our certificate of incorporation; and

 

   

establishing advance notice requirements for nominations for election to the board of directors or for proposing matters that can be acted on by stockholders at stockholder meetings.

We are subject to the provisions of Section 203 of the Delaware General Corporation Law which limit the right of a corporation to engage in a business combination with a holder of 15 percent or more of the corporation’s outstanding voting securities, or certain affiliated persons. We do not currently have a stockholder rights plan in place.

Although we believe that these charter and bylaw provisions, and provisions of Delaware law, provide an opportunity for the board to assure that our stockholders realize full value for their investment, they could have the effect of delaying or preventing a change of control, even under circumstances that some stockholders may consider beneficial.

 

Item 6. Exhibits

See the Exhibit Index on the page immediately preceding the exhibits for a list of exhibits filed as part of this Quarterly Report on Form 10-Q, which Exhibit Index is incorporated herein by reference.

SIGNATURE

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

OCLARO, INC.

(Registrant)

Date: May 10, 2012   By:  

/s/ Jerry Turin

    Jerry Turin
    Chief Financial Officer
    (Principal Financial and Accounting Officer)

 

52


Table of Contents

EXHIBIT INDEX

 

Exhibit
Number

 

Description of Exhibit

    2.1   Agreement and Plan of Merger dated March 26, 2012, among Oclaro, Inc., Tahoe Acquisition Sub, Inc. and Opnext, Inc. (previously filed as Exhibit 2.1 to Registrant’s Current Report on Form 8-K filed on March 26, 2011 and incorporated herein by reference).
    3.1   Amended and Restated Bylaws of Oclaro, Inc., including Amendments No. 1 and No. 2 thereto (previously filed as Exhibit 3.1 to Registrant’s Registration Statement on Form S-8 dated May 5, 2009 and incorporated herein by reference).
    3.2   Amendment No. 3 to Amended and Restated By-Laws of Oclaro, Inc. (previously filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed on July 28, 2011 and incorporated herein by reference).
    3.3   Restated Certificate of Incorporation of Oclaro, Inc. (previously filed as Exhibit 3.2 to Registrant’s Annual Report on Form 10-K filed on September 1, 2010 and incorporated herein by reference).
  10.1   2011 Employee Stock Purchase Plan (previously filed as Appendix A to our Proxy Statement for our 2011 Annual Meeting of Stockholders, filed with the SEC on September 9, 2011 and incorporated herein by reference).
  10.2   Variable Pay Program (previously filed as Appendix B to our Proxy Statement for our 2011 Annual Meeting of Stockholders, filed with the SEC on September 9, 2011 and incorporated herein by reference).
  10.3  

Form of Executive Severance and Retention Agreement, between Oclaro, Inc. and its executive officers

(previously filed as Exhibit 10.3 to Registrant’s Quarterly Report on Form 10-Q for the quarter ended October 1, 2011, and incorporated herein by reference).

  10.4(1)   Manufacturing and Purchase Agreement, dated November 9, 2011, between Oclaro, Inc. and Fabrinet (previously filed as Exhibit 10.4 to Registrant’s Quarterly Report on Form 10-Q for the quarter ended December 31, 2011, and incorporated herein by reference).
  10.5(2)(3)   Manufacturing and Purchase Agreement, dated March 19, 2012, between Oclaro Technology, Ltd and Venture Corporation Ltd.
  10.6(2)   Equipment and Inventory Purchase Agreement, dated March 19, 2012, between Oclaro Technology Ltd, Oclaro Technology (Shenzhen) Co., Ltd, Venture Electronics (Shenzhen) Co., Ltd, and Venture Electronics Services (M) Sdn Bhd.
  10.7   Form of Opnext, Inc. Voting Agreement (previously filed as Exhibit 99.1 to Registrant’s Current Report on Form 8-K filed on March 26, 2012 and incorporated herein by reference).
  10.8   Form of Oclaro, Inc. Voting Agreement (previously filed as Exhibit 99.2 to Registrant’s Current Report on Form 8-K filed on March 26, 2012 and incorporate herein by reference).
  10.9(1)(2)   Amendment Number One to the Amended and Restated Credit Agreement, dated as of March 29, 2012, among Oclaro, Inc., Oclaro Technology Ltd, Wells Fargo Capital Finance, Inc. and other lenders party thereto.
  31.1(2)   Certification of Chief Executive Officer Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
  31.2(2)   Certification of Chief Financial Officer Pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002
  32.1(2)   Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350
  32.2(2)   Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350
101.INS(4)   XBRL Instance Document
101.SCH(4)   XBRL Taxonomy Extension Schema Document
101.CAL(4)   XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB(4)   XBRL Taxonomy Extension Label Linkbase Document
101.PRE(4)   XBRL Taxonomy Extension Presentation Linkbase Document

 

53


Table of Contents
(1) Portions of this exhibit have been omitted pursuant to an order granting confidential treatment by the Securities and Exchange Commission.
(2) Filed herewith.
(3) Portions of this exhibit have been omitted pursuant to a request for confidential treatment submitted to the Securities and Exchange Commission.
(4) Pursuant to Rule 406T of Regulation S-T, XBRL (Extensible Business Reporting Language) information is furnished and not filed herewith, is not a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

54

Exhibit 10.5

MANUFACTURING AND PURCHASE AGREEMENT

THIS MANUFACTURING AND PURCHASE AGREEMENT (“ Agreement ”) made and effective this 19 th day of March, 2012 (“Effective Date”) by and between Oclaro Technology Ltd. , a company organized under the laws of the United Kingdom, having offices at Caswell Office, Towcester, Northamptonshire, NN12 8EQ (on behalf of itself and all of its Affiliates (collectively referred to as “ Oclaro ” or “ Buyer ”) and Venture Corporation LTD , a company incorporated in Singapore, for itself with its principal place of business at 5006 Ang Mo Kio Avenue 5, #05—1/12 TECHplace ll, Singapore 569873 on behalf of itself and all of its Affiliates (collectively referred to as “ Venture ” or “ Supplier ” and, together with “Buyer”, the “ Parties ”).

 

1. Term.

The initial term of this Agreement commences on the Effective Date and, unless earlier terminated pursuant to the terms of this Agreement, shall continue for a period of five (5) years, expiring five (5) years from the Effective Date (“Term”). The parties may extend the Term upon mutual written agreement. Notwithstanding the expiration of the Term, any executed Statement of Work or Purchase Order then valid shall continue under the terms and conditions of this Agreement until completion unless earlier terminated pursuant to the terms of this Agreement. BUYER shall provide written notice to SUPPLIER of its intent not to renew this Agreement no later than six months prior to the end of the Term.

 

2. Definitions . As used in this Agreement, the following terms shall have the following respective meanings:

 

  2.1 “Acquired Equipment” means any and all hardware, testers, equipment, tooling, molds, software (and related documentation), components, parts or other materials purchased or developed by SUPPLIER and paid for or reimbursed by BUYER and equipment which is within the scope of the Equipment and Inventory Purchase Agreement of even date.

 

  2.2 “Additional Products” means any BUYER products included in a Statement of Work that are not Transferred Products.

 

  2.3 “Affiliate” means any parent, subsidiary or other entity controlled by, controlling or under common control with, a party to this Agreement. For purposes of this definition, the term “control” shall mean the ownership of voting stock or other equity interest entitling the owner to exercise at least fifty percent (50%) of the voting rights of the entity.

 

  2.4 “Approved Manufacturing and Product Development Locations” means the manufacturing locations approved by BUYER in writing, as set forth in Exhibit A-1 , as amended by BUYER in writing from time to time.

 

  2.5 “Build Plan” means the mutually agreed upon order schedule for Products in the form attached at Exhibit B that BUYER shall agree upon with SUPPLIER on a periodic basis.

 

  2.6 “Build Request” means the initial periodic forecasted quantities of Products in the form attached at Exhibit B that BUYER shall provide to SUPPLIER setting forth the number and type of Products BUYER requests SUPPLIER to manufacture.

 

  2.7 “Business Day(s)” means, for purposes of timing and notification, each weekday, Monday through Friday, excluding any holidays at either BUYER and/or the Approved Manufacturing and Product Development Locations and the period of any previously scheduled shut downs of either party, provided that the party experiencing the shut down has notified the other party in writing at least ninety (90) days prior to the shut down. Any shut downs for which the party experiencing the shut down notifies the other party fewer that ninety (90) days prior to the start of such shut down shall be deemed to be Business Days, unless the other party provides written approval, which may be granted or withheld at such other party’s discretion. For the removal of doubt, the definition of Business Days does not relate to or in any way make any implication regarding manufacturing work scheduling and labor rates.

 

  2.8 “Buyer Controlled Components” means the list of Components that BUYER has responsibility for negotiating and providing the Component cost to SELLER. BUYER and SUPPLER will review this list on a quarterly basis to identify any additions or deletions. BUYER retains sole discretion as to the Components that are on the said list. BUYER shall retain the right to negotiate costs with or independent of SUPPLIER for any and all parts on BUYER’s approved vendor list.

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

1


MANUFACTURING AND PURCHASE AGREEMENT

 

  2.9 “BUYER Designated Destinations” means a ‘ship to’ address as designated by an authorized BUYER representative.

 

  2.10 “BUYER Properties” means the Acquired Equipment and Loaned Materials, collectively.

 

  2.11 “BUYER Software” means BUYER’s proprietary software or the proprietary software of BUYER’s licensors, to be embedded into or bundled with the Products. The parties agree that all BUYER Software shall solely be embedded into or bundled with the Products in object code format.

 

  2.12 “Buyer Supplied Components” means the list of Components that BUYER either manufactures or acquires directly and then sells to SUPPLIER. BUYER and SUPPLIER will review this list on a quarterly basis to identify any additions or deletions and costs. BUYER retains sole discretion as to the Components that are on the said list.

 

  2.13 “BUYER Technology” means the Technology and all Derivatives thereof (a) provided by BUYER to SUPPLIER pursuant to this Agreement, or (b) developed by BUYER or SUPPLIER pursuant to this Agreement including any work instructions developed or modified by SUPPLIER but excluding SUPPLIER Technology and any Technology which is demonstrably in the public domain.

 

  2.14 “Capital Efficiency” means the continual improvement in the production output of a piece of capital equipment per unit of time, typically per day or per week, including without limitation, increasing the speed of the equipment, reducing test time, improving machine availability time, increasing the machine utilization rate (measured on a 7X24 basis), reducing the machine load and unload time, reducing the number of tasks performed by the equipment, reducing change-over time, improving the process yield, and implementation and utilization of all engineering efficiencies.

 

  2.15 “Components” means any parts, material, or other items that are used in the manufacture and/or assembly of Products and any inventory purchased as set forth in the Equipment and Inventory Purchase Agreement.

 

  2.16 “Derivative” means: (a) for copyrightable or copyrighted material, any translation, abridgment, revision or other form in which an existing work may be recast, transformed or adapted; (b) for patentable or patented material, any improvement thereon; and (c) for material which is protected by trade secret, any new material derived from such existing trade secret material, including new material which may be protected under copyright, patent and/or trade secret laws.

 

  2.17 “Documentation” means the electronic or printed user guides, manuals, quick reference cards, getting started guides, literature, materials, flyers, license agreements, registration cards and other end user literature for the Products as provided to SUPPLIER hereunder. BUYER shall have the right, at no additional charge, to use and/or reproduce the SUPPLIER’s applicable literature, such as operating and maintenance manuals, technical publications, prints, drawings, training manuals, and other similar supporting documentation and sales literature. SUPPLIER shall advise BUYER of any updated information relative to the foregoing literature and documentation with timely notifications in writing.

 

  2.18 “Installed Costs” means the freight and all normal direct and indirect costs, such as installation and other assemblage costs, to make the Acquired Equipment fully operational.

 

  2.19 “Intellectual Property Rights” means copyright rights (including, without limitation, the exclusive right to use, reproduce, modify, distribute, publicly display and publicly perform the copyrighted work), trademark rights (including, without limitation, trade names, trademarks, service marks, and trade dress), patent rights (including, without limitation, the exclusive right to make, use and sell), trade secrets, moral rights, right of publicity, authors’ rights, contract and licensing rights, and all other intellectual property rights as may exist now and/or hereafter come into existence and all renewals and extensions thereof, regardless of whether such rights arise under the law of the United States or any other state, country or jurisdiction.

 

  2.20 “Joint Service Agreement” means a written statement describing the responsibilities, expectations, and entitlements of each party; designed to benefit both parties and improve the relationship for mutual advantage.

 

  2.21 “Leadtime” means (i) with respect to Components, the number of calendar days between the date upon which a Purchase Order is received by SUPPLIER and the date upon which the relevant Components will

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

2


MANUFACTURING AND PURCHASE AGREEMENT

 

  be delivered; and (ii) with respect to Products, means the number of calendar days between the date upon which a Purchase Order is received by SUPPLIER and the date upon which the relevant Product is delivered to the shipping location designated by BUYER.

 

  2.22 “Loaned Materials” means any and all test programs, testers, equipment, tooling, fixtures, components, parts or other materials provided to SUPPLIER by BUYER hereunder.

 

  2.23 “Materials Information” includes, but is not limited to, the following information and data for Components: (a) BUYER part number; (b) SUPPLIER part number; (c) manufacturer name; (d) manufacturer part number; (e) manufacturer description; (f) Leadtime; (g) where used; (h) quantity per type of Product; (i) purchase quantity authorized by BUYER; (j) purchase price authorized by BUYER; and (k) extended price.

 

  2.24 “Necessary Equipment” means any and all test programs, software (and related documentation), hardware, tooling, molds, fixtures or other equipment purchased by SUPPLIER and not reimbursed by BUYER and used by SUPPLIER to manufacture and/or assemble the Products.

 

  2.25 “Packed Out Product” means a Finished Product unit that is fully packaged and ready for distribution directly to BUYER’s customers.

 

  2.26 “Finished Product” means a product unit that is not packaged for sale, but is ready for shipping to packaging and a distribution location designated by BUYER.

 

  2.27 “Product(s)” means the Transferred Products and Additional Products identified in a Statement of Work.

 

  2.28 “Purchase Order” means a BUYER purchase order for the purchase of or Products issued to SUPPLIER pursuant to the provisions of this Agreement.

 

  2.29 “Specifications” means the functional and performance specifications (including, without limitation, bills of materials, schematic diagrams, parts and assembly drawings) relating to the testing and manufacturing of each Product as provided by BUYER, including, without limitation, the specifications set forth on the applicable Statement of Work governing the development and/or manufacture of a specific Product.

 

  2.30 “Statement of Work” means a written statement of work for the development and/or manufacture of the Products which has been or will be signed by both parties and attached hereto as Exhibit D .

 

  2.31 “Technology” means any and all technical information and/or materials, including, without limitation, ideas, techniques, designs, sketches, drawings, models, inventions, know-how, processes, apparatus, methods, equipment, algorithms, software programs, data, software source documents, other works of authorship, formulae and information concerning engineering, research, experimental work, development, design details and specifications.

 

  2.32 “Transferred Products” means the versions of BUYER products and their Derivative Products as identified in Exhibit A-2 and on a Statement of Work that will be transferred from BUYER’s or BUYER’s contract manufacturer’s existing site of manufacture to SUPPLIER’s Approved Manufacturing and Product Development Location.

 

  2.33 “SUPPLIER Properties” means any test programs, software, tooling, equipment or other materials provided to BUYER by SUPPLIER hereunder.

 

  2.34 “SUPPLIER Technology” means the Technology and all Derivatives thereof provided by SUPPLIER to BUYER pursuant to this Agreement which are (a) developed by SUPPLIER prior to, or independent of entering into this Agreement but excluding BUYER Technology and any Technology which is demonstrably in the public domain.

 

3. License and Ownership of the Product .

 

  3.1 License to Specifications and Loaned Materials . Subject to the terms and conditions of this Agreement, BUYER hereby grants SUPPLIER a personal, limited, non-exclusive, non-transferable, royalty-free license, without the right to sublicense, under BUYER’s Intellectual Property Rights to use the Specifications and the Loaned Materials provided by BUYER during the term of this Agreement, solely internally, and solely for the purpose of manufacturing the Products for BUYER.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

3


MANUFACTURING AND PURCHASE AGREEMENT

 

  3.2 License to BUYER Technology . Subject to the terms and conditions of this Agreement, BUYER hereby grants to SUPPLIER a personal, limited, non-exclusive, non-transferable and royalty-free license, without the right to sublicense, under BUYER’s Intellectual Property Rights to use the BUYER Technology (as embodied in the Specifications or as otherwise provided to SUPPLIER) during the term of this Agreement, solely internally, and solely for the purpose of manufacturing under the terms of this Agreement; provided, however, that such license granted to SUPPLIER will not be exercised to develop, manufacture or distribute any products other than the Products.

 

  3.3 License to BUYER Software and Documentation . Subject to the terms and conditions of this Agreement, BUYER hereby grants to SUPPLIER a personal, limited, non-exclusive, non-transferable and royalty-free license, without the right to sublicense, under BUYER’s Intellectual Property Rights and only during the term of this Agreement to: (i) use and reproduce the BUYER Software and Documentation for the limited purpose of manufacturing the Products; and (ii) distribute the BUYER Software and Documentation solely as incorporated into the Products as set forth in the applicable Statement of Work only to BUYER and the BUYER Designated Destinations.

 

  3.4 License to SUPPLIER Technology and SUPPLIER Properties . Neither SUPPLIER nor its licensors, suppliers or any other third party will retain any rights in any materials incorporated into the Products. To the extent that SUPPLIER provides any SUPPLIER Technology and/or SUPPLIER Properties to BUYER as set forth in a Statement of Work or otherwise, SUPPLIER hereby grants to BUYER a limited, perpetual, irrevocable, non-exclusive, non-transferable and royalty-free license under SUPPLIER’s Intellectual Property rights, to use the SUPPLIER Technology and/or SUPPLIER Properties provided to BUYER hereunder, if any, solely in connection with the marketing, sale and distribution of the Products. During the Term of this Agreement, unless otherwise agreed, If any SUPPLIER Technology is incorporated in the Products which are developed or manufactured by Seller under this Agreement, there shall not be any royalty or license fees payable by Buyer to the Seller.

 

  3.5 License to BUYER Trademarks . BUYER requests and SUPPLIER agrees to place certain markings and identification, which includes the trademark(s) and/or trade name of BUYER, on the Products ordered and delivered to BUYER, the Documentation and the Product packaging, as specified by BUYER. In addition, upon written approval of BUYER, SUPPLIER may use such trademarks and trade name in materials used in presentations made to suppliers of Components. The use of such markings and identification shall be strictly in accordance with the requirements of BUYER as set forth in BUYER’s Trademark Guidelines, as provided to SUPPLIER and as may be updated from time to time by BUYER. SUPPLIER is not authorized to use the trademark(s) and trade names of BUYER on any products, other than Products ordered by and delivered to BUYER, or for any other purpose not expressly set forth in this. BUYER hereby grants to SUPPLIER a limited, non-exclusive, non-transferable trademark license, without the right to sublicense, to use the BUYER trademarks set forth on Exhibit E and/or the Statement of Work solely (i) internally to mark the Products, Product packaging and Documentation as requested by BUYER, and (ii) in presentation materials upon BUYER’s prior written approval. All other use is prohibited. This license shall terminate on the earlier of termination of this Agreement or failure of SUPPLIER to maintain the quality requirements set out in this Agreement and/or BUYER’s Trademark Guidelines. SUPPLIER shall obtain no rights to or interest of any kind in any BUYER trademarks or trade names other than the limited right to use set out above.

 

  3.6 Restrictions . Except for the licenses as expressly set forth in this Agreement, each party retains all of its Intellectual Property Rights. There are no implied rights. No license is granted by BUYER to make, use or sell any other products under the BUYER Intellectual Property Rights or to make, use or sell any products for any other purpose. SUPPLIER will not disclose BUYER’s Intellectual Property Rights to any third party. SUPPLIER will not modify, decompile or reverse engineer the BUYER Software or any BUYER Technology. Any other provisions of this Agreement notwithstanding, SUPPLIER will have no right to use the trademarks, trade names or Product(s) names of BUYER directly or indirectly in connection with any product(s), promotion or publication without the prior written approval of BUYER.

 

  3.7 Ownership by BUYER . As between BUYER and SUPPLIER, BUYER will own all right, title, and interest in the Specifications, BUYER Software, Products, BUYER Properties and the BUYER Technology and all Intellectual Property Rights therein, and SUPPLIER hereby irrevocably transfers, conveys and

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

4


MANUFACTURING AND PURCHASE AGREEMENT

 

  assigns to BUYER all of its right, title, and interest therein. SUPPLIER will execute such documents, render such assistance, and take such other action as BUYER may reasonably request, at BUYER’s expense, to apply for, register, perfect, confirm and protect BUYER’s rights to the BUYER Technology and all Intellectual Property Rights therein.

 

  3.8 Ownership by SUPPLIER . As between SUPPLIER and BUYER, SUPPLIER will own all right, title and interest in the SUPPLIER Technology and Supplier Properties, and all Intellectual Property Rights therein.

 

  3.9 Design Work . If the parties agree to have SUPPLIER perform design work for the Products, including without limitation, process design work, such work shall be subject to the terms and conditions of this Section 3.9. performed under a Design Statement of Work. Subject to the terms and conditions of this Agreement, if the BUYER agrees to SUPPLIER performing design work for the Products, BUYER shall grant to SUPPLIER a personal, limited, non-exclusive, non-transferable and royalty-free license, without the right to sublicense, under BUYER’s Intellectual Property Rights to use the BUYER Technology (as embodied in the Specifications or as otherwise provided to SUPPLIER), solely internally, and solely for the purpose of performing the design work and only for the minimum period of time and to the minimum extent necessary to perform such design work. BUYER shall own all Technology and Intellectual Property Rights developed or created by SUPPLIER in the performance of such Design Statement of Work (“Work Product”), unless otherwise agreed. SUPPLIER hereby irrevocably transfers, conveys and assigns to BUYER all of its right, title, and interest in and to the Work Product. SUPPLIER will execute such documents, render such assistance, and take such other action as BUYER may reasonably request, at BUYER’s expense, to apply for, register, perfect, confirm and protect BUYER’s rights to the Work Product and all Intellectual Property Rights therein.

 

4. Manufacture of Products .

 

  4.1 Manufacturing . Pursuant to the terms of this Agreement, SUPPLIER agrees to manufacture each of the Products in accordance with this Agreement, the applicable Specifications, Statement of Work, and any other instructions provided in writing by BUYER and agrees not to stop or restrict the supply of the Products during the term. SUPPLIER acknowledges and agrees that time is of the essence for the provision of manufacturing services and the supply of Products to BUYER hereunder and that the full and timely provision of all manufacturing services and supply of Products to BUYER hereunder is a material condition of this Agreement. SUPPLIER shall manufacture the Products only according to the written instructions provided by BUYER. SUPPLIER shall only manufacture each Product at the applicable Approved Manufacturing and Product Development Location(s) for that Product. SUPPLIER will not change location of the facilities, building location or line location for the manufacture and assembly of the Products without BUYER’s prior written consent, which will not be unreasonably withheld. [***]. The cost of any move initiated by SUPPLIER shall be the sole responsibility of SUPPLIER. These costs may include, but are not limited to, additional buffer inventory, expedite fees, overtime, equipment rental costs, etc. Additionally, any move shall not be considered complete until BUYER has qualified the new location. SUPPLIER agrees to aggressively work with BUYER to develop strategies which will lead to ongoing reductions in costs, Leadtimes and cycle times, yields and improvements in Capital Efficiency.

 

  4.2 New Product Introduction . BUYER may from time to time issue Purchase Orders for advance, low-volume units of Products for testing of the Products and/or the manufacturing process (“NPI Units”). All NPI Units will be manufactured in the Approved Manufacturing and Product Development Location. Any additional terms regarding the manufacture and delivery of NPI Units shall be mutually agreed upon by the parties in a Statement of Work, which shall include, without limitation, pricing, manufacturing milestones and milestone schedule, testing procedures and quality assurance provisions. Such Statement of Work will be attached hereto as a sequentially numbered attachment (“Attachment”) to Exhibit D , and shall be deemed incorporated herein.

 

  4.3 Manufacturing Reporting . SUPPLIER shall perform the reporting obligations, to be established between BUYER and SUPPLIER. SUPPLIER agrees to maintain, and update on no less frequent than a weekly basis, the Materials Information, the Capacity Information and the Leadtime Information, as well as information regarding works in progress, works in stock, problems in the manufacturing process and all returns, and all such data shall be accessible to BUYER online, provided to BUYER via a direct data feed to BUYER’s internal information systems as reasonably specified by BUYER, or manually until such online or direct data feed can be established. To the extent that SUPPLIER is permitted access to BUYER’s internal information systems, SUPPLIER shall not disclose any BUYER data to any third party, or use such data for any purpose except as necessary to fulfill its obligations hereunder.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

5


MANUFACTURING AND PURCHASE AGREEMENT

 

  4.4 No Subcontracting . SUPPLIER agrees that no portion of the assembly of the Products will be subcontracted to third parties without BUYER’s prior written consent. Any permitted subcontractor approved in writing by BUYER (“Subcontractor”) that SUPPLIER may use to assist SUPPLIER shall be obligated to comply with the terms of this Agreement and SUPPLIER shall remain responsible for such Subcontractor’s performance. BUYER’s consent to SUPPLIER’s use of any Subcontractor shall not be deemed a waiver of any BUYER rights hereunder nor relieve SUPPLIER of any of its obligations pursuant to this Agreement. SUPPLIER shall enter into a written agreement with each approved Subcontractor which includes terms and conditions no less protective of BUYER’s proprietary and intellectual property rights than those set forth in this Agreement prior to SUPPLIER permitting any such Subcontractor to perform any obligation hereunder. SUPPLIER shall be solely responsible for the payment of all amounts payable to, and the performance of all of SUPPLIER’s obligations for, all such Subcontractors. Immediately upon request of BUYER, SUPPLIER shall commence such proceedings as necessary (i.e., termination notice, request to cure default) to terminate any Subcontractor that, in BUYER’s sole opinion, does not perform to the standards set forth by BUYER in this Agreement.

 

  4.5 Testing . Upon the completion of the manufacture of each Product, SUPPLIER will submit such Product to the testing procedures set forth on the applicable Statement of Work, in this Agreement or specified by BUYER from time to time. SUPPLIER, unless otherwise specified in writing, will only ship Products which have been tested successfully according to such procedures. At BUYER’s discretion, BUYER will provide training in the testing procedures set forth herein to certain personnel designated in writing by SUPPLIER. SUPPLIER will perform all required testing, as specified by BUYER, unless otherwise agreed by BUYER and SUPPLIER in writing, of all Products at a SUPPLIER manufacturing facility mutually agreed upon by the parties in writing.

 

  4.6 Storage of Property . SUPPLIER shall store all BUYER Properties required for the manufacturing of Products under this Agreement free of charge in a place of storage that is safe and suitable for the specific nature of the BUYER Properties in accordance with industry standard practice for the type of property stored and at a minimum meets any specified storage conditions for the property, and undertakes never to hide, damage or remove the identification plates on the BUYER Properties. SUPPLIER shall ensure that all of Loaned Materials and property (which shall include but not be limited to all Products) shall be kept distinct and separate from SUPPLIER’s or other third parties’ property and Loaned Materials shall be clearly identified as BUYER’s property. SUPPLIER shall ensure that none of BUYER’s property is seized by any third party, whether pursuant to an order of court or otherwise, while in SUPPLIER’s possession. SUPPLIER shall not allow any lien or encumbrance to be created over or otherwise encumber BUYER’s property. SUPPLIER will not at any time use the Loaned Materials for any other purposes or for any third parties or in any manner other than in performing SUPPLIER’s obligations under this Agreement.

 

  4.7 BUYER Properties .

 

  4.7.1 Loaned Materials . Subject to the license grant set forth above, BUYER agrees to loan free of charge to SUPPLIER, and SUPPLIER accepts on loan, certain items of Loaned Materials, as provided from time to time. All such Loaned Materials shall be sent to SUPPLIER at BUYER’s expense. All such Loaned Materials shall be provided to SUPPLIER on an “AS IS” and “AS AVAILABLE” basis and without warranty of any type or kind. BUYER HEREBY DISCLAIMS AND EXCLUDES ALL WARRANTIES, WHETHER STATUTORY, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF TITLE, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT AND MERCHANTABILITY. The Loaned Materials are to be used for the express purpose of Products and cannot be used to support the production, test, or service of any of SUPPLIER’s other customers. The Loaned Materials shall be loaned for an indefinite period during the term of this Agreement, but SUPPLIER’s right to use such Loaned Materials shall terminate automatically upon request by BUYER or termination of this Agreement, whichever is sooner. If BUYER requests that the Loaned Properties be returned to BUYER, the loan of Loaned Properties shall terminate when the applicable Loaned Materials are received by BUYER. BUYER agrees to reimburse any costs incurred by SUPPLIER for calibration and maintenance SUPPLIER has performed by third party vendors on Loaned Materials.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

6


MANUFACTURING AND PURCHASE AGREEMENT

 

  4.7.2 Use of Loaned Materials . SUPPLIER shall use the Loaned Materials solely for the benefit of BUYER and solely at the Approved Manufacturing and Product Development Locations, which address shall not change without the express prior written agreement of BUYER.

 

  4.7.3 Acquired Equipment . If SUPPLIER desires to purchase items to be included as Acquired Equipment, SUPPLIER shall provide a written request to BUYER at least five (5) Business Days prior to the purchase of such items. Such request shall include a quote setting forth the cost of each item. If BUYER agrees in writing to purchase some or all of the items, the approved items shall be deemed to be Acquired Equipment. The purchase price plus the Installed Costs will be amortized over a period of sixty (60) months, payable in monthly installments based upon an interest rate equal to the then-current one (1) year LIBOR rate (U.S. currency) plus one percent (1%) (“Supplier Net Book Value”). SUPPLIER shall provide to BUYER all relevant invoices corresponding to the Acquired Equipment purchased for reimbursing purposes. BUYER shall reimburse SUPPLIER for the cost of the Acquired Equipment according to the invoicing and payment terms in Exhibit C . At termination of work requiring this equipment, the BUYER will reimburse the SUPPLIER for the SUPPLIER Net Book Value not already reimbursed. BUYER shall have the option to purchase such Acquired Equipment from SUPPLIER, such request shall not be unreasonably refused: (a) on an exception basis; or, (b) upon termination of this Agreement, to the extent that SUPPLIER has not recovered payment for Acquired Equipment through amortization of the Supplier Net Book Value, BUYER will either (i) pay SUPPLIER for any such unrecovered amortization and SUPPLIER shall retain ownership or (ii) purchase the Acquired Equipment for a purchase price equal to the SUPPLIER’s Net Book Value. Notwithstanding the above, if SUPPLIER fails to meet BUYER’s cost, quality and delivery objectives, BUYER shall have no obligation to pay for such unrecovered amortization in subsection (i) but may purchase the Acquired Equipment as otherwise described herein in subsection (ii). Upon mutual agreement the Parties may decide to designate an item proposed to be treated as Acquired Equipment as Necessary Equipment, in which case such item will deemed to be Necessary Equipment subject to the below.

 

  4.7.4 Necessary Equipment . SUPPLIER may purchase Necessary Equipment to manufacture and/or assemble the Products. Within ten (10) days after acquisition, SUPPLIER shall provide written notice to BUYER of acquisition of the Necessary Equipment. Upon mutual agreement BUYER shall have the option to purchase such Necessary Equipment upon termination of this Agreement.

 

  4.7.5 Return of BUYER Properties . Within two (2) Business Days of BUYER’s request, SUPPLIER shall send BUYER Properties that are in electronic and paper form to any location requested by BUYER, at SUPPLIER’s expense. SUPPLIER shall use best efforts to send all other Loaned Materials to any location requested by BUYER within five (5) business Days of BUYER’s request. SUPPLIER agrees to provide all reasonable assistance for this purpose and to adequately ship and insure the applicable BUYER Properties.

 

  4.7.6 Insurance . In addition to any other insurance requirements set forth herein SUPPLIER shall take out insurance to adequately cover all Loaned Materials, and add BUYER as a loss payee with respect to the Loaned Materials, at its own cost, and give proof of such insurance to BUYER on request, and be responsible for any damage occurring to the Loaned Materials while in SUPPLIER’s possession that is not due to normal wear.

 

  4.7.7 Expenses . SUPPLIER shall assume all expenses due to the operation, and use of all BUYER Properties. In any case, SUPPLIER will be responsible for any loss or damage caused to any BUYER Properties while in SUPPLIER’s possession. BUYER shall at all times retain title and ownership of allLoaned Materials. In the event major repairs or replacement of BUYER Properties is necessary, SUPPLIER shall notify BUYER in writing for instructions on how to proceed but in no case will such major repair or replacement be at SUPPLIER expense. BUYER agrees to reimburse any costs incurred by SUPPLIER for calibration and maintenance which SUPPLIER has had performed by third party vendors on BUYER Properties.

 

  4.8 Transferred Products . During the Term, BUYER will continue to have SUPPLIER produce the Transferred Products including any updates or upgrades or enhancements in functionality of those Products (“Derivative Products”) subject to SUPPLIER’S meeting cost, quality and delivery objectives. In the event

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

7


MANUFACTURING AND PURCHASE AGREEMENT

 

  of performance issues SUPPLIER shall have thirty (30) days to cure. In the event the issue remains unresolved the Parties shall escalate to their executive management for resolution. If after ten (10) days there remains no resolution the Products in question shall lose their respective exclusivity terms. During the first 30 days of this Agreement, Parties will finalise the Flight Plans. The preliminary Flight Plans are set out in Exhibit A-3 of this Agreement, the Parties will amend the Flight Plans as needed during the transition period. The Transferred Products shall be transferred from BUYER’s facilities to Supplier’s facilities according to the Flight Plans as mutually agreed.

 

  4.9 Non-Exclusivity . Except for Transferred Products as may be otherwise expressly specified in a specific Statement of Work, this Agreement is non-exclusive. Additional Products may be added to future Statements of Work, at BUYER’s sole discretion, based on a competitive quote process, SUPPLIER’s performance under this Agreement, and then current overall SUPPLIER/BUYER business level and partnership. SUPPLIER will be provided notification of potential significant opportunities that would reasonably be considered consistent with the intent and capabilities of SUPPLIER associated with the Transferred Products. BUYER shall have the right to use other contract manufacturers to manufacture the Additional Products. Nothing in this Agreement will be construed or deemed to prevent or otherwise inhibit BUYER’s ability or right to manufacture the Products, whether at BUYER’s facility or at an alternate or additional third-party facility(ies) of BUYER’s choice. Further, nothing in this Agreement will be construed or deemed to (a) require BUYER to order any minimum number of units of the Products to be manufactured by SUPPLIER, or (b) prevent or otherwise inhibit BUYER’s ability or right to design, develop, manufacture, have manufactured, market, use, sell, and or distribute any follow-on products or Derivatives of the Products.

 

  4.10 PCBA’s . SUPPLIER shall be allowed to manufacture the PCBA’s for the Transferred Products so long as SUPPLIER maintains cost, quality and delivery competiveness.

 

5. Build Request and Build Plan . BUYER shall provide SUPPLIER with a good faith twelve (12) month, non-binding, forward-looking, rolling forecast in the form of a Build Request and shall update such forecast on periodic basis. The Build Requests are not binding on BUYER and do not represent any commitment by BUYER to purchase a minimum number of Products. Build Requests will be in weekly or monthly buckets for the first six (6) months and monthly buckets for the subsequent six (6) months. SUPPLIER shall promptly and in no case longer than five (5) Business Days respond to any Build Request issued by BUYER with a committed Build Plan. The Build Request and Build Plan shall set forth, as applicable, the following information: Product name, BUYER Product numbers, Product quantities, and requested delivery dates. BUYER and SUPPLIER shall jointly review and agree on a committed Build Plan. The Build Request shall be updated at least monthly and shall be used by SUPPLIER to plan for production capacity, resources, and materials planning to support BUYER’s anticipated orders. SUPPLIER shall only purchase Components in accordance with the mutually agreed upon purchasing parameters, and the Buyer shall be responsible for the costs of Components purchased within such purchasing parameters.

 

6. Procurement, Inventory Management and Purchase Orders .

 

  6.1 Procurement and Management of Materials and Components .

Procurement of BUYER Approved Materials and Components . SUPPLIER will maintain the Lead-time for each Product that is specified in the applicable Statement of Work. SUPPLIER is authorized to purchase Components for the Products in a manner so as to meet the mutually agreed Build Plans, Purchase Orders and any long Lead-time requirements specified by BUYER in the applicable Statements of Work. All such procurement by SUPPLIER shall be done based on industry competitive Lead-times. SUPPLIER’s material liability shall be consistent with the terms of this Agreement. On a quarterly basis, the Parties will jointly review the BOM’s, on a product by product basis, and mutually agree to a list of standard parts, non-standard parts, non-cancellable, non-returnable parts, Lead-times, long Lead-time Components, and MOQ. On a quarterly basis, BUYER shall identify any SUPPLIER Controlled Components. Such lists are to be agreed to, signed by the Parties and included in the quarterly RFP. SUPPLIER shall purchase all Components for Products solely from suppliers listed on BUYER’s most current approved vendor list (the “AVL”) as provided by BUYER to SUPPLIER as updated by BUYER from time to time. Any purchases made from suppliers not listed on the AVL or contrary to BUYER’s written instructions must be approved by BUYER in advance in writing. BUYER agrees to use commercially reasonable efforts to have BUYER’s approved vendors on the AVL extend to SUPPLIER the same pricing such vendor extends to BUYER, but solely for purchases of Components to be used in the manufacture of Products made under this Agreement. BUYER may assist SUPPLIER in securing certain

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

8


MANUFACTURING AND PURCHASE AGREEMENT

 

long Lead-time Components for a Product. Such assistance may include placing orders for long Lead-time Components directly with the manufacturer, providing written authorizations for the purchase of certain Components in short supply or issuing advance Purchase Orders. SUPPLIER shall purchase BUYER produced Components pursuant to this Agreement. SUPPLIER shall collect all invoices issued by BUYER for BUYER produced Components under the Agreement during each month (“Accumulation Period’) and initiate payment for the invoices on the first business day of the month forty five (45) days following the end of the Accumulation Period. Notwithstanding the foregoing, if SUPPLIER rejects BUYER Supplied Components under the Agreement, SUPPLIER may delay payment of the applicable invoice until the BUYER Supplied Components are repaired or replaced. Delivery shall be EXWORKS (INCOTERMS 2010) unless otherwise agreed in writing .

For purchases of Components, BUYER shall receive all rebates, discounts and other price reductions, monetary and non-monetary, and in any way relating to such Components purchases in proportion to such purchases. Should an audit determine non-compliance with the obligations in this Section 6.1.1, the parties agree that BUYER will be entitled to a refund of the amount of the determined non-compliance and costs of audit, any exceptions shall be mutually agreed by the Parties. [***].

 

  6.1.1 Procurement Policy: SUPPLIER will purchase all Components to meet the latest approved Build Plan. BUYER shall not be liable for any purchased Components unless pre-approved by BUYER in writing other than the Build Plan. As a guideline, SUPPLIER will not transform Components into a non-returnable condition (e.g., programming of flash memory, tape and reeling Components supplied in trays) at any Approved Manufacturing Location in excess of the quantity necessary to meet the Product cycle times according to Exhibit D attached hereto. Exceptions will be granted for items that are packaged in large quantities and are considered non-cancellable, nonreturnable by the SUPPLIER once the packaging is opened or a piece is consumed. [***]. BUYER agrees that within the Products being manufactured, there are standard parts, non-standard parts and non-cancellable, non-returnable parts. BUYER’s maximum liability for standard parts will be to the Build Plan or the Components Lead-time whichever is less, and which cannot be returned for credit or consumed on any other of the SUPPLIER’s manufactured products, with the exception of items that are packaged in large quantities and such large package quantities must be approved by BUYER in writing. BUYER’s maximum liability for non-standard parts will be to the Build Plan or the Components Lead-time whichever is less plus any Components held in VMI which cannot be returned for credit or consumed on any other of the SUPPLIER’s manufactured products, plus Components on-order within the Component Lead-time cancellation window (SUPPLIER will use best efforts to cancel or mitigate BUYER’s exposure). BUYER’s maximum liability for non-cancellable, non-returnable parts will be to the inventory on-hand plus the total quantity on-order. Each Product-specific Statement of Work will identify any requirements that deviate from these guidelines. [***].

 

  6.1.2 Material Management . SUPPLIER will, at a minimum, at no additional cost to Buyer, comply with the following obligations to ensure good Component material management for the Products: (a) ensure Component level failure analysis is performed by the vendor; (b) expedite Component returns, failure analysis and corrective actions regarding defective Components with the vendors and promptly communicate this information to BUYER; (c) actively work with vendors to reduce Component Leadtime and costs; (d) address poor Component yields with vendors and promptly provide analysis and corrective plans regarding same to BUYER; and (e) provide regular performance feedback to vendors, with a copy to BUYER. SUPPLIER will not use components procured for BUYER in any other customer products without advance written approval from BUYER.

 

  6.1.3 Allocation of Resources . SUPPLIER will notify BUYER promptly whenever SUPPLIER identifies a reasonable likelihood that there is or will be a capacity constraint that adversely affects SUPPLIER’s ability to meet the Build Plan (“Capacity Constraint”). During any period of Capacity Constraint, SUPPLIER agrees, at a minimum, to allocate capacity to BUYER under whichever of the following formulas would give BUYER the greatest quantity of Products: (i) in proportion to BUYER’s percentage of capacity used of all of SUPPLIER’s customer manufacturing capacity for the previous two (2) calendar months; (ii) in proportion to BUYER’s percentage of capacity, as set forth in applicable Build Requests, of all of SUPPLIER’s customers forecasts for manufacturing capacity; or (iii) any other more favorable allocation

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

9


MANUFACTURING AND PURCHASE AGREEMENT

 

  formula which SUPPLIER utilizes with any other customer. SUPPLIER will notify BUYER, in advance if possible, of any change the program management resources. In the event that a change to any program management resource is required, BUYER will have the ability to approve any new members before they are assigned to the account.

 

  6.1.4 Vendor Managed Inventory . SUPPLIER shall establish and properly manage a Vendor Managed Inventory (VMI) program whereby suppliers will deliver Components to a VMI location for SUPPLIER’s withdrawal as needed. SUPPLIER shall execute agreements with suppliers to ensure the proper delivery to and handling of Components at the VMI location. [***]. Such VMI programs may be set forth in separate VMI agreements, as applicable, if desired by the parties.

 

  6.2 Build Plans

 

  6.2.1 Build Plan . SUPPLIER shall reserve for BUYER capacity to manufacture the quantity and type Products specified in each Build Plan and shall have available the extra capacity for increases within the flexibility matrix as described below.

 

  6.2.2 Terms . All Build Plans and Purchase Orders for Products placed by BUYER hereunder and Build Plans agreed upon by the parties shall be governed by the terms and conditions of this Agreement. In the event of a conflict between the provisions of this Agreement and the terms and conditions of BUYER’s Purchase Order, a Build Plan, SUPPLIER’s acknowledgment or other written communications, the provisions of this Agreement shall prevail. In the event of a conflict between the terms in a Purchase Order and those in a Build Plan, the terms of the Purchase Order shall prevail.

 

  6.2.3 Flexibility . Changes in the quantity of units of a particular Product ordered by BUYER shall be provided by written or electronically dispatched notice from BUYER. SUPPLIER shall notify BUYER of acceptance of change in [***].[***]. SUPPLIER will accept all increases or decreases in Purchase Order quantities, without additional charges subject to installed capacity restraints according to the Product Capacity schedule to be defined as part of a Statement of Work, within the flexibility matrix set forth below (unless otherwise set forth in Exhibit C ). Multiple upside requests within the materials replenishment windows will be at SUPPLIER’s reasonable efforts;

 

Number of Weeks Until Delivery Date

  

Percent Increase or Decrease from Purchase Order Quantity

[***]

   [***]

[***]

   [***]

[***]

   [***]

If there are extra costs to SUPPLIER to fulfill orders for quantities in excess of the above flexibility matrix, SUPPLIER will promptly determine the extra costs in good faith, inform BUYER in writing of such extra costs and how they were calculated, and obtain BUYER’s prior written approval before fulfilling such orders. If a BUYER order cancellation causes inventory to exceed the excess inventory criteria set forth herein the inventory policy applies to those items.

 

  6.3 Reschedule or Cancellation of Delivery . BUYER shall be permitted to cancel or reschedule delivery of Products as within the parameters of the flexibility terms in Section 6.3 above and otherwise as set forth below subject to the terms specified herein. BUYER shall be entitled to request a reschedule of delivery of Products that are in a Build Plan or WIP at any time. SUPPLIER shall accommodate a request to expedite the ship date. [***].

 

  6.3.1 Effect of Cancellation/Reduction of Products under a Purchase Order . If BUYER should cancel, reschedule or reduce the quantity of Products ordered in a Purchase Order (whether in whole or in part) for any reason, and such cancellation is a net reduction to the total open order position, and such deemed cancellation [***], then BUYER’s maximum liability to SUPPLIER for such cancelled Purchase Order (or portion thereof) shall be no more than: (i) a combination of partially assembled units of the Product, within published Product Cycle Times and whose

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

10


MANUFACTURING AND PURCHASE AGREEMENT

 

  manufacture or assembly is irreversible, such as completed surface-mount manufacture, for which BUYER shall pay reasonable and actually incurred costs, not to exceed the Purchase Order price for the Product based on level of completion. (i.e., cost to manufacture); and (ii) all custom or non-cancellable, nonreturnable, MOQ and approved long Lead-time Components that are not consumed [***]; provided, that the applicable Components were approved for purchase by BUYER based on Lead-times in conjunction with the Build Plan and agreed to in writing as part of an special inventory buy relating to MOQ, buffer stock or other exceptions. The calculation described in the immediately prior sentence shall be made as of the date of BUYER’s notice of cancellation or reduction. SUPPLIER acknowledges responsibility to minimize BUYER’s liability by [***] stop the manufacture of outstanding cancelled orders and to cancel the orders SUPPLIER has with vendors for related Components immediately upon receipt of BUYER’s notice. Provided SUPPLIER has taken the foregoing measures, BUYER agrees to pay the applicable cancellation fees described herein in full satisfaction of its liability for such cancellation. Upon BUYER’s request, SUPPLIER shall make available to BUYER for inspection and audit any and all relevant information in support of SUPPLIER’s claim for reimbursement.

 

  6.3.1.1 Excess Inventory Owing to BUYER Cancellations .

 

  6.3.1.1.1 Obsolete Inventory . BUYER and SUPPLIER will conduct a formal assessment of SUPPLIER’s inventory as defined in the Joint Services Agreement. If BUYER has cancelled an order for a particular Product under a Purchase Order because it will discontinue to utilize SUPPLIER as a manufacturer of that Product or because of an engineering change initiated by BUYER, then SUPPLIER must make any claims for reimbursement to BUYER within thirty (30) days, otherwise such claims will be deemed waived by SUPPLIER. BUYER shall have thirty (30) days to evaluate SUPPLIER’s claim made pursuant to this Section and to request any adjustments. The parties shall negotiate in good faith the amount of the reimbursement. Once the parties have agreed upon the reimbursement amount, BUYER shall issue a Purchase Order for the sum of the agreed upon reimbursement amount for such obsolete inventory within ten (10) Business Days from the date of the agreement on the reimbursement amount. The parties agree to meet monthly to review any open claims regarding Obsolete Inventory.

 

  6.3.1.1.2 Other Inventory . When BUYER cancels or reduces an order for a particular Product under a Purchase Order for reasons other than the discontinuance of SUPPLIER as a manufacturer of the Product or because of an engineering change initiated by BUYER, BUYER will purchase approved custom, non-cancellable, nonreturnable, MOQ, or long Leadtime Components purchased in accordance with the agreed upon Build Plan and the terms of this Agreement for the Products (“Excess Materials”) which remain in SUPPLIER’s inventory [***], upon the execution of this Agreement, for a particular Product under a Purchase Order. BUYER may elect to store them at SUPPLIER and pay SUPPLIER a storage fee based on actual space required at the current quarters quoted warehouse space cost.

Once the Excess Materials have been stored at SUPPLIER [***], BUYER will use reasonable efforts to disposition the Excess Materials [***].

 

  6.4 Transfer of Inventory to Other Manufacturers . SUPPLIER understands that BUYER may use other manufacturers which use the same Components as SUPPLIER. SUPPLIER will promptly transfer its inventory of Components for unfilled Purchase Orders to such other manufacturers as required by BUYER without service charges for such transfer. SUPPLIER also agrees to sell the Components then-currently in SUPPLIER’s inventory to BUYER’s designated manufacturer at a cost not to exceed the actual purchase price plus a two percent (2%) mark-up. BUYER also agrees to pay for transportation of equipment and/or materials to the new manufacturing facility at cost.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

11


MANUFACTURING AND PURCHASE AGREEMENT

 

 

7. Pricing .

 

  7.1 Prices . The prices for the Products and shipping terms shall be set forth on Exhibit C . The shipping terms shall be Ex Works, Supplier’s site.

 

  7.2 Periodic Price Reviews . SUPPLIER and BUYER shall meet at least once during each BUYER fiscal quarter (BUYER’s fiscal year is July through June), unless BUYER requests that such price reviews be conducted monthly, in which case the parties shall meet at least once each calendar month, to review prices of each Product and determine if any price adjustment is required. The prices in the initial SOW will be the maximum prices for the Products unless mutually agreed by the Parties. Prices will be adjusted to reflect (i) changes to the costs of the Products (other than Component costs), which will be calculated in accordance with the cost model in Exhibit C and then passed through to BUYER, and (ii) changes in the costs of Components, which will be passed through to BUYER on a dollar-for-dollar basis (iii) changes in the USD exchange rate against the Supplier’s domestic currency of greater than plus/minus five percent (+/- 5%).

 

  7.3 Implementation of Cost Reductions . Each party shall be responsible for actively taking steps to reduce the cost of the Products, as agreed upon by the parties during the periodic price reviews. With regard to Components, BUYER shall notify SUPPLIER of price changes for Components that BUYER has negotiated with its Component supplier(s), and may revise its instructions to SUPPLIER regarding quantities and sources of supply from time to time as permitted herein. SUPPLIER agrees to implement such price changes within one (1) week of receiving notice from BUYER and adjust its outstanding Purchase Orders and Build Plans and sources of supply as soon as possible and BUYER agrees to buy down the inventory where Components prices have decreased, as defined in the PPV process in Section 7.5 below. SUPPLIER must obtain BUYER’s prior written approval before purchasing Components contrary to BUYER’s instructions. The split for sharing of cost reductions is shown in the following table:

 

Originator of Change

  

Benefits from Cost Reduction

(after exhausting on-hand inventory, any
non-recurring costs associated with cost
reduction activity and non-changeable POs):
First 3 Months

  

Benefits from Cost Reduction:

After 3 Months

[***]

   [***]    [***]

[***]

   [***]    [***]

[***]

   [***]    [***]

In the event that SUPPLIER expends extraordinary effort, BUYER may extend the cost sharing period for SUPPLIER from three (3) to six (6) months. BUYER shall have the option at any time to work with SUPPLIER to revise costs to reflect supplier cost reductions for Components or increase coverage on a forward-looking basis. Components that have already been received by SUPPLIER that are affected by SUPPLIER cost reductions or increase coverage shall be addressed via the cost adjustment process set forth herein.

 

  7.4 Committed Cost Reductions . BUYER will own the BOM and provide SUPPLIER with pricing, approved suppliers, and split percentages (for multi-sourced Components) for BUYER Controlled components on the BOM. For non-controlled components, BUYER will provide SUPPLIER with approved suppliers but will leverage SUPPLIER’s negotiated pricing for those parts on BUYER’s approved supplier list. SUPPLIER will use best efforts to a minimum percentage cost takedown each quarter for all non-controlled components as specified in the Statement of Work. BUYER will work in good faith to support SUPPLIER in evaluating and qualifying SUPPLIER-suggested alternate sources of supply. BUYER will drive cost reductions for BUYER-controlled components. For new products, BUYER and SUPPLIER may agree to greater quarterly cost takedowns and this will be specified in each Statement of Work.

 

  7.5 Purchase Price Variance Reports . BUYER shall not be responsible for increases in materials and Component prices of [***], except for BUYER Controlled Components. Unless SUPPLIER receives prior written approval, Buyer will not be liable for increases in materials and Component prices of [***]. thus generating a Purchase Price Variance (“PPV”). For materials or Component price increases [***], SUPPLIER must notify BUYER and submit a PPV Variance Form, in the form set forth on Exhibit G , within three (3) Business Days after SUPPLIER discovers a potential Component price increase. BUYER

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

12


MANUFACTURING AND PURCHASE AGREEMENT

 

  may either accept or reject the price increase within five (5) Business Days BUYER will pay amounts to SUPPLIER for pre-approved items listed in the PPV Form, based on when the materials or Components were received and the charges incurred. Such payments shall only be made for materials or Components purchased by SUPPLIER within the parameters set forth in the Build Plan and only from vendors on the AVL.

 

  7.6 SUPPLIER’s Bill of Materials . Upon BUYER’s request, and no less than quarterly, SUPPLIER shall furnish BUYER with SUPPLIER’s updated costed BOM for the Products in accordance with BUYER’s requirements and within the time period specified by BUYER. SUPPLIER and BUYER agree to work together actively to reduce the cost of Components, processes associated with the manufacture of Products, and the Products .

 

  7.7 Taxes and Duties .

 

  7.7.1 Taxes . The parties’ obligations with respect to the taxes and duties on the Products shall be set forth on Exhibit C or the applicable Statement of Work. Taxes, when applicable, will appear as a separate item on SUPPLIER’s invoice. If applicable law requires BUYER to withhold any taxes levied by any governmental authority on payments to be made pursuant to this Agreement (“Withholding Tax”), BUYER shall be entitled to deduct such Withholding Tax from the payments due SUPPLIER hereunder. If SUPPLIER is eligible to take advantage of the reduced Withholding Tax provided for by an applicable taxing agency, SUPPLIER shall furnish BUYER with all appropriate forms, documents and paperwork required to obtain such reduced Withholding Tax.

 

  7.7.2 Exemption . Where the law permits, SUPPLIER will treat BUYER as exempt from applicable state and/or local sales tax for Product(s) purchased pursuant to this Agreement. Where required by state or local law, BUYER will provide SUPPLIER with a valid reseller’s exemption certificate for each taxing jurisdiction to which SUPPLIER ships Product(s) and SUPPLIER shall promptly execute and furnish such certificate to BUYER.

 

  7.8 Most Favored Customer Prices . SUPPLIER shall treat BUYER as a most favored customer. SUPPLIER represents and warrants that all of the prices, warranties, benefits and other terms set forth hereunder are equivalent to or no less favorable than the terms being offered by SUPPLIER to its other customers and distributors of similar product(s). If, during the term of this Agreement, SUPPLIER enters into an agreement with any other customer that contains more favorable terms than are provided hereunder, then this Agreement shall be deemed automatically amended to provide such terms to BUYER, which shall be effective as of the effective date of such agreement. BUYER may, at its option, either elect to receive from SUPPLIER a credit against future invoices for the retroactive amounts due to BUYER by reason of such favored customer status or a cash refund. SUPPLIER agrees to fulfill its most favored customer obligations to BUYER in good faith and will not create any terms, conditions, purchasing program, pricing formulas or other conditions that serve to deny BUYER the benefits of its most favored customer status.

 

  7.9 Reports and Meeting . SUPPLIER shall promptly submit the reports described in the Joint Services Agreement in accordance with the times contained therein and all other elements that make up the cost of the Products. The parties will also meet with the frequency described in the Joint Service Agreement, on the specific dates as agreed to by the parties.

 

8. Delivery Terms .

 

  8.1 Delivery Point . The shipping terms shall be [***]. Title to and risk of loss of the Products shall pass to BUYER upon SUPPLIER’s tender of delivery to the common carrier or BUYER’s designee.

 

  8.2 Shipping . SUPPLIER may ship partial orders provided SUPPLIER notifies BUYER and BUYER agrees in writing prior to shipment. BUYER’s Purchase Order and/or Build Plan shall specify the carrier or means of transportation or routing, and SUPPLIER will comply with BUYER’s instructions, including, without limitation, drop shipping directly to a BUYER designated destination. If BUYER fails to provide shipping instructions, SUPPLIER shall, in its reasonable discretion, select the best available carrier, on a commercially reasonable basis. At the time of each shipment, SUPPLIER shall notify BUYER (and/or its designated recipient) in writing as to the quantity shipped and the anticipated arrival date of the shipment. If SUPPLIER utilizes SUPPLIER’s carrier based on the exception above, BUYER will be invoiced for the shipping cost with no supplier markup.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

13


MANUFACTURING AND PURCHASE AGREEMENT

 

 

  8.3 Packing Instructions . All Products shall be packaged and prepared for shipment in a manner which (i) follows the requirements set forth in the applicable Statement of Work, (ii) follows good commercial practice, (iii) is acceptable to common carriers for shipment, and (iv) is adequate to ensure safe arrival. SUPPLIER shall mark the outside of each shrink wrapped pallet with the applicable BUYER part numbers and any necessary lifting and handling information. Each shipment shall be accompanied by a packing slip which will include BUYER’s part numbers, Purchase Order or Build Plan number, the quantity shipped and country of origin. Shipping marks and labels shall not contain any identifying references such as Product names and model numbers, to minimize the risk of theft and shrinkage.

 

  8.4 Responsibility for Export Licensing . SUPPLIER agrees, upon BUYER’s request, to deliver Products to BUYER’s freight forwarder for export from the country of origin. BUYER will be responsible for obtaining the appropriate licenses or permits necessary to export Products from the country of origin with assistance from SUPPLIER as provided for in this Section. SUPPLIER shall furnish BUYER or BUYER’s designee with the information necessary for BUYER to timely obtain all required export and import documentation.

 

  8.5 Delivery Schedule . Delivery shall be pursuant to the schedule set forth in BUYER’s Purchase Order and/or Build Plan. Upon learning of any potential delivery delays, SUPPLIER shall immediately notify BUYER in writing of any anticipated delay in meeting the delivery schedule, stating the extent and reasons for the delay. If SUPPLIER fails to meet the committed delivery schedule, then SUPPLIER, upon BUYER’s request, shall expedite the delivery at SUPPLIER’s expense by employing accelerated measures such as paying for material expediting fees, premium transportation costs, or overtime labor required to minimize the lateness of the Delivery; provided, however, if SUPPLIER fails to meet the delivery schedule [***], then BUYER, at its sole option and without liability or any additional expense, may (i) require SUPPLIER to expedite the delivery by the fastest available commercial carrier; (ii) reschedule the delivery; or (iii) cancel the delivery in whole or in part.

 

  8.6 Incomplete Shipments . No delivery of Products shall be deemed complete unless such delivery: (i) complies with the terms of the Purchase Order for the Products ordered; (ii) is accompanied by a certificate of conformity, required test sheets and all other required documents corresponding to the relevant Specifications; and (iii) is accompanied by the relevant pro-forma invoice and any other documents required for transportation. BUYER will not have any obligation to accept any such incomplete shipments, except as BUYER may otherwise agree in advance and in writing, and BUYER may return incomplete shipments to SUPPLIER at SUPPLIER’s sole risk and expense.

 

  8.7 Timing . SUPPLIER shall not deliver any Products earlier than three (3) Business Days prior to the scheduled delivery date or later than the acknowledged delivery date, without BUYER’s written consent, and BUYER may return early, excess or late shipments to SUPPLIER at SUPPLIER’s sole risk and expense.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

14


MANUFACTURING AND PURCHASE AGREEMENT

 

 

9. Invoicing and Payment .

 

  9.1 SUPPLIER will submit invoice(s) to BUYER upon shipment of Product(s). The invoices must include the BUYER Purchase Order number, Product number, and price (unit, extended). All such invoices shall indicate any discounts which are applicable to such purchase. Subject to acceptance of the Products all invoices shall be due and payable in accordance with Exhibit C . Payment shall not constitute acceptance of the Products by BUYER. SUPPLIER shall furnish bills of lading, express receipts, or other proof of delivery upon BUYER’s request.

 

  9.2 Supplier shall submit invoices (an original and two copies) to Buyer at the address on the Statement of Work or Purchase Order containing at least the following information: (i) the name of the Supplier, address to which invoice payments should be made, and all bank details required for invoice payments (unless cheque payment applies and bank details had been exchanged before) ; (ii) invoice date; (iii) Supplier’s order number; (iv) description, quantity, unit of measure, unit price and extended price of the goods delivered; (v) transportation charges, including domestic and foreign inland freight and insurance, and any applicable taxes or duties, if applicable and specifically allowed under this Agreement; (vi) reference this Agreement and to the applicable Statement of Work or Purchase Order purchase is authorized under; and (vii) any other information specified in the applicable order.

 

10. Quality and Acceptance .

 

  10.1 At BUYER’s Designated Facility . All Products are subject to BUYER’s inspection and testing at any BUYER-designated facility before final acceptance, as set forth in Exhibit I .

 

  10.2 At SUPPLIER’s Facility . BUYER shall be entitled to conduct inspections and qualifications at SUPPLIER’s facility, as set forth in Exhibit I .

 

  10.3 Failure to Inspect . Notwithstanding anything to the contrary contained in this Agreement, inspection or failure to inspect the Products upon delivery will not affect BUYER’s rights under the warranty provisions of this Agreement.

 

  10.4 ISO 9001 and ISO 14001 Certified Supplier . SUPPLIER represents that SUPPLIER has, and will at all times during the term of this Agreement have, ISO 9001 and ISO 14001 certifications. SUPPLIER represents that any Subcontractors used by SUPPLIER in the manufacture of Products have, at a minimum, ISO 9001 certification, unless specifically agreed to, on a case-by-case basis, in writing by BUYER. Further terms and conditions concerning SUPPLIER’s qualifications as an ISO 9001 and ISO 14001 are set forth in Exhibit I .

 

  10.5 Epidemic Failure . “Epidemic Failure” for any particular Product shall mean a failure resulting from defects in material, workmanship, and manufacturing process, including but not limited to the use of Components with known defects. The Epidemic Failure clause shall be invoked [***]. The failure rate may be calculated [***], as determined by BUYER. Epidemic failures do not supersede the requirements of any expressed or implied warranty defined herein. In the case of an epidemic failure, SUPPLIER’s obligation is to propose an action plan to fix the failure of any affected Product within seventy-two (72) hours of discovery. SUPPLIER shall implement this action plan upon BUYER’s acceptance thereof. If the action plan is not acceptable to BUYER, BUYER can require SUPPLIER to repair or replace, at BUYER’s option, the affected Product. In addition to bearing the costs associated therewith, if requested by BUYER, SUPPLIER shall support and provide at SUPPLIER’s expense a sufficient number of units of the Product to permit the field exchange or “hot swap” of Products at customer sites. The parties agree to make all reasonable efforts to complete the repair or replacement of all affected Products within eight (8) Business Days after written notice of epidemic failure by BUYER to SUPPLIER. SUPPLIER also agrees that BUYER will be supported with accelerated shipments of replacement Product to cover BUYER’s supply requirements. If an Epidemic Failure is caused by (i) a design, including a BUYER-provided test process, as required by the Specifications or (ii) a failure by a Component required by the Specifications, (iii) misuse or damage during transit or damage by a third party at no fault of SUPPLIER, SUPPLIER shall perform the obligations in this Section 10.5 and BUYER shall pay to SUPPLIER the fees mutually agreed upon by the parties in writing. If an Epidemic Failure is caused by any other reason other than as set forth in the immediately preceding sentence, SUPPLIER shall perform the obligations set forth in this Section free of charge.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

15


MANUFACTURING AND PURCHASE AGREEMENT

 

11. Compliance with Specifications . All Products delivered hereunder shall fully comply with: (i) the Specifications; (ii) any end user documentation that may be included with each Statement of Work for a Product; and (iii) all applicable laws, rules and regulations.

 

12. Regulatory Agency Compliance . All Products delivered hereunder, shall fully comply with known regulatory agency requirements (e.g., Product Safety). SUPPLIER will support BUYER in obtaining all required agency certifications and approvals for the Products in BUYER’s name. SUPPLIER will be open to inspections by all compliance agencies as it relates to BUYER Products. All compliance agency inspection reports will be provided by SUPPLIER to BUYER within twenty-four (24) hours of receipt.

 

13. Representations and Warranties .

 

  13.1 Hardware Products .

 

  13.1.1 Hardware Warranty . SUPPLIER warrants that all hardware portions of the Products (including associated firmware media) sold by SUPPLIER to BUYER under the terms of this Agreement will (i) be free from defects in workmanship and Component (save and except for latent Component defects which could not be detected through the tests processes which are mutually agreed), and (ii) conform to the Specifications for a [***]. If BUYER, in its reasonable opinion, believes that any Product or part thereof contains a defect in materials or workmanship, or otherwise fails to conform to the Specifications, during the warranty period, SUPPLIER shall at its expense correct any such defect by repairing such defective Product or part or, at BUYER’s option, by delivering to BUYER an equivalent Product or part replacing such defective Product or part. Except as set forth in the immediately following sentence, nonconforming and/or defective Products shall be managed in accordance with Exhibit H . In the event a Product completely fails to function within the first seventy-two (72) hours of installation (dead-on-arrival or DOA), SUPPLIER agrees to replace the failed Product with a new Product and will ship replacement within four (4) hours of notification using same day, if possible, or at the latest next day delivery. SUPPLIER shall waive any expedite charges to BUYER in order to affect earliest reasonable replacement of such defective Product(s). Notwithstanding the foregoing, if a unit of the Product under warranty should fail owing to a defective Component part, SUPPLIER shall manage the warranty process and provide assistance and information to BUYER required to enforce, or pass on SUPPLIER’s rights or otherwise support BUYER in order to enforce the original manufacturers’ warranty terms, this includes BUYER providing evidence, testimony engagement of, and working with expert witnesses in any claim for damages against the Component manufacturer.

 

  13.1.2 Return of Products . BUYER will notify SUPPLIER of nonconforming Product. Such notification shall include serial numbers and reason for nonconformance. Nonconforming Products will be repaired as specified in Exhibit H .

 

  13.1.3 Failure Trend . For any Product family set forth on Exhibit C which has a failure rate resulting from defects in material, workmanship, manufacturing process and/or design deficiencies, including but not limited to the use of Components with inherent or latent defects, that exceeds one percent (1%) from the same root cause during any two (2) consecutive calendar months, a “Failure Trend” shall be deemed to have occurred for the applicable Product family. Such failure rate shall be calculated as the greater of: (i) the total number of units of the applicable Product family that contain such defects divided by the total number of units of that Product family shipped by BUYER to date, or (ii) the total number of units in the applicable Product family that have been registered with BUYER that contain such defects divided by the total number of units of that Product family that have been registered with BUYER to date, as determined by BUYER in its sole discretion. SUPPLIER shall immediately take corrective action with respect to the Failure Trend to reduce the failure rate of the applicable Product family to one percent (1%) or less by the last day of the calendar month following the occurrence of the Failure Trend. If SUPPLIER is unable to reduce such failure rate to one percent (1%) or less by the last day of such following calendar month, BUYER, at its sole discretion, may return any defective Product to SUPPLIER for evaluation and repair in accordance with Exhibit H . In addition, nothing in this Section shall have any effect on, and BUYER shall retain all of its rights and remedies herein. This Section shall not apply if the Failure Trend is caused by (i) a design required by the Specifications or (ii) a failure by a Component required by the Specifications.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

16


MANUFACTURING AND PURCHASE AGREEMENT

 

  13.2 Title; No Conflict . Each Party represents and warrants that it has sufficient right, title and interest to enter into this Agreement and to perform its obligations hereunder. Further, each Party represents and warrants that it has not granted to any third party any rights which conflict or interfere with or supersede the rights granted to the other Party hereunder.

 

14. Inventory Control and Security Measures .

 

  14.1 Inventory Control . At all times during the term of this Agreement, SUPPLIER shall (i) physically segregate the Products in a SUPPLIER inventory location so as not to mix BUYER inventory with other customer inventory; (ii) physically segregate agency approved (e.g., RoHS) components from non-agency approved (e.g., non-RoHS) components; and (iii) maintain clear and accurate records of all inventory transactions, including, without limitation, receipts, usage and scrap. At predetermined times, SUPPLIER and BUYER shall conduct a physical inventory of the Products.

 

  14.2 Security Measures . At all times during the term of this Agreement, SUPPLIER shall take security measures reasonably necessary (as determined by BUYER) as may be more fully described in a Statement of Work and, including but not limited to the minimum security provisions set forth in Exhibit J .

 

15. Engineering Change Procedures

Buyer may at any time during the term of this Agreement request in writing changes to the Products or services provided under a Statement of Work. Within a reasonable time after receiving such a request but in any event within five (5) Business Days, the SUPPLIER will inform BUYER in writing whether the requested change(s) is technically feasible and advise as to its impact on cost, resource requirements, schedule and any other consequent changes to the Products or services. For any such changes, the SUPPLIER will give BUYER a written fixed price quotation or its firm estimate. If the Parties agree to proceed with the as changed, then the details of such changes will be recorded in writing on a engineering change document similar to the template included as an exhibit to this Agreement and executed by both parties. No changed order shall be binding on Buyer without a valid executed Change Order document.

 

16. Confidentiality.

The parties agree that the terms of the non-disclosure agreement executed between the parties on the 1st of April, 2011 shall govern the exchange of confidential information between the parties (“NDA”). The terms of the NDA shall continue to apply to this Agreement until the Agreement terminates or expires regardless of the termination or expiration of the NDA.

 

17. Relationship of the Parties.

 

  17.1 The relationship of the parties hereto is that of independent contractors. Under no circumstances shall any employees of one party be deemed to be the employees of the other for any purpose. Each party shall pay all wages, salaries, and other amounts due its respective employees relative to this Agreement and shall be responsible for all obligations respecting them relating to applicable payroll taxes, income tax withholdings, disability, workers’ compensation and unemployment insurance premiums, health care and pension plan contributions and other similar responsibilities. Neither party has the right nor authority to assume or to create any obligation or responsibility on behalf of the other party, except as may, from time to time, be provided by written instrument signed by both parties. Nothing contained herein shall be construed as creating an agency or joint venture, consortium or partnership between the parties. Supplier and its employees shall not acquire any of the rights or privileges of any Buyer employee.

 

  17.2 SUPPLIER agrees to indemnify BUYER from any claims, losses, costs, fees, liabilities, damages, attorney’s fees and expenses suffered by BUYER arising directly or indirectly from any allegation or determination that SUPPLIER or its employees or subcontractors are employees of BUYER.

 

  17.3 If any employee or subcontractor of SUPPLIER makes a claim that an employee or independent contractor of BUYER may be treating them in an improper manner, including subjecting them to discrimination or harassment, SUPPLIER shall report this immediately to BUYER. BUYER shall be relieved of liability to the extent that SUPPLIER fails to inform BUYER of any such instance of improper behavior.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

17


MANUFACTURING AND PURCHASE AGREEMENT

 

18. Termination

 

  18.1 Termination for Cause. In the event that SUPPLIER materially breaches or defaults any of its obligations, duties or responsibilities under this Agreement or any Statement of Work or Purchase Order, which breach or default has not been remedied within thirty (30) days after written notice is given to SUPPLIER specifying the breach or default, BUYER may, at no liability to BUYER, provide written notice terminating this Agreement or any Statement of Work or Purchase Order as of the date specified in such termination notice. Before BUYER exercises BUYER’s right to terminate under this Section 18.1, BUYER will use the dispute resolution procedure set forth in Section 22.

 

  18.2 Obligations in the Event of Termination

 

  18.2.1 In the event of Termination, BUYER may require SUPPLIER to promptly transfer and assign title and immediately deliver to BUYER any completed Products, WIP, Components, BUYER Tools, BUYER’s Intellectual Property, BUYER’s confidential information and other items that SUPPLIER has produced or acquired for the performance of the canceled portions of the order and for which BUYER has paid.

 

  18.2.2 Supplier will return all BUYER Confidential Information, BUYER Data and other information received from BUYER that pertains to the Products or services described herein upon BUYER’s request. Any Confidential Information, BUYER Data or which cannot be returned must be destroyed and so certified by SUPPLIER.

 

  18.2.3 Unless otherwise agreed to in advance and in writing SUPPLIER hereby grants and agrees to grant BUYER a worldwide, non-exclusive, irrevocable, perpetual license to use any SUPPLIER Technology necessary for the, manufacture, production, marketing and sales of any of the BUYER designed Products; provided, however, BUYER covenants not to exercise such license until the effective date of termination of this Agreement or upon delivery to BUYER of the BUYER Properties, whichever is earlier. BUYER agrees to pay a reasonable royalty or license fees for the license of the applicable SUPPLIER Technology. The parties will only negotiate the amount of the royalty or license fees for such license. The parties shall negotiate such royalties or fees in good faith promptly upon termination of this Agreement; provided that SUPPLIER will offer to BUYER a fee for such license that is no higher than that offered to any other customer of SUPPLIER for comparable technology and in no case will this fee exceed one percent (1%) of the total cost of producing the Products that use SUPPLIER Technology based upon the pricing model in Exhibit C .

 

  18.2.4 SUPPLIER will immediately cease the use of all of the BUYER Technology and BUYER Properties, except that upon the termination of this Agreement for any reason, SUPPLIER will complete the production of any Products of which SUPPLIER has accepted a Build Plan as of the effective date of such termination and deliver such completed Products to BUYER within twenty (20) days of the effective date of such termination;

 

  18.2.5 SUPPLIER shall promptly provide all Loaned Materials to BUYER. To the extent that BUYER has exercised its option to purchase Necessary Equipment upon termination of this Agreement, BUYER agrees to pay a reasonable one-time fee to SUPPLIER to be negotiated in good faith by the parties at the time of termination, taking into consideration the condition and fair market value of the items. In addition, SUPPLIER shall promptly transfer to BUYER any title and/or license with respect to the Necessary Equipment held in its name.

 

  18.3 Payments following Termination. In the event of termination of this Agreement; or a Statement of Work or Purchase Order for convenience, BUYER shall pay SUPPLIER for all Products and/or services provided up to the effective date of termination as specified in the Agreement and/or the applicable Statement of Work or Purchase Order.

 

  18.3.1 Completed Products or services: BUYER shall pay SUPPLIER for the purchase price of any completed Products or services required for a Purchase Order prior to the date of Supplier’s receipt of BUYER’s Termination or Suspension Notice (“Notice Date”). BUYER shall not be required to pay for any Products or services completed after the receipt of the Buyer’s Termination or Suspension Notice.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

18


MANUFACTURING AND PURCHASE AGREEMENT

 

  18.3.2 Product WIP and Components: BUYER shall pay SUPPLIER the reasonable and actual costs incurred by Supplier, prior to the Notice Date, for Components and WIP for the canceled or changed portion of the order. In all cases, however, the SUPPLIER’s recovery will be limited as follows: (a) SUPPLIER will only be reimbursed for Components and WIP which are not cancelable, saleable, or otherwise usable by SUPPLIER; (b) The reasonable manufacturing cycle time period for the Products in question will be the maximum period for which SUPPLIER may claim WIP costs prior to the notice date; and (c) The reasonable lead time necessary to order Components for the Products in question will be the maximum period for which SUPPLIER may claim Components’ costs prior to the Cancel Date.

 

  18.4 Transition Services. Upon expiration or termination of this Agreement, BUYER may request that SUPPLIER provide transition services to BUYER to ensure an orderly transfer of services to BUYER or any other third party BUYER may designate as a successor to SUPPLIER. Transition services, if any, will be undertaken at agreed upon rates in accordance with the terms of a Statement or Work or change request, signed by both parties. During any such transition period Supplier agrees to maintain the same level of performance of services and use its best efforts to cooperate with BUYER and the successor to effect an orderly and efficient transition.

 

19. Force Majeure/Business Continuity Plan

 

  19.1 Business Continuity Plan. Beginning 30 days following the Effective Date of this Agreement and continuing through the termination or expiration of this Agreement, SUPPLIER shall maintain a mutually agreeable Business Continuity Plan to ensure the uninterrupted flow of Product to BUYER in the case of the diminution or cessation of operations of SUPPLIER for any reason that may affect BUYER’s relationships with BUYER’s customers including Force Majeure. SUPPLIER shall provide such Business Continuity Plan to BUYER for BUYER’s review no later than thirty (30) days from the date of this Agreement. If a catastrophic event occurs including Force Majeure, SUPPLIER shall notify BUYER immediately of the situation and shall implement, within three (3) days, the Business Continuity Plan to resolve the problem. Only if BUYER complies with the obligations set forth in this Section 19.1 will SUPPLIER be temporarily relieved of its obligations under this Agreement. Notwithstanding the foregoing, BUYER reserves the right to terminate the Agreement or Statement of Work or Purchase Order if BUYER reasonably determines such delay is or will detrimentally affect the value and usefulness of the Products or services or SUPPLIER failed to promptly implement its Business Continuity Plan.

 

  19.2 Force Majeure. Subject to Section 19.1 above, neither party shall be liable for any delay in performance or non-performance (including payment obligations), directly or indirectly caused by Act of God, fire, explosion, flood, war, act of terrorism, act of, or authorized by any government, accident or any other circumstances beyond the control of the Party. Any Party so delayed in its performance will immediately notify the other by email or telephone or by the most timely means otherwise available.

 

20. Insolvency

In the event that a party:

 

  (a) Becomes insolvent or unable to pay its debts or perform its obligations as they mature;

 

  (b) Becomes the subject of any voluntary or involuntary proceeding in liquidation, dissolution, receivership, attachment, composition or general assignment for the benefit of creditors; or

 

  (c) Pursues any other remedies under any other law relating to relief for debtors,

Then such party will provide prompt notice to the other and reasonable assurances therefore, as may be requested from the other party from time to time, that it can and will perform its obligations under this Agreement. If such notices or assurances are not received in a timely manner or are not reasonably satisfactory to the party receiving the assurances, then such party may terminate any Statement of Work or Purchase Order or this Agreement in whole or in part without any cost or liability.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

19


MANUFACTURING AND PURCHASE AGREEMENT

 

21. Governing Law

This Agreement shall be construed, governed and interpreted in accordance with the laws of the United States of America and the State of California, without regard to choice of law principles. The U.N. Convention on Contracts for the International Sale of Goods does not apply to this Agreement.

 

22. Disputes

The Parties shall attempt, in good faith, to resolve any dispute promptly by discussion and negotiation which shall be conducted as follows:

 

  (a) the dispute shall be referred, by either Party, first to the senior managers of each of the Parties for resolution;

 

  (b) if the dispute cannot be resolved by the senior managers of the Parties within 14 days after the dispute has been referred to them, either Party may give notice to the other Party in writing (“Dispute Notice”) that a dispute has arisen; and

 

  (c) within seven days of the date of the Dispute Notice, each Party shall refer the dispute to the most senior representative of each of the Parties for resolution.

If the most senior representative of each of the Parties are unable, or fail, to resolve the dispute within 21 days of the date of the Dispute Notice, the Parties may attempt to resolve the dispute by mediation in accordance with this clause.

If, within 30 days of the Dispute Notice, the Parties have failed to agree on a resolution, either Party may refer any dispute for mediation, but neither shall be a condition precedent to the commencement of any arbitration proceedings as set forth in this Section 22, and either Party may issue and commence arbitration proceedings prior to or contemporaneously with the commencement of mediation. All disputes arising out of or relating to this Agreement that are referred to arbitration as set forth above will be resolved by binding arbitration to take place in County of Santa Clara, State of California, United States of America, under the Rules of Arbitration of the International Chamber of Commerce (the “RAICC”). The arbitration administration and appointing authority will be the International Chamber of Commerce (the “ICC”), and the arbitrator(s) shall apply the governing law as set forth in Section 21, to decide the dispute. The arbitration will be conducted by a panel of three arbitrators, one chosen by each party to this Agreement and the third by agreement of the parties; failing agreement within 30 days of commencement of the arbitration proceeding, the ICC will appoint the third arbitrator in accordance with the RAICC. The proceedings will be confidential and conducted in English. The arbitral tribunal will have the authority to grant any equitable and legal remedies that would be available in any judicial proceeding instituted to resolve a disputed matter. The arbitration award will be final and binding on the parties and the award may be entered by any court of competent jurisdiction, and each of the parties irrevocably submits to the jurisdiction of such court for confirmation and/or recognition and/or enforcement of any award rendered by the arbitral tribunal in accordance with, inter alia, the United Nations Convention on the Recognition and Enforcement of Foreign Arbitral Awards. The arbitral tribunal will determine how the parties will bear the costs of the arbitration. Notwithstanding the foregoing, with respect to claims relating to intellectual property, each party will have the right at any time to immediately seek injunctive relief, an award of specific performance or any other equitable relief against the other party in any court or other tribunal of competent jurisdiction. During the pendency of any arbitration or other proceeding relating to a dispute between the parties, SUPPLIER will continue to exercise its remaining respective rights and fulfill its remaining respective obligations under this Agreement. SUPPLIER hereby consents to being served outside the State of California, United States of America with any documents relating to any dispute, or proceedings in any court, permitted under this Agreement. The rights and remedies provided by BUYER in this Agreement shall be cumulative and in addition to any other rights and remedies provided by law or equity or those provided under the Uniform Commercial Code.

 

23. Assignment

No part of this Agreement may be assigned or subcontracted by SUPPLIER without the prior written approval of BUYER.

 

24. Change of Control

This Agreement shall inure to the benefit of, and be binding upon, the parties hereto and their respective successors and assigns. SUPPLIER may request that any acquirer of all or substantially all of the assets of BUYER provide written confirmation of its obligations under this Agreement within thirty (30) days of the closing of such acquisition.

 

25. Compliance with Laws

 

  25.1 SUPPLIER shall comply with all applicable laws and regulations and shall monitor any modifications to them. This includes, but is not limited to, the laws and regulations governing the following: environmental,

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

20


MANUFACTURING AND PURCHASE AGREEMENT

 

  health, safety, labor, employment, child labor, intellectual property, discrimination and human rights. SUPPLIER shall comply with the standards of the industry. SUPPLIER must not use forced labor. SUPPLIER shall ensure the compliance of its Products with specific legal requirements applicable to the countries into which Products are being sold to BUYER.

 

  25.2 Export Compliance

 

  25.2.1 SUPPLIER shall promptly notify, and provide Buyer with, necessary or applicable supporting documents, permits, approvals or information required to comply with export or import regulations and/or BUYER policy, including manufacturer’s affidavit, certificate of origin, manufacturer’s safety data sheet and other items.

 

  25.2.2 Transfer, export, re-export or import of Product, software or technology may require an approved government license, permit, or other authorization from the applicable government(s). Each party shall comply, at its own expense, with all applicable import and export laws, restrictions, and regulations of the United States and all other applicable foreign governments relevant to such party.

 

  25.2.3 Each party hereby acknowledges that it will not export any Product, related documentation or technical data without first obtaining the required export licenses. SUPPLIER hereby agrees to comply with the requirements of the U.S. Foreign Corrupt Practices Act (“Act”) and shall refrain from making any payments to third parties that would cause SUPPLIER or BUYER to violate the Act.

 

  25.2.4 The Parties agree to comply with all laws, ordinances, rules, regulations, and other requirements of all governmental units or agencies, including obtaining all import/export and other permits, certificates, and licenses required by foreign jurisdictions.

 

26. Indemnification

 

  26.1 General Indemnification : SUPPLIER is solely responsible for and shall indemnify, defend and hold BUYER and its respective directors, officers, agents, employees and customers (each an “BUYER Indemnitee”) harmless from and against all claims, demands, threats, damages, losses, liabilities, costs, expenses and reasonable attorney’s fees (collectively “Damages”) arising out of a claim by a third party against an BUYER Indemnitee resulting from or alleged to have resulted from any act or omission of SUPPLIER, its employees or agents under or related to this Agreement which has not been rectified in accordance with the terms herein including. BUYER will provide SUPPLIER with prompt written notice of the claim and permit SUPPLIER, at SUPPLIER’s expense, to control the defense, settlement, adjustment or compromise of any such claim. BUYER may employ counsel at its own expense to assist it with respect to any such claim. SUPPLIER shall have no authority to settle any claim on behalf of BUYER if any such settlement imposes any obligation on BUYER.

 

  26.2 Infringement Indemnification : SUPPLIER shall indemnify and hold harmless BUYER, and, at BUYER’s request, defend BUYER and the BUYER Indemnitees from and against any Damages arising from or relating to any claim that BUYER infringes any proprietary rights of any third party as a result of the manufacturing services provided under this Agreement including, but not limited to: the actual or alleged infringement of any patent, copyright, trade secret, trademark, mask work or other third party right worldwide arising from or related to the manufacturing of any Products or services furnished under this Agreement and alleged defect in the Components or services, whether latent or patent, including any failure of the Components, Products or services to comply with their specifications. BUYER will provide SUPPLIER with prompt written notice of the claim and permit SUPPLIER, at SUPPLIER’s expense, to control the defense, settlement, adjustment or compromise of any such claim. BUYER may employ counsel at its own expense to assist it with respect to any such claim. SUPPLIER shall have no authority to settle any claim on behalf of BUYER.

 

  26.2.1 If the exercise by BUYER or any BUYER Indemnitee of any rights granted herein is enjoined, or in BUYER’s reasonable opinion is likely to be enjoined, at BUYER’s request and option, and without prejudice to any other rights and remedies Buyer otherwise may have at law, in equity, or under this Agreement, SUPPLIER shall, at its expense, use its best efforts to:

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

21


MANUFACTURING AND PURCHASE AGREEMENT

 

 

  (a) Procure from the person(s) claiming infringement a license for BUYER to continue to exercise all rights granted under this Agreement; or,

 

  (b) Modify, without diminishing existing functionality, the allegedly infringing item to avoid infringement.

 

  26.2.2 If options (a) and (b) cannot be accomplished despite such attempts, then, in addition to any other rights at law or in equity or otherwise provided for in this Agreement, SUPPLIER shall refund to BUYER all amounts previously paid to SUPPLIER under this Agreement related to such infringing item.

 

  26.3 BUYER infringement Indemnification : BUYER shall indemnify and hold harmless SUPPLIER, and, at SUPPLIER’s request, defend SUPPLIER and its respective directors, officers, agents, and employees (“SUPPLIER Indemnitees”) from and against any Damages arising from or relating to any claim that SUPPLIER infringes any proprietary rights of any third party as a result of the use and sale of the Products under this Agreement including, but not limited to: the actual or alleged infringement of any patent, copyright, trade secret, trademark, mask work or other third party right worldwide arising from or related to the use and sale of any Products under this Agreement and alleged defect in the Products, whether latent or patent, including any failure of the Products to comply with their Specifications not subject to the indemnification provided in Section 26.2. SUPPLIER will provide BUYER with prompt written notice of the claim and permit BUYER, at BUYER’s expense, to control the defense, settlement, adjustment or compromise of any such claim. SUPPLIER may employ counsel at its own expense to assist it with respect to any such claim.

 

27. LIMITATION OF LIABILITY

 

  27.1 EXCEPT FOR LIABILITY RESULTING FROM SUPPLIER’S INDEMNIFICATION OBLIGATIONS UNDER THIS AGREEMENT OR A PARTY’S BREACH OF ANY OBLIGATION OF CONFIDENTIALITY, IN NO EVENT SHALL EITHER PARTY OR THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, AND AGENTS BE LIABLE FOR ANY INDIRECT, SPECIAL, PUNITIVE, EXEMPLARY, OR CONSEQUENTIAL DAMAGES OF ANY KIND, INCLUDING BUT NOT LIMITED TO LOST PROFITS, WITH RESPECT TO THIS AGREEMENT, EVEN IF THE PARTIES HAVE BEEN ADVISED OF THE POSSIBILITY OF THE SAME OR EVEN IF SAME WERE REASONABLY FORESEEABLE.

 

  27.2 The entire and aggregate liability of BUYER and SUPPLIER’s exclusive remedy for all claims of any nature against BUYER shall not exceed [***].

 

  27.3 Nothing in any of SUPPLIER’s documentation, any Statement of Work or any Purchase Order shall have the effect of extending or changing the liabilities of the parties, their directors, officers, employees and agents as provided for in this Section.

 

  27.4 The provisions of this Section apply whether the claim for damages arises a result of contract, tort (including negligence), or any other statutory, legal or equitable grounds.

 

28. Audits

 

  28.1 SUPPLIER shall keep and maintain accurate records relevant to this Agreement and all Statements of Work and Purchase Order issued hereunder for a period of five (5) years after final payment under this Agreement. In the event that BUYER has specific records that require a longer retention period BUYER shall make such written request and such request shall not be unreasonably refuse.

 

  28.2 SUPPLIER warrants and represents that it has internal controls in place, as well as auditing procedures (scheduled and random), consistent with industry best practices and standards.

 

  28.3 BUYER, or its authorized agent subject to signed non-disclosure agreement, as mutually agreed between the parties, shall have the full right to audit and review any and all relevant BUYER-related SUPPLIER records and facilities to ensure compliance with the terms of this Agreement. Such audit may be conducted any time during the term of the Agreement, and for a period of up to twelve (12) months following termination or expiration of the agreement, after BUYER provides written notice at least five (5) Business

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

22


MANUFACTURING AND PURCHASE AGREEMENT

 

  Days in advance and shall take place during SUPPLIER’s normal business hours. In the event an audit determines material non-compliance with the terms of the Agreement, SUPPLIER shall bear the costs of the audit.

 

  28.4 Where applicable, BUYER may impose additional audit requirements where deficiencies in compliance are determined as related to support of the terms of this Agreement.

 

29. Acquisition.

 

  29.1 For any business where Oclaro acquires controlling interest:

 

  29.1.1 If that acquired business has an existing agreement with SUPPLIER, the volume for that agreement will be included in the BUYER volume discount calculations immediately for discount purposes (retroactive to the beginning of the current measurement period for determining the discount); and,

 

  29.1.2 If that acquired business has more favorable terms for BUYER in its existing agreement with SUPPLIER, the more favorable terms will immediately apply to this Agreement.

 

  29.2 If SUPPLIER acquires or is acquired by a contract manufacturer that has an agreement with BUYER with more favorable terms than in this Agreement, the more favorable terms will immediately apply to this Agreement.

 

30. Insurance

 

  30.1 Minimum Insurance Required. During the term of this Agreement, SUPPLIER will obtain and maintain at its sole expense, with financially reputable insurers licensed to do business in all jurisdictions where Products are manufactured and services are performed, liability insurance sufficient to protect BUYER from any claims described herein, and in any event no less than the policies and limits set forth below. SUPPLIER will pay the premiums therefore, and deliver to BUYER, upon execution of this Agreement, proof of such insurance.

 

Minimum Coverage    Limits
1) Worker’s Compensation    Statutory
2) Employer’s Liability    $500,000 each accident
4) Automobile Liability Insurance    $1,000,000 each occurrence
5) Commercial General Liability    $10,000,000

 

  30.2 Where applicable, BUYER may impose additional insurance requirements based upon the nature of the specific Products and services to be purchased from SUPPLIER such additional requirements shall be outlined in an “Additional Insurance Requirements” Exhibit to this Agreement.

 

  30.3 Every insurance policy providing the coverage required in this Section shall contain the following or equivalent clause: “No reduction, cancellation or expiration of the policy shall be effective until thirty (30) days from the date written notice thereof is actually received by SUPPLIER.” Upon receipt of any notice of reduction, cancellation or expiration, SUPPLIER shall immediately notify BUYER.

 

  30.4 BUYER and its affiliates shall be named as an additional insured under the Commercial General Liability Insurance policies described in this Section. SUPPLIER waives all rights of recovery against BUYER and its affiliates for any loss or damage covered by the Commercial General Liability Insurance policies.

 

  30.5 SUPPLIER is solely responsible for the claims of its employees and shall release, defend, and indemnify BUYER and its affiliates from and against such claims.

 

  30.6 The complete or partial failure of SUPPLIER’s insurance carrier to fully protect and indemnify BUYER and its affiliates or the inadequacy of the insurance coverage shall not in any way lessen or affect the obligations of SUPPLIER to indemnify BUYER or its affiliates.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

23


MANUFACTURING AND PURCHASE AGREEMENT

 

 

31. Notices

Any notice or other document or communication required or permitted hereunder to the parties hereto will be deemed to have been duly given only if in writing and delivered by any of the following methods: (i) certified U.S. mail, return receipt requested, postage prepaid; or (ii) deposit with a recognized commercial overnight courier service, fees prepaid, in each case delivered to the addresses of the receiving parties set forth below or such other addresses as such parties may subsequently dictate according to the notice provisions hereof. Notice is deemed to have been given five (5) Business Days after deposit in the mail or one day after deposit with overnight carrier or delivery service, except that notice of change of address is effective only upon receipt. Notice is not deemed to have been given to BUYER unless the notice to BUYER’s General Counsel has been delivered.

If to SUPPLIER, all notices shall be addressed and delivered to:

 

Venture Corporation LTD,

5006 Ang Mo Kio Avenue 5, #05—1/12

TECHplace ll, Singapore 569873

Attention: President, Copy to: CFO

Telephone: (65) 6482 1755

Facsimile: (65) 6482 0122

If to BUYER, all notices shall be addressed and delivered to:

 

Oclaro Inc.

2560 Junction Ave.

San Jose, CA 94538

Attention: General Counsel

Telephone: 408-383-1400

Facsimile: 408-919-1501

 

32. Amendment

Any and all amendments, alterations, or additions to this Agreement must be in writing and executed by SUPPLIER and an authorized representative of BUYER. No modifications to this Agreement proposed by SUPPLIER, or “riders” whether inserted in the page margins or attached on separate pages, shall be binding on BUYER unless signed or initialed by a duly authorized representative of BUYER.

 

33. Waiver

The failure of either party at any time to require performance by the other party of any provision hereof will not affect in any way the right to require such performance at any time thereafter. The waiver by either party of a breach of any provision hereof will not be taken or held by the other party to be a waiver of the provision itself unless such a waiver is expressed in writing.

 

34. Severability

 

  34.1 Any provision in this Agreement which is held to be illegal or unenforceable in any jurisdiction shall be ineffective to the extent of such illegality or unenforceability without invalidating the remaining provisions and any such illegal or unenforceable provision shall be deemed to be restated to reflect as nearly as possible the original intentions of the parties in accordance with applicable law.

 

  34.2 IT IS EXPRESSLY AGREED THAT EACH PROVISION OF THIS AGREEMENT (INCLUDING THE STATEMENT(S) OF WORK and PURCHASE ORDERS) THAT PROVIDES FOR A LIMITATION OF LIABILITY OR REMEDIES, DISCLAIMER OF WARRANTIES, INDEMNIFICATION OF A PARTY OR EXCLUSION OF DAMAGES OR OTHER REMEDIES IS SEVERABLE AND INDEPENDENT OF ANY OTHER PROVISION AND IS INTENDED TO BE ENFORCED AS SUCH. FURTHER, IT IS EXPRESSLY AGREED THAT IN THE EVENT ANY REMEDY UNDER THIS AGREEMENT IS DETERMINED TO HAVE FAILED OF ITS ESSENTIAL PURPOSE, ALL LIMITATIONS OF LIABILITY AND EXCLUSIONS OF DAMAGES OR OTHER REMEDIES SET FORTH IN THIS AGREEMENT SHALL REMAIN IN EFFECT.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

24


MANUFACTURING AND PURCHASE AGREEMENT

 

 

35. Survival

The provisions of this Agreement that would naturally survive termination shall so survive.

 

36. Agreement of Precedence

Each Statement of Work and Purchase Order shall be governed by the terms of this Agreement and the terms set out in the Statement of Work or Purchase Order. In the event of any conflict or inconsistency between the provisions of this Agreement and any Joint Service Agreement, Statement of Work or Purchase Order, the same shall be resolved by giving precedence to this Agreement (including any exhibits or addenda).

 

37. Counterparts

This Agreement may be signed in counterparts, including but not limited to facsimile or scanned versions of the full document, each of which shall be deemed to be an original but all of which shall constitute an original and the same instrument.

 

38. Entire Agreement

This Agreement, together with all valid attachments, exhibits, supplemental sheets and riders, constitutes the entire understanding and agreement of the Parties with respect to the subject matter hereof, and supersedes all prior or contemporaneous communications, understandings, representations and agreement, whether written or oral, with respect to such subject matter.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

25


MANUFACTURING AND PURCHASE AGREEMENT

 

IN WITNESS WHEREOF the parties have executed this Agreement on the day and year first above written.

 

OCLARO Technology Ltd.    Venture Corporation Ltd

 

  

 

Date

   Date

 

  

 

Signature

   Signature

 

  

 

Printed Name

   Printed Name

 

  

 

Title

   Title

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

26


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit A-1

APPROVED MANUFACTURING AND PRODUCT DEVELOPMENT LOCATIONS

1.     Approved Manufacturing and Product Development Locations .

Venture Electronics Services (Malaysia) Sdn. Bhd.

Plot 44, Bayan Lepas Industrial Park IV 11900 Penang

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

27


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit A-2

TRANSFERRED PRODUCTS

[***18 pages redacted***]

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

28


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit A-3

Preliminary FLIGHT PLANS

[***one page redacted***]

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

29


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit B

BUILD REQUEST AND BUILD PLAN FORM

These forms are set forth for example only. The parties may mutually agree in writing to any change in format.

Build Request

The Build Request is provided by BUYER to SUPPLIER at least monthly.

Build Request Form (BUYER Requested MPS)

 

Product

 

Units

 

Wk1

 

Wk2

 

...

  

Wk26

  

Mo7

  

Mo8

  

...

  

Mo12

Name, #

                    

Name, #

                    

Name, #

                    

Name, #

                    

Name, #

                    

Build Plan

The Build Plan is provided by SUPPLIER to BUYER, after receiving Build Request, and then jointly reviewed. The proposed Build Plan is discussed, any adjustments are made, and the Build Plan is agreed upon jointly. The updated and agreed upon Build Plan is then published by SUPPLIER.

Build Plan Form (SUPPLIER Committed MPS)

 

Product

 

Units

 

Wk1

 

Wk2

 

...

  

Wk26

  

Mo7

  

Mo8

  

...

  

Mo12

Name, #

                    

Name, #

                    

Name, #

                    

Name, #

                    

Name, #

                    

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

30


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit C

PRICES AND SHIPPING TERMS

Description of Products

SUPPLIER and BUYER shall set forth the requirements for transferring the Transferred Products from BUYER’s Shenzhen facility to the Approved Manufacturing and Product Development Locations in sequentially numbered Statements of Work (E.g., SOW #1, SOW#2, etc.). Additional Products to be manufactured by SUPPLIER for BUYER will be specified in a sequentially numbered Statement of Work.

Product Price

The unit prices charged by SUPPLIER for the Products shall be those set forth on the applicable Statement of Work, less the applicable discount, if any, stated therein. SUPPLIER shall be solely responsible for the purchase of all Components and parts required for manufacture production of the Products within the Leadtime. All prices are Ex Works . Prices are exclusive of costs of Product delivery, insurance, taxes, customs, duties, landing, storage and handling fees included in the original price quotation, and/or cost for documents or certificates required for Product exportation or importation.

Out of Warranty Repair Charge

Out of warranty repair requirements will be defined and set forth on each Statement of Work. If desired, BUYER may request SUPPLIER to repair out of warranty products. For such Products, BUYER and SUPPLIER will agree on pricing in the applicable Statement of Work.

Invoices

Unless otherwise set forth on the applicable Statement of Work, subject to acceptance of Products as provided in Section 10 of the Agreement, BUYER shall [***]. Notwithstanding the foregoing, if BUYER rejects Products under the Agreement, BUYER may delay payment of the applicable invoice until the Products are repaired or replaced in accordance with Section 13.

Product Pricing

Definitions:

CM G&A means the SUPPLIER’s general and administrative costs including the cost of capital for the purposes of pricing

CM Profit means the amount of SUPPLIER’s profit for the purposes of pricing

CM Mark-Up means the CM G&A and CM Profit attributed to a Product by BUYER

Consumables means the agreed consumable consumption for the necessary materials to manufacture the Products that are not included in the Bills of Materials. Where allocation assumptions are required, allocation will be made on the basis of Direct Labor hours. Examples are; cleanroom supplies, process gases, etc.

Depreciation and Equipment Support means the cost applied for a piece of Equipment upon its transfer and qualification at SUPPLIER’s manufacturing facility determined according to Table C-5 and as otherwise set forth below, including SUPPLIER’s incurred cost for shipping, support and maintenance of such equipment

Direct Labor means the agreed fully-loaded direct labor cost applied to agreed touch time per unit, including standard rate, “yielded rate”, and rework labor

Direct Materials means the actual direct materials costs per unit, net of any discounts or rebates (BOM cost)

Facilities Costs means the agreed costs for all facilities and infrastructure support for Products, including without limitation building and facilities staff; equipment; warehouse facilities and staff; security; maintenance; utility cost. Where allocation assumptions are required, Facilities Costs will be allocated to Product families based upon their facility requirements and to Products within a Product family on the basis of Direct Labor hours

Freight means the variable freight charges associated with the purchase of Components which shall be determined as a maximum of 0.5% of Direct Materials cost

Indirect Labor means the agreed costs for all indirect support for Products including without limitation engineering, purchasing, maintenance, quality, planning, purchasing, etc. Where allocation assumptions are required, Indirect Labor costs will be allocated to Product families based upon their actual support and requirements and to Products within a Product family on the basis of Direct Labor hours

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

31


MANUFACTURING AND PURCHASE AGREEMENT

 

Overhead Cost means the Indirect Labor, Facilities and Depreciation Costs attributed to a Product by BUYER

Scrap means the agreed scrap rate, net of salvage/rework value

Variable Cost means the Direct Materials, Direct Labor, Scrap and Consumables attributed to a Product by BUYER

Pricing Model

Pricing shall be determined and adjusted as set forth herein. The parties agree that the price shall consist of the sum of Variable Cost plus Overhead plus CM Mark-Ups in total, as further illustrated in Table C-1.

Table C-1

Pricing Model Elements

 

Cost Element

  

Components

Variable Cost    Direct Materials
   Direct Labor
   Scrap
   Freight
   Consumables
Overhead Cost    Indirect Labor
   Facilities Costs
   Depreciation and Equipment Support
CM Mark-Ups    CM G&A, including cost of capital
   CM Profit

Variable costs and Overhead shall be agreed to based upon the actual costs and the parties agree that BUYER shall have access to all documentation to determine actual costs. Overhead costs shall be determined as described herein below. Upon notice, BUYER may audit SUPPLIER records to determine actual costs.

Variable Cost

Direct materials pricing will reflect the actual BOM costs attributable to the Product on a quarterly basis, subject to the provisions of sections 6 and 7 of this agreement. Direct Labor, Scrap, Freight and Consumables shall be set with agreed upon rates, established quarterly, which will be based upon the actual SUPPLIER costs for the respective line items without additional charges or mark-ups.

Scrap will be adjusted quarterly, with within-quarter adjustments if actual scrap rates are outside +/- 10% from the current quarter’s agreed value.

Overhead Cost

Indirect Labor and Facilities rates shall be agreed on an annual basis, based upon actual costs of operations without additional charges or mark-ups.

The Parties shall allocate Indirect Labor and Facilities by category of Product. On an annual basis Each Product will be assigned an overhead pricing category as described in Table C-2 and as illustrated in Table C-3, and all Products in that category will have the same Overhead rate.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

32


MANUFACTURING AND PURCHASE AGREEMENT

 

Table C-2

Overhead Rate Methodology

 

Timing

  

Activity

Initial Cost
Program Setup
  

•    Assign Product to an Overhead category containing like Products with similar support requirements.

 

•    Establish actual costs for Indirect Labor and Facilities for each Product family.

 

•    Define Overhead rates for each category as the median of per-unit costs for all Products in that category.

 

•    Define boundaries of each category to be the midpoint between the Overhead rate for that category and the next lower/higher category.

 

•    Compare actual costs per Product to the category boundaries. Re-assign Products to lower/higher categories when actual costs for that Product are outside the boundaries for the initially-assigned category.

Annually   

•    Reset Overhead rates for each category based on current actual support costs, as mutually assessed and agreed.

 

•    Establish quarterly volume forecast by Product family and volume variability limits which would shift the Product family to a higher/lower category.

Quarterly   

•    Shift Products to different Overhead categories based on current actual support requirements, and establish the appropriate volume adjustment to reflect prior quarter actual family volumes.

Table C-3

Overhead Rate Illustrative Example

 

VALUES ARE FOR ILLUSTRATIVE EXAMPLE ONLY

Overhead Cost
Category

  

Overhead Rate

(per DL Hour)

    

Products

1    $ 1.50       Product A, Product C, Product F, Product N
2    $ 2.25       Product B, Product E, Product R
3    $ 3.00       Product D, Product G, Product L, Product M
4    $ 4.50       Product H, Product J, Product K
          
N    $ 7.00       Product P

Overhead categories will be specified in the Statement of Work for a Product.

Overhead adjustments

On a quarterly basis, BUYER and SUPPLIER will adjust the Product family Overhead rate based upon the prior quarter actual volume for the Product family. In the case of volumes significantly above or below the volumes planned in the annual rate setting process, an adjustment factor shall be applied to the actual Overhead rate to compensate for Overhead over or under absorption as set forth in Table C-4 (“Adjustment Factor”). The quarterly rate will be calculated as follows: [Product family Overhead rate] x [Adjustment Factor].

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

33


MANUFACTURING AND PURCHASE AGREEMENT

 

Table C-4

Adjustment Factors

 

Volume Deviation from Plan

  

Adjustment Factor

(Volumes above Plan)

  

Adjustment Factor

(Volumes below Plan)

[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]

Depreciation and Equipment charges will be allocated to product cost on a proportionate basis based upon actual usage of the equipment, utilizing the amortization schedule as indicated in Table C-5. The parties will agree on the applied charges on a product basis as part of the quarterly pricing process. In the event that there are insufficient units to apply the depreciation charges on a quarterly basis the parties will mutually agree to an alternative billing mechanism for SUPPLIER to recover depreciation cost.

Table C-5

Equipment Amortization Schedule

 

Age of Asset

(Years)

  

Depreciation Timeline

(Years)

[***]    [***]
[***]    [***]
[***]    [***]
[***]    [***]

In the event anticipated volumes during a quarter are insufficient to fully absorb the depreciation the following quarter’s pricing will be adjusted to ensure “true-up” of the full amount within the quarter.

SUPPLIER may use the Acquired Equipment for SUPPLIER’s other customers as long as no BUYER intellectual property is used without BUYER’s prior written consent. Depreciation will be calculated by excluding the proportionate share of the Acquired Equipment used or made available for use by SUPPLIER’s other customers.

CM Mark-Ups

CM Mark-Ups shall be as follows, for the duration of this agreement, calculated as a portion of total cost:

- [***]

- [***]

NPI Pricing

The Parties shall establish pricing for newly introduced Products (NPI) as described herein.

(i) Variable Cost will be priced in the same manner as described above

(ii) Overhead will be priced as follows: Upon SUPPLIER’s award of a new Product, SUPPLIER and BUYER shall determine: (a) the cost of Overhead, (b) the Overhead category for the initial ramp period for NPI based upon additional support requirements; (c) the Overhead category for volume production (based on the anticipated support requirements for volume production), and (d) the timing required to reach volume production as a result

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

34


MANUFACTURING AND PURCHASE AGREEMENT

 

of a ramp plan including the anticipated calendar quarter of migration from NPI to volume production, The Product will shift Overhead categories as part of a quarterly reassignment for all Products at which time any significant departures from the ramp plan will be addressed.

(iii) CM Mark-up will be priced equal to the CM Mark-Up for volume production.

Volume Discounts

For each Product, BUYER shall establish volume discounts for Overhead and CM Mark-Ups upon Product volume reaching established thresholds. For Overhead, BUYER shall set a percentage change in the Overhead cost for all Overhead categories based on a set deviation from the standard volume in such Overhead categories. For CM Mark-Up, BUYER shall set a percentage reduction in the CM Mark-Up cost for all Products upon reaching a series of volume thresholds using the prior quarter’s actual total business volume with the SUPPLIER as set forth in Table C-6.

Overhead and CM Mark-Up rates based upon volume shall be established/reset on an annual basis, and applied each quarter using volumes from the prior quarter, except as adjusted in Section 27 above.

Table C-6

Volume price adjustments will be calculated as follows:

 

Revenue

(Quarterly)

  

SG&A Adjustment

  

Profit Margin Adjustment

[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]
[***]    [***]    [***]

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

35


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit D

EXAMPLE STATEMENT OF WORK

This Statement of Work is entered into as of <month>, <year>, (“SOW Effective Date”) between BUYER and SUPPLIER

NOW, THEREFORE, in consideration of the promises and agreements of the parties set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

Equipment

Description of Equipment to be transferred;

Inventory

Description of Inventory to be transferred;

Transition Plan .

Pricing

All prices are based on the agreed upon Overhead pricing matrix for these Products per Exhibit C of the Manufacturing and Purchase agreement.

Specifications

Engineering Specifications for each Product are attached to this Statement of Work.

Approved Manufacturing and Product Development Locations

All Products under this Statement of Work will be manufactured at SUPPLIER’s facility:

SUPPLIER

Address1

Address2

City, State Zip

Materials

Schedule

Append transfer / transition / ramp schedule here, including milestones, target quantities, and target yields

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

36


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit E

BUYER TRADEMARKS

Page intentionally left blank

 

37


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit F

Intentionally left blank

 

38


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit G

PURCHASE PRICE VARIANCE FORM

[EXAMPLE]

 

BUYER
Component
Part No

  

Descr

   SUPPLIER
Site
   Mfg    MPN    SUPPLIER
Site
Buyer
Name
   SUPPLIER
Commodity
Mgr
   Current
QtrStd
W/
BUYER
   Total
Lead
Time
   Purchase
Price
   Unit
PPV
$
   Qty
Received
Last
Month
   Extended
PPV
$
   Explanation
For
PPV
                                      
                                      
                                      
                                      
                                      
                                      

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

39


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit H

RETURN AND REPAIR SERVICES

Product Repairs . SUPPLIER will Repair a defective Product and forward the same back to BUYER or BUYER’s customer as requested by BUYER. SUPPLIER will Repair defective Product to BUYER Specifications. SUPPLIER will upgrade Repaired Product to the most recent BUYER approved ECO level. SUPPLIER shall charge rates as specified in a Statement of Work. Any Repair shall be warranted for the remainder of the warranty period or six (6) months, whichever is longer. This statement excludes Product which has been damaged by accident, abuse or misuse. BUYER reserves the option to perform out-of-warranty Repairs at Repair facilities designated by BUYER. In the event BUYER exercises the option to perform Repairs at such designated facilities, SUPPLIER shall provide all required product specifications, engineering documentation, and test and Repair procedures.

 

2. Return Material Authorization (RMA) . SUPPLIER shall provide BUYER with RMA procedures. The following procedure shall apply to SUPPLIER’s Repair of Products.

 

  (i) Turn-Around Time . SUPPLIER will use its best efforts to provide BUYER with RMA number within one (1) Business Day after receipt of request. SUPPLIER will Repair the defective Product and forward the same back to BUYER within five (5) Business Days after receipt. SUPPLIER will provide expedited Repair service to accommodate BUYER emergency requirements at a minimal expedite charge, not to exceed five (5%) of Repair charge.

 

  (ii) Reporting . BUYER Repaired Products will be returned with a detailed Repair report for each unit. SUPPLIER will provide a monthly report of: (i) RMAs processed, including failure analysis and (ii) physical inventory of BUYER owned material. Upon special request, SUPPLIER will provide inventory status within two (2) Business Days.

 

  (iii) Shipping charges . SUPPLIER will pay all inbound and outbound shipping charges on all in-warranty Products shipped to SUPPLIER for Repair. BUYER will pay all inbound and outbound shipping charges on out-of-warranty Products shipped to SUPPLIER for Repair.

 

  (iv) Marking requirements . On all Products returned to BUYER, SUPPLIER will affix label that identifies Product, including model number, serial number, current hardware and/or software revision level, and RMA number.

 

3. Problem with Specification or Component . If a defect in a Product is caused by (i) a design required by the Specifications or (ii) a failure by a Component required by the Specifications, SUPPLIER shall perform the obligations in this Exhibit H and BUYER shall pay to SUPPLIER the costs mutually agreed upon by the parties in advance in writing.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

40


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit I

QUALITY REQUIREMENTS

This Exhibit sets forth SUPPLIER’s obligations with respect to the quality of the Products. SUPPLIER agrees to conform to the minimum requirements established by the BUYER Quality Systems Requirements. In addition, SUPPLIER shall conform to SUPPLIER’s internal ISO 9001 compliant Quality Systems Requirements for the term of this Agreement.

 

1. SUPPLIER Quality Control Plan and Process Capability

SUPPLIER will establish, maintain and manage a quality assurance plan and program for the Products that is consistent with standard industry practices to ensure that the overall reliability, quality and performance objectives stated in the applicable Statement of Work are achieved and the Products comply with the Specifications (the “Quality Control Plan”). The Quality Control Plan is subject to BUYER’s prior written approval. BUYER will have the right during normal business hours to audit SUPPLIER’s compliance with the Quality Control Plan. Such audit will include, without limitation, BUYER’s access, on-line or otherwise, to SUPPLIER’s: (i) Product test data and any statistical analysis of such data, (ii) Product improvement issues and data, (iii) Product time studies, test yields, repair and scrap reports, efficiency reports and incoming and outgoing inspection details, (iv) in-process repair and service repair and statistical data, and (v) corrective and preventive action systems. Such documentation will be logged into a permanent file and will be available for BUYER’s inspection at all times during the term of this Agreement.

As part of the Quality Control Plan, SUPPLIER is required to document and retain objective evidence of the following: a detailed production process flow showing how SUPPLIER will control the production system; receiving inspection and material certification processes; outgoing inspection, in-process inspection, calibration of all Inspection Measurement and Test Equipment (IMTE); Measurement Systems Analyses for all IMTE used in the production of BUYER Products; maintenance of all equipment defined in production process flow; an organizational chart which identifies the members of SUPPLIER team who formulate and execute SUPPLIER approach to quality; and title and number of all applicable documents.

 

2. Inspection and Testing

Products purchased pursuant to this Agreement shall be subject to initial inspection, testing, and acceptance or non-acceptance by BUYER, which shall occur within thirty (30) days of final test. SUPPLIER shall perform First Article Inspection (FAI). BUYER’s quality assurance personnel (“BUYER Quality Assurance”) may approve the Product for production, disapprove the Product for production or require immediate corrective action for all the non-conformances found during the FAI. BUYER may have the SUPPLIER approve or disapprove the Product for production with BUYER’s authorization. Any non-conformances shall be corrected within the time periods determined by BUYER.

SUPPLIER will manufacture the Products in accordance with the quality requirements, standards and expectations as set forth in the Specifications, and as otherwise mutually agreed upon by the parties in writing. SUPPLIER will not ship any Product to BUYER which is not in conformance with the Specifications, and shall provide certification with such Product shipment of such shipment’s conformity to the foregoing.

SUPPLIER agrees that it will perform testing and inspection of the Product as mutually agreed upon by the parties in writing prior to the delivery, pack out or distribution of the Products. The testing and inspection procedures shall be documented in the Quality Control Plan. Containment of defective Product either in work in progress (“WIP”) or packed and waiting for shipment shall begin immediately after the discovery of a defective Product. Should Products or SUPPLIER’s processes be found to be non-conforming, SUPPLIER shall notify BUYER Quality Assurance and withhold shipping Product until such non-conformance is resolved. SUPPLIER shall be wholly responsible for Products that fail to meet the acceptance criteria and/or Specifications.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

41


MANUFACTURING AND PURCHASE AGREEMENT

 

In addition to the foregoing, all deliveries of Products are subject to, at BUYER’s option, BUYER’s inspection and testing, before final acceptance by BUYER. BUYER may inspect any Product within thirty (30) days after receipt of such Products and may reject any Product that fails to meet the Specifications. BUYER has the right to reject the order in whole or in part during such thirty (30) day period. To reject a Product, BUYER will, within such thirty (30) day period, notify SUPPLIER in writing of its rejection and request a Return Material Authorization (“RMA”) number.

 

3. Specifications

SUPPLIER agrees that all Products will conform to the Specifications established by BUYER for the part number stated on the Bill of Materials or the Purchase Order. Additionally, all Products produced by SUPPLIER shall conform to the workmanship specifications of IPC-610 Class II, latest revision, and to all currently accepted commercial manufacturing practices.

 

4. Nonconforming Material

Any material identified as nonconforming material shall be isolated and segregated in a secure location. Nonconforming material shall be clearly identified with the SUPPLIER part number, the BUYER part number, reason for rejection and date of rejection. SUPPLIER must dispose of all nonconforming material within 96 hours of discovery of nonconformance. In the event that SUPPLIER, BUYER or a Component supplier identifies discrepant material in WIP Products, SUPPLIER shall immediately purge all discrepant material from WIP Products, remove such material from inventory and store it in the secure location. Upon completion of such purge procedure, SUPPLIER shall provide to BUYER written verification that WIP Products and inventory have been purged of the discrepant material.

 

5. Traceability

SUPPLIER shall provide electronic Product or Component serial number traceability for all units produced at SUPPLIER’s facility. The traceability process must have the capability to trace all in-coming material, WIP and all Products shipped from the SUPPLIER’s facility. The traceability process shall have the capability of detecting and rejecting any unit with a duplicate serial number either in WIP or already in the installed base. The traceability process shall meet BUYER’s requirements and be approved by BUYER.

 

6. Quality Performance

SUPPLIER shall comply with the quality performance metrics, including but not limited to, the following: Cumulative Yield, Defects per Million Opportunities (DPMO), defect and process paretos and corrective action for agreed upon process control points in the manufacturing process, incoming inspection or outgoing inspection.

 

7. Corrective Action

If upon inspection the Products do not comply with the Specifications, BUYER may issue a Corrective Action Request (CAR). SUPPLIER will comply with BUYER’s closed-loop quality and corrective action process associated with any CAR given by BUYER. The parties shall engage in continuous improvement activities to reach higher levels of Product quality and cost improvements, and SUPPLIER shall participate in quality performance reviews through meetings set forth in Section 14.2 below.

 

8. ISO Certification

SUPPLIER shall conform to the requirements of ISO 9001 and ISO 14001 at all times in manufacturing the Products hereunder. SUPPLIER warrants and represents that it currently is certified under ISO 9001 and ISO 14001, and during the term of this Agreement will remain ISO 9001 and ISO 14001 certified. If at any time hereafter certification under ISO 9001 or ISO 14001 is no longer generally appropriate, SUPPLIER will ensure that it is certified under another comparable or higher standard, which is acceptable to BUYER. Should SUPPLIER lose the ISO 9001 or ISO 14001 certification, SUPPLIER will immediately notify BUYER Quality Assurance in writing. SUPPLIER shall inform BUYER of the specific reason(s) for the loss of the certification. SUPPLIER shall inform BUYER of an Action Plan that defines the specifics of regaining compliance to ISO 9001 and/or ISO 14001 and defines the short-term corrective actions that will insulate BUYER from SUPPLIER noncompliance.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

42


MANUFACTURING AND PURCHASE AGREEMENT

 

9. Defective Product

If SUPPLIER identifies defective Product(s) during the manufacturing process, pack out or distribution process, SUPPLIER shall notify BUYER Quality Assurance immediately. SUPPLIER shall implement appropriate actions that minimize the possibility that additional defective Products will be processed or delivered. SUPPLIER shall implement appropriate corrective actions to prevent reoccurrence of the defect. All corrective actions that affect Products are subject to approval by BUYER Quality Assurance. SUPPLIER shall respond to any defective Product as set forth in Section 14.3 below. Within 4 hours of discovery, SUPPLIER shall use best efforts to implement appropriate containment activity for: (1) all such Product, including WIP, finished goods and component level. SUPPLIER’s containment action shall also include identification by serial number, the manufacturing site for all defective Product and any other appropriate action to minimize the possibility that additional defective Products will be delivered to pack out, distribution or the customer; (2) shall notify BUYER of all such Product already shipped, including serial number, manufacture date and ship date; and (3) SUPPLIER shall submit the initial written response for short-term corrective action plan. In no event shall the implementation of the foregoing containment activities exceed twenty-four (24) hours of discovery. SUPPLIER further agrees to conduct a detailed root-cause failure analysis and to report the failure analysis data and root-cause correction plan to BUYER within a minimum of five (5) working days of notification of the defective Product. SUPPLIER agrees to preserve and maintain all data associated with Product and process failure analysis, corrective actions and to make that data available to BUYER upon request.

If the defective Product is not DOA and is situated outside of SUPPLIER’s facilities, then SUPPLIER shall promptly commit the necessary resources to repair the defective Product on-site at SUPPLIER’s facility and at SUPPLIER’s sole expense, including, without limitation, the costs of shipping the Product to and from SUPPLIER’s facility. In addition, SUPPLIER shall comply with BUYER’s closed-loop corrective action process. If the Product is DOA, SUPPLIER shall repair or replace the DOA Product in accordance with Section 15.1 of the Agreement.

 

10. Epidemic Failure

The terms and conditions defining Epidemic Failure shall be as specified in Section 10.5 of the Agreement.

 

11. RMA – Return Material Authorization

SUPPLIER shall provide a Return Materials Authorization (RMA) within 24 hours after receipt of request for an RMA from BUYER for a nonconforming or defective Product. After receipt of the written RMA number, BUYER or BUYER’s customer will return to SUPPLIER the rejected or defective Product, freight collect and properly insured, with the RMA number displayed on the outside of the carton.

 

12. Supplier Change Notification

Written approval from BUYER is required prior to the implementation of changes and deviations by SUPPLIER. Approval may be withheld at BUYER’s sole discretion. In the event an approved SUPPLIER-proposed change fails BUYER’s Product qualification, SUPPLIER is obligated to provide the existing qualified Product until the Product with the proposed change can be qualified. BUYER shall respond to the change or deviation request within fifteen (15) Business Days of receipt or the change or deviation will be deemed rejected. In the event SUPPLIER fails to follow the requirements defined herein, SUPPLIER assumes all costs and responsibilities for the Product affected by the change, including to, but not limited to, Product in transit, Product in finished goods inventory, and any Product located with a BUYER customer.

In the case of changes to materials or sources of supply, such notice shall be provided to BUYER no less than the Components Lead-time plus thirty (30) days prior to the proposed implementation of the change. Written approval from BUYER is required prior to the implementation of the requested change. If BUYER does not respond to the change request within fifteen (15) Business Days of receipt, the changes will be deemed rejected.

 

13. Site Assessments and Inspections at SUPPLIER Site

Upon two (2) Business Days’ notice, BUYER shall have the right to perform vendor qualifications and/or on-site inspections at SUPPLIER’s manufacturing facilities during SUPPLIER’s normal business hours. If an inspection or test is made on SUPPLIER’s premises, SUPPLIER shall provide BUYER’s inspectors with access to facilities and reasonable assistance at no additional charge. SUPPLIER shall also provide BUYER with final acceptance documentation/criteria. In the event that any on-site inspection of the Products indicates that the Products do not

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

43


MANUFACTURING AND PURCHASE AGREEMENT

 

conform to the requirements of this Agreement, SUPPLIER shall not ship such Products to BUYER until such nonconformity has been corrected and BUYER has approved shipment of such Products in writing. This audit right does not limit BUYER’s right to perform additional acceptance testing at BUYER’s facilities.

 

14. Quality Goals and Support

 

  14.1 Quality Performance and Goals

Depending on the exact processing and testing sequence used, quality performance metrics may include but are not limited to, the following:

 

   

SMT Yield (% and raw data)

 

   

ICT Yield (% and raw data)

 

   

Functional Test Yield (% and raw data)

 

   

Cumulative Yield (% and raw data)

 

   

Trend charts documenting each metric

 

   

Pareto of actual defects found for each yield metric

 

   

Pareto of cost of actual defects for each yield metric

 

   

DPMO calculations

Performance goals for the metrics utilized shall be mutually agreed to by the parties in writing prior to the first customer shipment of each Product. Reporting shall be accomplished via BUYER-approved electronic medium according to a schedule approved by BUYER Quality Assurance. SUPPLIER agrees to continually improve their performance against the goals and targets for the above categories and any other categories included by BUYER.

 

  14.2 Quality Reviews and Continuous Improvement Meetings

 

   

SUPPLIER shall submit periodic reports via BUYER-approved electronic medium and on the BUYER-approved schedule. Each report concerning the Products which will, at a minimum, provide information regarding the production yield and major defect data for each Product in production during the applicable time period.

 

   

The parties shall participate in mutually agreed to cross-site, cross-supplier improvement projects.

 

   

The parties shall conduct quarterly business reviews. Such reviews shall be at a mutually agreed upon time and place.

 

  14.3 Corrective Action Timetable for Defective Product Detected Prior to Shipment

 

Event

  

Maximum Response Time

Problem notification by SUPPLIER to BUYER    Within 4 hours—verbal; within 1 Business Day—written
Containment plan communicated to BUYER    4 hours
Initial SUPPLIER problem verification and short-term
corrective action plan
   Written—8 hours
SUPPLIER failure or problem analysis completed,
results communicated, and root-cause corrective
action plan communicated
   7 Business Days
SUPPLIER corrective action plan approval/rejection by
BUYER
   2 days after communication of plan
SUPPLIER corrective and preventative actions
implemented and verified
   6 Business Days

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

44


MANUFACTURING AND PURCHASE AGREEMENT

 

15. Reliability Corrective Action Plan

If a Product does not meet the required SUPPLIER’s reliability specification, SUPPLIER shall provide to the BUYER, within ten (10) days or as mutually agreed a plan identifying steps the SUPPLIER will take, including milestones and dates, to ensure that the Product meets the required reliability specification.

 

  15.1 Out-of-Box Failure Corrective Action Plan

SUPPLIER shall submit a non-recurring failure corrective action plan to prevent such failures, to the BUYER’s quality supplier engineers within twenty four (24) days of receipt of failed unit from BUYER.

 

  15.2 Corrective Action Request (CAR):

 

  15.2.1 Upon discovery of a problem, BUYER will submit a written request to SUPPLIER for corrective action.

 

  15.2.2 Supplier shall submit a corrective action report to BUYER that includes the details from the final root cause/failure analysis report, analysis of the problem described by the BUYER (commensurate with the level of detail provided by BUYER), details of containment activity (as required), a casual analysis, and a corrective action plan that includes the steps already taken to prevent recurrence of the same.

 

  15.3 Delivery of Reports:

 

  15.3.1 Upon request, a preliminary root cause/failure analysis report will be provided by SUPPLIER to BUYER within five (5) working days after receipt of the defective Product or mutually agreed upon time objective.

 

  15.3.2 The detailed root cause/ failure analysis corrective action report will be due from SUPPLIER within twenty four (24) calendar days after receipt of the defective Product by SUPPLIER, or as mutually agreed.

 

  15.3.3 SUPPLIER will achieve a fourteen (14) day failure analysis and corrective action cycle time eighty (80) percent of the time. BUYER shall provide at a minimum, complete problem description, product P/N, s/n, date of failure, action taken to fix problem in order to receive a complete failure analysis and corrective action plan.

 

  15.3.4 The BUYER may approve or disapprove the corrective action plan submitted by SUPPLIER prior to implementation.

 

  15.3.4.1 In the event of disapproval, the Buyer will provide details regarding the reason for disapproval and any additional requirements or issues that must be addressed.

 

  15.3.4.2 The SUPPLIER will take action to conform to the requested action, correct the actions as needed, and re-submit for approval so that BUYER and SUPPLIER can mutually agree on a final plan. Upon receipt of approval the action is to be implemented by SUPPLIER.

 

16 Field Failure Reports

 

  16.1 In the event the BUYER has a Product failure inside the warranty period and requests a failure analysis be performed, the SUPPLIER will provide a comprehensive failure analysis to the Buyer, at no charge, within twenty four (24) calendar days or as mutually agreed. SUPPLIER will use all reasonable efforts to provide expedited failure analysis reports on returned Products designated by BUYER to be of high priority. All reports will contain the following elements:

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

45


MANUFACTURING AND PURCHASE AGREEMENT

 

  16.1.1 Failure analysis for units outside the warranty period will carry a charge to the BUYER.

 

  16.1.2 Date the returned Product was originally shipped to BUYER.

 

  16.1.3 Date the Product was received by the SUPPLIER for repair and revision level of the specific Product returned to the SUPPLIER.

 

  16.1.4 Description of the testing prior to any repair activity with a detailed description of the symptoms.

 

  16.1.5 Identification of the failure mode and action taken to repair the specific Product returned for analysis including any component or assembly replaced that corrected the cause of failure.

 

  16.1.6 Analysis of the cause of the failure to the component level including photographs as required.

 

  16.1.7 Latest revision level of the components/assemblies used to repair the failed Product and new revision level of the repaired Product if the repair caused an advance in the revision level.

 

  16.2 BUYER shall provide the following information (at minimum) as contingency to receive an failure analysis/corrective action from SUPPLIER:

 

  16.2.1 Product P/N

 

  16.2.2 Product S/N

 

  16.2.3 Problem Description

 

  16.2.4 Action taken to fix failure

 

  16.2.5 Date of Failure

 

  16.2.6 Troubleshooting used

 

  16.3 Component/Failure mode pareto information shall be provided monthly to cover the preceding six months of Products purchased.

 

17 Compliance General . SUPPLIER warrants that the processes used in the manufacturing of Products sold to BUYER are (i) Safe for normal use and non-toxic, (ii) RoHS compliant and (iii) meets WEEE requirements at date of shipment, as applicable. Any additional safety requirements or Product marking will be defined in Statement of Work.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

46


MANUFACTURING AND PURCHASE AGREEMENT

 

Exhibit J

SECURITY PROVISIONS

This exhibit outlines SUPPLIER’s minimum security requirements and obligations for manufacturing and printing Products. This is a non-exclusive list. Additional or different measures than those outlined below may be required for SUPPLIER to comply with the terms and spirit of the Agreement.

To protect BUYER Intellectual Property Rights and based upon the type of Product being manufactured by SUPPLIER, SUPPLIER shall provide three levels of segregation (No Segregation, Partial Segregation and Full Segregation) as set forth in Table J-1 below and as shall be further defined by BUYER.

Table J-1

 

Category of Protection

  

No Segregation

  

Partial Segregation

  

Full Segregation

Facility    Shared    Shared    Dedicated, restricted access to Oclaro support only, frosted windows
Equipment    Shared    Mixed—some dedicated    Dedicated
Direct Labor    Shared    Shared    Shared, but will work with CM to avoid sharing DL with competitors
Product Engineers    Shared    Shared with non-competitors    Dedicated
Process Engineers    Shared    Shared    Dedicated
Test Engineers    Shared    Shared with non-competitors    Dedicated
Quality    Shared    Shared    Dedicated
Other IDL    Shared    Shared    Shared
Tours Allowed    Allowed    Only for customers in non-competitive industries (automotive, healthcare, etc.) or for customers sharing manufacturing lines with Oclaro    Not Allowed

General:

BUYER may, at its sole expense, perform a security assessment of SUPPLIER’s operations and assist the SUPPLIER in the development and implementation of cost effective security procedures for the protection of the BUYER’s Product.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

47


MANUFACTURING AND PURCHASE AGREEMENT

 

SUPPLIER agrees, at its sole expense, to develop and maintain its own security procedures as they relate to the manufacture, handling, storage and transport of BUYER Product.

Should, as a part of its business model, SUPPLIER subcontract any portion of BUYER’s freight or warehousing business to a third party, SUPPLIER warrants that appropriate security procedures consistent with those employed by SUPPLIER and customarily used in the industry will be developed and maintained.

SUPPLIER agrees to designate a management-level employee to oversee the security function of their facilities. This individual will act as the security interface for all BUYER business, and will be available for reasonable periods of time to coordinate the SUPPLIER’s security efforts with BUYER security management.

Handling Guidelines:

SUPPLIER shall provide a storage area for all units of the Product. This area will be designed to prevent unauthorized access as well as protect the Product from damage, loss and theft.

Product sealed in shipping boxes shall not be re-opened unless an inspection is necessary to determine the adequacy of packing; or the existence and/or extent of damage; or the accuracy of the description of contents; or the acceptability of the shipment for transportation in accordance with SUPPLIER tariffs.

SUPPLIER shall avoid exposing BUYER product or materials to conditions that may cause damage. SUPPLIER must implement procedures for communicating incidents of damaged or loss of Product and/or materials to BUYER within 24 hours of each occurrence and a plan of action for preventing re-occurrence in the future.

SUPPLIER shall not pre-load Product into trailers or vehicles intended for later collection or shipment without the prior written authorization of BUYER.

If BUYER authorizes Product or materials to be stored in trailers parked within a facility’s truck yard, trailers must be sufficiently and adequately secured. Examples of security precautions to be taken for such freight include, without limitation: Pin locks, Padlocks on container or trailer doors, Numbered, logged, and inspected seals, containers or trailers backed up against each other or against a structure so that the unit’s cargo doors cannot be opened.

SUPPLIER’s Premises Protection:

At locations where Product will be stored in excess of six (6) hours, SUPPLIER will provide and maintain, at all times, adequate security and handling practices to allow continuous security monitoring and protection of BUYER product against fire, damage, and theft. The use of electronic security systems including intrusion detection and security camera systems is encouraged.

Control of BUYER freight information:

SUPPLIER agrees to implement and maintain adequate procedures and precautions for the protection of records involving BUYER and BUYER freight; such as load contents, customers’ identity, the times and dates of shipments, destinations, and shipping routes.

Hiring / Supervising / Training of Employees

SUPPLIER will ensure that all SUPPLIER’s employees and subcontracted personnel involved with handling or transportation of BUYER Products are subjected to vetting and background checks as permitted by local laws, regulations and availability, to confirm that such employees are free from records of criminal convictions involving drugs, theft, or dishonesty.

SUPPLIER agrees to provide security awareness orientation and training to each employee handling or transporting BUYER Product within thirty (30) days of hire.

SUPPLIER shall not allow unauthorized employees, temporary employees, contractors or visitors access to the BUYER inventory or controlled access areas.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

48


MANUFACTURING AND PURCHASE AGREEMENT

 

Audits :

BUYER Security personnel and representatives of BUYER’s insurance carriers reserve the right to conduct security audits of the SUPPLIER’s premises and/or transit locations containing Product, and will report audit results and proposed corrections within thirty (30) days of the completed audit. Likewise, SUPPLIER will make every effort to ensure that its third-party forwarders and/or warehouses subcontracted to handle or store BUYER Product consent to these audit terms.

General Security Responsibilities:

SUPPLIER will report to BUYER and the proper legal authorities loss, theft or damage to the Products and/or Components used to make the Products and cooperate at all times with the subsequent investigation and documentation of each such incident. SUPPLIER will promptly complete loss / theft / damage investigations as such incidents are reported or made known. Results and/or conclusions are to be forwarded to the local BUYER security contact as this information is made available. BUYER security management shall be invited to participate in any investigation involving the loss of BUYER Product.

SUPPLIER will maintain written security operating procedures for BUYER Products and will ensure that those procedures are (1) consistent with these guidelines, (2) communicated clearly, prominently and frequently to SUPPLIER’s employees and permitted third-party contractors, and (3) updated as needed.

As requested, SUPPLIER will provide BUYER with a full report on all known losses and thefts at specific facilities for a stated period of time not to exceed two (2) years, in accordance with Carrier Tariffs for loss and damage claims.

Labeling Requirements for Confidential Information .

SUPPLIER’s originators of Confidential Information documents are responsible for prominently labeling every page as “Confidential” (or with a similar designation); information in electronic form should be identified as “Confidential” (or with a similar designation) at the beginning or header of every data set or file. All magnetic media must have “confidential” marked (or a similar designation) on the contents and the exterior of its container. Prototypes shall be treated as confidential, and labeled (if possible).

Safekeeping .

Confidential information shall not be left exposed and shall be secured at the end of the workday in a locked cabinet, desk or other locked container or in a secured room with access limited to those with a need to access the information.

Confidential information stored on computing systems must be protected by the use of strong passwords (e.g., passwords of an adequate length and alphanumeric mix consistent with best industry practices). Confidential information stored on PCs laptops or workstations should be encrypted.

SUPPLIER shall require all employees, temporary employees (directly or through their temporary agencies), independent contractors and subcontractors either to be bound by an employee handbook containing a confidential or non-disclosure requirement and/or sign a separate non-disclosure agreement prior to access to Confidential Information of BUYER.

SUPPLIER shall limit access to BUYER Confidential Information (logs of accessibility shall be kept current and made available to BUYER on reasonable request).

SUPPLIER shall maintain visitor logs for all controlled access areas containing BUYER Confidential Information and/or other high risk assets materials such as, but not limited to, Serial numbers and the like. Logs of accessibility shall be kept current and made available to BUYER on reasonable request.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

49


MANUFACTURING AND PURCHASE AGREEMENT

 

Mail Requirements .

When it is necessary for SUPPLIER to send media containing confidential information between the parties or elsewhere, it shall be sent by courier, registered mail or an internationally recognized overnight delivery service (i.e. Federal Express, Emery, etc.) Items sent by SUPPLIER shall require recipients to sign for deliveries and the information to be entered into a log by the courier, postal or delivery service.

Electronic .

Confidential information must be encrypted when sent over the Internet.

Faxes containing confidential information must include an ownership statement and the recipient should be notified prior to transmission in order to receive the fax.

Media containing confidential information must be disposed of in a manner that destroys it beyond recognition and reconstruction.

Inventory .

Inventory shall be kept in controlled dedicated work areas with no commingling of BUYER’s Inventory with that of other entities.

Regular cycle counts, consistent with the sensitivity of the inventory, shall be made with all results forwarded to BUYER.

Any incidents of burglary, theft, unaccounted Inventory, shrinkage of Products, or Components theft shall be reported immediately to BUYER. In the event of any of the foregoing, SUPPLIER shall investigate the reasons therefore, and promptly take the necessary steps to prevent such situation from arising again.

SUPPLIER shall maintain 100% accountability of Components and scrap.

SUPPLIER shall keep sensitive materials such as, but not limited to, Serial number labels and the like, stored in a secure area with limited employee access.

Scrap and Sensitive Material

All inventory, Confidential Information, and Products (includes any Components thereof) shall be disposed of by SUPPLIER, as authorized by BUYER. SUPPLIER shall keep accurate records of the disposition of the said material. The logs of accessibility shall be kept current and made available to BUYER on reasonable request.

Under no circumstances shall SUPPLIER allow BUYER Product, Components, serial numbers, Confidential Information or other BUYER property to be disposed of in SUPPLIER’s dumpster. SUPPLIER shall not transfer scrap produced as a result of this Agreement in a black or gray market transaction of any sort.

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

 

50

Exhibit 10.6

EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

THIS EQUIPMENT AND INVENTORY PURCHASE AGREEMENT (“Agreement”) made and effective this 19th day of March, 2012 (“Effective Date”) by and amongst :

 

(1) Oclaro Technology Ltd., a company organized under the laws of the United Kingdom, having offices at Caswell Office, Towcester, Northamptonshire, NN12 8EQ on behalf of itself and all of its Affiliates (collectively referred to as “Oclaro”);

 

(2) Oclaro Technology (Shenzhen) Co., Ltd, (“Oclaro Shenzhen”),2 Phoenix Road, Futian Free Trade Zone, Shenzhen, P.R.C. 518038

 

(3)

Venture Electronics (Shenzhen) Co., Ltd, (“Venture Shenzhen”) a company incorporated in the People’s Republic of China, having its registered office at 2 Bin Lang Road, 5 th Floor B/C Zone, Wei Guang Lian Logistics Building, Futian District Free Trade Zone, Shenzhen 518038; and

 

(4) Venture Electronics Services (M) Sdn Bhd (“Venture Penang”), a company incorporated in Malaysia, having its registered office at Plot 44, Bayan Lepas, Industrial Park IV, 11900, Penang, Malaysia

(collectively referred to as the “Parties”).

Definitions .

Active Inventory ” is raw materials or completed sub-assemblies that are forecasted to be required for production within the next 180 days from the Effective Date. Oclaro will continue to own or consign Inventory with no forecasted demand within the next 180 days as set forth in Section 6 of the Manufacturing and Purchase Agreement.

Affiliate ” means any parent, subsidiary or other entity controlled by, controlling or under common control with, a party to this Agreement. For purposes of this definition, the term “control” shall mean the ownership of voting stock or other equity interest entitling the owner to exercise at least fifty percent (50%) of the voting rights of the entity.

Appraised Value ” shall have the meaning set out in Section 2.1.2.b.

Common Equipment ” means equipment that is generally available in the industry and does not contain any Oclaro intellectual property in its base state and includes equipment currently owned by Oclaro and located in Shenzhen, Zurich and Sanmina Texas.

Custom Equipment ” means equipment that the Parties mutually agree is not generally useable by other customers in the optical or electronics industries.

Equipment Value ” has the meaning set out in Section 2.1.

Flight 1 Inventory ” means raw material and completed sub-assemblies required to manufacture and assemble products that are part of Flight 1 as set forth in a Statement of Work under the Manufacturing and Purchase Agreement.

Manufacturing and Purchase Agreement ” means the manufacturing agreement of even date by and between Oclaro Technology Ltd. for itself and its Affiliates, and Venture Corporation Ltd for itself and its Affiliates.

Net Book Value ” means the net value as set forth on Oclaro’s books in accordance with US GAAP, as of the most recent fiscal quarter prior to the physical transfer of the Common Equipment.

Restricted Equipment ” means equipment that contains Oclaro intellectual property in its base state or as a result of unique combinations of equipment and processes or is identified as Restricted Equipment by Oclaro in its sole discretion. Oclaro will continue to own Restricted Equipment and consign Restricted Equipment to Venture Penang for the sole purpose of manufacturing Oclaro products.

 

1


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

Supplemental Inventory ” means the additional $2.5 million in inventory to be transferred from Oclaro to Venture Penang in accordance with Section 2.5 below.

Transition Period ” means the period beginning on the Effective Date and ending when the final piece of Common Equipment, Custom Equipment and Restricted Equipment associated with the Flight Plans is transferred to Venture Penang.

“$” means US Dollars.

Capitalized terms not defined in this Agreement shall have the same meaning as the terms defined in the Manufacturing and Purchase Agreement of even date. References to Exhibits shall be references to Exhibits in the Manufacturing and Purchase Agreement.

 

1. Term

The initial term of this Agreement commences on the Effective Date and shall terminate upon the termination of the Manufacturing and Purchase Agreement. The Parties may extend the term upon mutual agreement.

 

2.0 Venture Purchase of Equipment and Inventory .

 

2.1 Equipment Value

 

2.1.1 For Common Equipment in serviceable condition which are less than four (4) years old at the time of shipment, the Equipment Value shall be the Net Book Value.

 

2.1.2 (a) Common Equipment which are more than four (4) years old at the time of shipment will be categorized into two categories, Category A shall comprise Common Equipment which are between four (4) to six (6) years old and Category B shall comprise Common Equipment which are more than six (6) years old. Within each Category the Common Equipment shall be sub-categorized according to functionality of the Common Equipment.

(b) The Equipment Value for the Category A and B Common Equipment shall be the fair market value as determined by a mutually appointed equipment appraiser, the costs of which shall be borne equally by the Parties. To determine the fair market value for each sub-category, the appointed appraiser shall appraise one or more Common Equipment within each sub-category, which is/are representative of that sub-category. The fair market value shall be expressed as a percentage of the original purchase price for that equipment (“Appraised Value”). The fair market value of all Common Equipment within that same sub-category shall be determined applying the Appraised Value.

 

2.1.3 The first appraisal will be conducted within 30 days of the Effective Date for the Common Equipment mutually identified to be transferred to Venture Penang, within the next 12 to 15 months of the Effective Date. A second appraisal will be conducted 12 months from the date of the first appraisal for the remaining Common Equipment mutually identified to be transferred to Approved Manufacturing and Product Development Location.

 

2.1.4 If Oclaro disagrees with the fair market value of any Common Equipment determined by the appointed appraiser, Oclaro has the option of consigning that Common Equipment to Approved Manufacturing and Product Development Location instead.

 

2.1.5 The value of any Common Equipment that does not appear on the current asset lists but is necessary to manufacture the Products will be determined by the procedure outlined in Section 2.1. In the event that the exact purchase date cannot be determined, the equipment will be categorized as Category B equipment.

 

2.2 Common Equipment

 

2.2.1

Within 30 days from the Effective Date, the Parties will mutually identify $2.5 million of Common Equipment which Oclaro will transfer from its sites in Zurich and Shenzhen to Venture Penang based upon the Equipment Value. Oclaro shall ship the Common

 

2


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

  Equipment to Venture Penang. Venture Penang shall pay Oclaro for the Common Equipment within 35 days from the Effective Date for the Common Equipment from Zurich and upon receipt in good condition of the Common Equipment from Shenzhen. Title to the Common Equipment shall be transferred to Venture Penang upon shipment or payment, whichever is the earlier.

 

2.2.2 At such other time, Parties may mutually identify Common Equipment which Oclaro will transfer to Venture Penang and which Venture Penang shall purchase based upon the Equipment Value.

 

2.2.3 A representative from each Party will be present at the packing of the Common Equipment at Oclaro’s site and at the unpacking in the Approved Manufacturing and Product Development Location.

 

2.3 Flight 1 Inventory

Within 30 days from the Effective Date, Parties will mutually identify a total of $2.5 million of Flight 1 Inventory to be shipped to Venture Penang from Oclaro’s sites in Zurich and Shenzhen. Venture Penang shall pay Oclaro for the Flight 1 Inventory upon receipt of the Flight 1 Inventory. Title to the Flight 1 Inventory shall transfer upon shipment.

 

2.4 $7.5 million of Active Inventory

 

2.4.1 Within 30 days from the Effective Date, Parties will mutually identify a total of $7.5 million of Active Inventory which Oclaro will physically transfer to Venture Shenzhen. Venture Shenzhen will pay Oclaro $7.5 million for the Active Inventory 30 days after the Effective Date or upon receipt of the Bill of Lading naming Venture Shenzhen as consignee, whichever is the later.

 

2.4.2 In the event that Venture Shenzhen does not pay Oclaro, Venture Penang shall pay the said sum to Oclaro on behalf of Venture Shenzhen. Upon receipt of the said sum from Venture Penang, Oclaro shall authorize Venture Shenzhen to pay the $7.5 million to Venture Penang and Oclaro shall have no further claims against Venture Shenzhen for the said sum.

 

2.4.3 The Parties agree that title transfer will occur in Hong Kong between Oclaro Technology, LTD and Venture Shenzhen.

 

2.4.4 Within 30 days of the Effective Date, Parties shall jointly develop a process by which Active Inventory can be imported by Venture Shenzhen into the Futian Free Trade Zone (“FFTZ”) and held by Venture Shenzhen’s location or another location that is mutually agreed to by the Parties.

 

2.4.5 Oclaro Shenzhen will issue purchase orders for $1.5 million Active Inventory plus an additional three (3) percent mark up as carrying cost, to fulfill production requirements of Oclaro’s Shenzhen facility at intervals of 30 days, the first beginning 60 days after the Effective Date. Venture Shenzhen will physically transfer Active Inventory to Oclaro’s Shenzhen facility and invoice Oclaro Shenzhen for the Active Inventory. Subject to Section 2.7, the credit and payment terms shall be 120 days for purchase orders issued within 3 months of the Effective Date and 105 days for the subsequent three (3) purchase orders, calculated from the end of month of each buy-back. Oclaro shall pay Venture Penang an administrative fee of $37,500 as set forth in Schedule C of the Management Services Agreement.

 

2.4.6 Oclaro Shenzhen undertakes to settle all payments for the Active Inventory within the credit and payment terms mentioned above or otherwise in accordance with Section 2.7 below. A late payment interest of three (3) percent per annum shall be imposed on the outstanding balance unpaid beginning from the date payment is due and will continue to be charged on a daily basis until the full settlement of the outstanding balance.

 

3


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

 

2.5 $2.5 million Supplemental Inventory

On or before June 30th, 2012 or 3 months after Effective Date, whichever is later and contingent on Flight schedule, Oclaro will transfer at least an additional $2.5 million of Supplemental Inventory required to support Flight 1 production by Venture in Venture Penang. The Parties will mutually agree on the best location to store and manage this inventory during the Transition Period. Payment will be made by Venture Penang to Oclaro upon receipt of Supplemental Inventory.

 

2.6 Unforeseen Delays

In the event of a delay beyond thirty (30) days through no fault of one of the Parties, the Parties shall use reasonable commercial efforts to mitigate and end such delay as soon as reasonably practicable.

 

2.7 Adjustment of Credit and Payment Terms for $7.5 million Active Inventory

The Parties recognize that during the Transition Period, Venture Penang may purchase Additional Equipment pursuant to Section 3.1 and/or additional inventory as necessary to support the production in Venture Penang.

If within 270 days from the Effective Date, Venture Penang has to acquire additional equipment and/or inventory, then the payment terms referred to in Section 2.4.5 will be adjusted such that Venture Shenzhen and Venture Penang’s payments net of receipts do not exceed $15 million for Active Inventory, Common Equipment, Supplemental Inventory, Flight 1 Inventory and the additional equipment and inventory during that period.

If within 270 days from the Effective Date, Venture Penang and Venture Shenzhen’s payments net of receipts are below or exceed $15 million for Active Inventory, Common Equipment, Supplemental Inventory and Flight 1 Inventory during that period, the payment terms referred to in Section 2.4.5 shall be adjusted accordingly to ensure that the payments for the Active Inventory, Common Equipment, Supplemental Inventory, Flight 1 Inventory and the additional equipment and inventory purchased remains at $15 million.

 

3.0 Additional Equipment Purchases .

 

3.1 The Parties recognize that during the Transition Period, Oclaro may purchase additional equipment that ultimately will be transferred to an Approved Manufacturing location. The Parties agree that this additional equipment will be categorized by mutual agreement into Common Equipment, Custom Equipment or Restricted Equipment and, will be treated in accordance with the terms of this Agreement and/or the Manufacturing and Purchase Agreement. Venture agrees to purchase all Common Equipment required to manufacture the Products set forth in the Manufacturing and Purchase Agreement.

 

3.2 During the Transition Period, and in accordance with the flight schedules, the Parties will identify Custom Equipment and Restricted Equipment that will be transferred to Venture Penang but will remain the property of Oclaro. Oclaro will manage Custom Equipment and Restricted Equipment on a consignment basis per the terms of the Manufacturing and Purchase Agreement. Where title to equipment is transferred from Oclaro to Venture, but no physical transfer occurs, Venture will consign such Common Equipment to Oclaro for use until physical transfer occurs and Oclaro will manage these Common Equipment on the consignment terms set forth in Section 7.4 below.

 

4.0 Use of Common Equipment for Venture’s other customers .

 

4.1 Venture may use Common Equipment for Venture’s other customers so long as no Oclaro intellectual property is disclosed or used without Oclaro’s written consent. Oclaro will be responsible for only the proportionate share of this Common Equipment’s depreciation when such Common Equipment is also used or made available for use by Venture’s other customers, per the terms of the Manufacturing and Purchase Agreement.

 

4.2 From time to time, the Parties may mutually agree to convert Restricted Equipment or Custom Equipment into Common Equipment. Venture will pay Oclaro the Equipment Value by wire transfer at the time Oclaro transfers title and the converted equipment will then be treated in accordance with the terms of this agreement and/or the Manufacturing and Purchase Agreement.

 

4


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

 

5.0 Oclaro Warranty.

 

5.1 Oclaro warrants that Oclaro holds, and will transfer, upon receipt of payment, good and marketable title to the Flight 1 Inventory, Supplemental Inventory, Active Inventory and Common Equipment, free and clear of any encumbrances, including any encumbrance by Wells Fargo, liens, liabilities and claims of any third parties.

 

5.2 Oclaro warrants that (i) the Common Equipment capable of being used for the purposes for which they were designed and for the purposes of the Manufacturing and Purchase Agreement, for which they are being acquired by Venture Penang; (ii) the Common Equipment is in good operating condition and repair, subject only to ordinary wear and tear and (iii) the Flight 1 Inventory, Supplemental Inventory and Active Inventory shall be in substantially the same condition in which it was received or has been repackaged consistent with the manner in which it was received.

 

5.3 If any of the Active Inventory transferred to Venture is found to be defective, Oclaro shall pursue all claims related to all defective or nonconforming Active Inventory against the manufacturers. Oclaro shall have no claims or demands for loss or damage against Venture Shenzhen in connection with the defective or nonconforming Active Inventory.

 

5.4 If any of the Common Equipment is found defective after having been transferred to Venture Penang, and any Common Equipment or part thereof are to be repaired or replaced, Oclaro shall bear the costs and expense of such repair or replacement. This shall be the sole remedy and Venture Penang shall have no further claims against Oclaro in respect thereof.

 

5.5 Except as otherwise set forth herein, Oclaro offers no other warranties express or implied.

 

6.0 Limitation Of Liability

 

6.1 NEITHER PARTY OR THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, AND AGENTS BE LIABLE FOR ANY INDIRECT, SPECIAL, PUNITIVE, EXEMPLARY, OR CONSEQUENTIAL DAMAGES OF ANY KIND, INCLUDING BUT NOT LIMITED TO LOST PROFITS, WITH RESPECT TO THIS AGREEMENT, EVEN IF THE PARTIES HAVE BEEN ADVISED OF THE POSSIBILITY OF THE SAME OR EVEN IF SAME WERE REASONABLY FORESEEABLE.

 

6.2 The entire and aggregate liability of Oclaro for all claims by Venture Penang and Venture Shenzhen in respect of the warranties set out in Section 5 above shall not exceed the total amounts paid by Venture Shenzhen or Venture Penang to Oclaro and shall be further limited solely to direct damages.

 

6.3 The provisions of this Section apply whether the claim for damages arises a result of contract, tort (including negligence), or any other statutory, legal or equitable grounds.

 

7.0 Transfer of Common Equipment Warranties, Manuals etc

 

7.1. Together with the Common Equipment, Oclaro shall deliver to Venture all available maintenance and repair records and warranty certificates.

 

7.2. Oclaro shall provide, where available, information regarding installation procedures with the Common Equipment. Installation information shall include plans for managing the installation process, logistical aspects of the installations and storage or delivery requirements. The costs of, replacement of any missing or parts damaged during transportation and transit shall be borne by Oclaro.

 

7.3. Oclaro shall assign to Venture, Oclaro’s rights, title and interest in all agreements between Oclaro and the manufacturers and suppliers of the Common Equipment, any engines and any parts thereof, including any rights which may have accrued prior to delivery but which have not fully been exercised by Oclaro and agrees to give notice of such assignments to such manufacturers and suppliers and to obtain their consents to such assignments.

 

5


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

7.4. In respect of Common Equipment which will remain in the possession of Oclaro:

 

7.4.1 Oclaro shall store such Common Equipment required for the manufacturing of products free of charge in a place of storage that is safe and suitable for the specific nature of the Common Equipment in accordance with industry standard practice for the type of property stored and at a minimum meets any specified storage conditions for the property, and undertakes never to hide, damage or remove the identification plates on the Common Equipment. Oclaro shall ensure that all of the Common Equipment shall be clearly identified as Venture Penang’s property. Oclaro shall ensure that none of Common Equipment is seized by any third party, whether pursuant to an order of court or otherwise, while in Oclaro’s possession. Oclaro shall not allow any lien or encumbrance to be created over or otherwise encumber the Common Equipment.

 

7.4.2 Oclaro shall take out insurance to adequately cover such Common Equipment, and add Venture Penang as a loss payee with respect to the Common Equipment, at Oclaro’s own cost, and give proof of such insurance to Venture Penang on request.

 

8. Bill of Sale .

Upon receipt of payment, Oclaro agrees to provide Venture a bill of sale or other instrument of transfer evidencing such transfer in any jurisdiction where necessary to establish a sale has occurred.

 

9. Delivery, and Risk of Loss .

 

9.1 Equipment . Risk of loss shall pass upon delivery to Venture’s premises. Delivery shall be Ex Works (INCOTERMS 2010), Hong Kong.

 

9.2 Inventory . Risk of loss shall transfer upon delivery. Delivery shall be DDP (INCOTERMS 2010), Shenzhen or Penang (as applicable).

 

10. Transition From Shenzhen to Approved Manufacturing and Development Location

The Parties have entered into this Agreement on the basis that a Manufacturing and Purchase Agreement related to the manufacture of the Transferred Products would be entered into. In the event that any of the Flight Plans in Exhibit A-3 does not take place as envisaged and have been cancelled or delayed beyond a mutually acceptable date, Parties shall take the following action :

(a) meet to review the extent of the Transferred Products which are affected by the cancellation or delay and consequential effects; and

(b) Identify Common Equipment and inventory which Venture Penang and Venture Shenzhen have purchased in accordance with the terms of this Agreement which are associated with the Flight Plans which have been cancelled or delayed and Oclaro shall acquire the Common Equipment and inventory so identified at Venture Penang and Venture Shenzhen’s cost of acquisition.

 

11. General Terms.

 

11.1 Governing Law

This Agreement shall be construed, governed and interpreted in accordance with the laws of the United States of America and the State of California, without regard to choice of law principles. The U.N. Convention on Contracts for the International Sale of Goods does not apply to this Agreement.

 

6


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

11.2 Disputes

All disputes arising out of or relating to this Agreement will be resolved by in accordance with the process established in Section 22 of the Manufacturing and Purchase Agreement.

 

11.3 Miscellanous

The failure or delay of a party to insist on performance of any provision of this Agreement, or to exercise any right or remedy available under this Agreement, shall not be construed as a waiver of that or any other provision (or any right or remedy with respect thereto) with respect to any failure or delay that has or may later occur. If any provision of this Agreement is or becomes void or unenforceable by operation of law, the remaining provisions shall be valid and enforceable. No part of this Agreement may be assigned or subcontracted by Venture without the prior written approval of Oclaro.

 

11.4 Change of Control

This Agreement shall inure to the benefit of, and be binding upon, the Parties hereto and their respective successors and assigns. Venture may request that any acquirer of all or substantially all of the assets of Oclaro provide written confirmation of its obligations under this Agreement within thirty (30) days of the closing of such acquisition.

 

11.5 Amendment

Any and all amendments, alterations, or additions to this Agreement must be in writing and executed by the Parties. No modifications to this Agreement proposed by a Party, or “riders” whether inserted in the page margins or attached on separate pages, shall be binding on the other Party unless signed or initialed by a duly authorized representative of the other Party.

 

11.6 Waiver

The failure of either Party at any time to require performance by the other Party of any provision hereof will not affect in any way the right to require such performance at any time thereafter. The waiver by either Party of a breach of any provision hereof will not be taken or held by the other Party to be a waiver of the provision itself unless such a waiver is expressed in writing.

 

11.7 Severability

Any provision in this Agreement which is held to be illegal or unenforceable in any jurisdiction shall be ineffective to the extent of such illegality or unenforceability without invalidating the remaining provisions and any such illegal or unenforceable provision shall be deemed to be restated to reflect as nearly as possible the original intentions of the Parties in accordance with applicable law.

 

11.8 Survival

The provisions of this Agreement that would naturally survive termination shall so survive.

 

11.9 Counterparts

This Agreement may be signed in counterparts, including but not limited to facsimile or scanned versions of the full document, each of which shall be deemed to be an original but all of which shall constitute an original and the same instrument.

 

11.10 Entire Agreement

This Agreement, together with all valid attachments, exhibits, supplemental sheets and riders, constitutes the entire understanding and agreement of the Parties with respect to the subject matter hereof, and supersedes all prior or contemporaneous communications, understandings, representations and agreement, whether written or oral, with respect to such subject matter.

 

7


EQUIPMENT AND INVENTORY PURCHASE AGREEMENT

 

IN WITNESS WHEREOF the Parties have executed this Agreement on the day and year first above written.

 

Oclaro Technology, Ltd    Venture Electronics Services (M) Sdn Bhd
Date   

 

   Date   

 

Signature   

 

   Signature   

 

Printed

Name

  

 

   Printed Name   

 

Title   

 

   Title   

 

Oclaro Technology (Shenzhen) Co., Ltd    Venture Electronics (Shenzhen) Co., Ltd
Date   

 

   Date   

 

Signature   

 

   Signature   

 

Printed Name   

 

   Printed Name   

 

Title   

 

   Title   

 

 

8

Exhibit 10.9

AMENDMENT NUMBER ONE TO THE AMENDED AND RESTATED CREDIT AGREEMENT,

DATED AS OF MARCH 29, 2012, AMONG OCLARO, INC., OCLARO TECHNOLOGY LTD,

WELLS FARGO CAPITAL FINANCE, INC. AND OTHER LENDERS PARTY THERETO.

AMENDMENT NUMBER ONE TO AMENDED AND RESTATED CREDIT AGREEMENT

This Amendment Number One to Amended and Restated Credit Agreement (“ Amendment ”) is entered into as of March 29, 2012, by and among WELLS FARGO CAPITAL FINANCE, INC. , a California corporation, as administrative agent (the “ Agent ”) for the lenders (the “ Lenders ”) identified on the signature pages to the Credit Agreement (as defined below), and the Lenders, on the one hand, and OCLARO, INC. , a Delaware corporation (“ Parent ”), OCLARO TECHNOLOGY LIMITED , a company incorporated under the laws of England and Wales (“ Borrower ”), on the other hand, with reference to the following facts:

A. Agent, Lenders, Parent and Borrowers have previously entered into that certain Amended and Restated Credit Agreement, dated as of July 26, 2011 (as amended, supplemented, amended and restated, or otherwise modified, the “ Credit Agreement ”).

B. Borrower, Parent, Agent, and Lenders desire to amend the Credit Agreement as provided for and on the conditions herein.

NOW, THEREFORE, Borrower, Parent, Agent and Lenders hereby amend and supplement the Credit Agreement as follows:

1. DEFINITIONS . All initially capitalized terms used in this Amendment shall have the meanings given to them in the Credit Agreement unless specifically defined herein.

2. AMENDMENTS TO THE CREDIT AGREEMENT .

(a) Schedule 1.1 of the Credit Agreement is hereby amended by deleting the definitions of “Triggering Event” therein in its entirety and replacing it with the following:

Triggering Event ” means, as of any date of determination, that (a) an Event of Default has occurred and is continuing, or (b) Liquidity is less than (i) on or prior to September 30, 2012, $20,000,000 or (ii) thereafter, $15,000,000, or (c) Excess Availability is an amount less than (x) on or prior to September 30, 2012, $2,500,000 or (y) thereafter, $7,500,000.

(b) Schedule 1.1 of the Credit Agreement is hereby amended by deleting clause (a) in the definition of “Eligible Accounts” therein in its entirety and replacing it with the following new clause (a):

(a) Accounts that the Account Debtor has failed to pay within 90 days of original invoice date or Accounts with selling terms of more than 60 days (or 90 days with respect to [***].

(c) Schedule 1.1 of the Credit Agreement is hereby amended by deleting clause (i) in the definition of “Eligible Accounts” therein in its entirety and replacing it with the following new clause (i):

(i) Accounts with respect to an Account Debtor whose total obligations owing to Borrower exceed 10% (or (x) 20% with respect to [***] and (y) 15% with respect to [***] (as defined below)) of all Eligible Accounts (such percentage, as applied to a particular Account Debtor, being subject to reduction by Agent in its Permitted Discretion if the creditworthiness of such Account Debtor deteriorates), to the extent of the obligations owing by such Account Debtor in excess of such percentage; provided, however, that, in each case, the amount of Eligible Accounts that are excluded because they exceed the foregoing percentage shall be determined by Agent based on all of the otherwise Eligible Accounts prior to giving effect to any eliminations based upon the foregoing concentration limit,

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.


AMENDMENT NUMBER ONE TO AMENDED AND RESTATED CREDIT AGREEMENT

 

3. REPRESENTATIONS AND WARRANTIES . Parent and Borrower each hereby affirms to Agent and Lenders that, after giving effect to the amendments herein, all of such its representations and warranties set forth in the Credit Agreement are true, complete and accurate in all respects as of the date hereof.

4. NO DEFAULTS . Parent and Borrower each hereby affirm to the Lender Group that no Event of Default has occurred and is continuing as of the date hereof.

5. CONDITION PRECEDENT . The effectiveness of this Amendment is expressly conditioned upon receipt by Agent of a fully executed copy of this Amendment and the Reaffirmation of Guaranty atrtached hereto.

6. COSTS AND EXPENSES . Borrower shall pay to Agent all of Agent’s out-of-pocket costs and reasonable expenses (including, without limitation, the fees and expenses of its counsel, which counsel may include any local counsel deemed necessary, search fees, filing and recording fees, documentation fees, appraisal fees, travel expenses, and other fees) arising in connection with the preparation, execution, and delivery of this Amendment and all related documents.

7. LIMITED EFFECT . In the event of a conflict between the terms and provisions of this Amendment and the terms and provisions of the Credit Agreement, the terms and provisions of this Amendment shall govern. In all other respects, the Credit Agreement, as amended and supplemented hereby, shall remain in full force and effect.

8. COUNTERPARTS; EFFECTIVENESS . This Amendment may be executed in any number of counterparts and by different parties on separate counterparts, each of which when so executed and delivered shall be deemed to be an original. All such counterparts, taken together, shall constitute but one and the same Amendment. This Amendment shall become effective upon the execution of a counterpart of this Amendment by each of the parties hereto.

[Signatures on next page]

 

Page 2

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.


IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first set forth above.

 

WELLS FARGO CAPITAL FINANCE, INC.,

a California corporation, as Agent and a Lender

By:

 

 

Title:

 

 

 

S-1

Amendment Number One to Amended and Restated Credit Agreement

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.


OCLARO, INC.,
a Delaware corporation, as Parent
By:  

 

Name:   Jerry Turin
Title:   CFO

OCLARO TECHNOLOGY LIMITED,

a limited liability company incorporated under the laws of England and Wales, as Borrower

By:  

 

Name:   Jerry Turin
Title:   Director
By:  

 

Name:   Catherine H. Rundle
Title:   Director

 

S-2

Amendment Number One to Amended and Restated Credit Agreement

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.


REAFFIRMATION OF GUARANTY

Each of the undersigned has executed a General Continuing Guaranty (Domestic) or General Continuing Guaranty (Foreign) (each, a “ Guaranty ”), in favor of Wells Fargo Capital Finance, Inc., a California corporation, (“ WFCF ”), as agent (in such capacity, the “ Agent ”) for the lenders (the “ Lenders ”) from time to time party to Credit Agreement (as defined above) respecting the obligations of Oclaro Technology Limited, a limited liability company organized under the laws of England and Wales (the “ Borrower ”) and Oclaro, Inc., a Delaware corporation (the “ Parent ”), owing to the Lenders. Each of the undersigned acknowledges the terms of the above Amendment and reaffirms and agrees that: (i) its Guaranty remains in full force and effect; (ii) nothing in such Guaranty obligates Agent or any Lender to notify any of the undersigned of any changes in the financial accommodations made available to the Borrower or to seek reaffirmations of any of the Guaranties; and (iii) no requirement to so notify any of the undersigned or to seek reaffirmations in the future shall be implied by the execution of this reaffirmation.

 

OCLARO INNOVATIONS, LLP

a limited liability partnership organized under the laws of England and Wales
Oclaro, Inc.
By:  

 

Name:   Jerry Turin
Title:   CFO
Oclaro (North America), Inc.
By:  

 

Name:   Jerry Turin
Title:   CEO

BOOKHAM NOMINEES LIMITED,

a company incorporated under the laws of England and Wales

By:  

 

Name:   Jerry Turin
Title:   Director
By:  

 

Name:   Catherine H. Rundle
Title:   Secretary

BOOKHAM INTERNATIONAL LTD.,

a company organized under the laws of the Cayman Islands

By:  

 

Name:   Jerry Turin
Title:   Director
OCLARO CANADA, INC.,
a federally incorporated Canadian corporation
By:  

 

Name:   Jerry Turin
Title:   President & Treasurer

 

S-1

Reaffirmation of Guaranty - Amendment Number One to Amended and Restated Credit Agreement

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.


OCLARO, INC.,
a Delaware corporation
By:  

 

Name:   Jerry Turin
Title:   CFO

OCLARO TECHNOLOGY, INC.,

a Delaware corporation

By:  

 

Name:   Jerry Turin
Title:   Treasurer

OCLARO (NEW JERSEY), INC.,

a Delaware corporation

By:  

 

Name:   Jerry Turin
Title:   President & CFO

OCLARO PHOTONICS, INC.,

a Delaware corporation

By:  

 

Name:   Jerry Turin
Title:   President

MINTERA CORPORATION,

a Delaware corporation

By:  

 

Name:   Jerry Turin
Title:   President & CFO

OCLARO (NORTH AMERICA), INC.,

a Delaware corporation

By:  

 

Name:   Jerry Turin
Title:   CEO

 

S-2

Reaffirmation of Guaranty - Amendment Number One to Amended and Restated Credit Agreement

 

Confidential treatment is being requested for portions of this document. This copy of the document filed as an exhibit omits the confidential information subject to the confidentiality request. Omissions are designated by the symbol [***]. A complete version of this document has been filed separately with the Securities and Exchange Commission.

Exhibit 31.1

SECTION 302(a) CERTIFICATION

I, Alain Couder, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oclaro, Inc. for the period ended March 31, 2012;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2012     By:  

/s/ Alain Couder

      Alain Couder
     

Chairman of the Board

and Chief Executive Officer

      (Principal Executive Officer)

Exhibit 31.2

SECTION 302(a) CERTIFICATION

I, Jerry Turin, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oclaro, Inc. for the period ended March 31, 2012;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 10, 2012     By:  

/s/ Jerry Turin

      Jerry Turin
      Chief Financial Officer
      (Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Oclaro, Inc. (the “Company”) for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Alain Couder, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 10, 2012     By:  

/s/ Alain Couder

      Alain Couder
     

Chairman of the Board

and Chief Executive Officer

      (Principal Executive Officer)

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Oclaro, Inc. (the “Company”) for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Jerry Turin, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: May 10, 2012     By:  

/s/ Jerry Turin

      Jerry Turin
      Chief Financial Officer
      (Principal Financial and Accounting Officer)